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ABSTRACT 
Soybeans are a major source of high quality protein, edible oil, food products, and also 
several industrial non food applications such as paper coating, textiles and plastics. It is 
difficult to develop soybeans with high protein and high oil, however, due to the inverse 
relationship between these two components. Consequently, increasing seed protein 
concentration without adversely affecting the yield and oil content has been difficult to 
achieve. It has been demonstrated that the temperature and genotype of soybeans influence 
the protein or lipid composition considerably. However, the interactions between various 
pathways responsible for the changes in the composition are unknown.  
Metabolic flux analysis (MFA) quantifies carbon flow in a biological system, which is 
an important characteristic reflective of the system physiology. The application of MFA to 
study complex plant metabolic networks has however been recent. Towards this goal, MFA 
using carbon labeling (13C) experiments, nuclear magnetic resonance spectroscopy (NMR) 
combined with a generic mathematical framework (NMR2Flux) has been developed in our 
group. Metabolic flux maps, developed from 13C MFA are effective tools for comparing 
pathway interactions between genetic or environmental variants of biological systems and 
identifying possible targets for genetic manipulations. 
13C MFA has been performed to understand response of central carbon metabolism of 
developing soybeans to two parameters: temperature and genotype. Experimental treatments 
were designed to distinguish between temperature effects prior to and during incubation in 
vitro of Evans genotype. Biomass accumulation increased with temperature as did carbon 
partitioning into lipid. The flux through the plastidic oxidative pentose phosphate pathway 
(pglP) relative to total sucrose intake remained fairly constant (~56 % (±24%)) when 
cotyledons were transferred from an optimum growth temperature in planta to optimum, 
lower and higher temperatures in in vitro culture. The pglP flux ranged from 57 to 77% of 
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total sucrose intake, however, when growth temperature in planta varied and were cultured in 
vitro at the same temperature (as the plant). These results indicate that temperature during 
early stages of cotyledon development has a dominant effect on establishing capacity for flux 
through certain components of primary metabolism. The flux of carbon through the 
anaplerotic reactions catalyzed by the plastidic malic enzyme (mep), cytosolic pep 
carboxylase (ppc) and the malate transporters (malT1 and malT2) between cytosol, 
mitochondrion and plastid varied considerably with temperature. The redirection of carbon 
between these cellular compartments had a direct influence on the carbon partitioning into 
protein and oil from the plastidic pyruvate pool.  
BC3-128 genotype, a back crossed lined created from High PI and Evans, produced 
more protein than Evans and less than High PI. 13C MFA was performed on soybeans of the 
above three genotypes cultured at two stages of development, 21 DAF (Set 2 TP1) and 
around 32-35 DAF (Set 2 TP2). For 21 DAF, there was an additional replicate (Set 3 TP1). 
Comparison of metabolic fluxes between High PI and BC3-128 Set 2 TP1 showed that the 
flux ratio of oxPPPtotal relative to glycolysistotal on a C mol basis was statistically similar 
(~2.2). The oxPPPtotal relative to glycolysistotal ratio in Evans was lower (~1.6) indicating 
lower carbon flux through the oxPPP. The oxPPP node being an important source of 
reductant NADPH, the above result could be a direct influence of the higher plastidic 
NADPH requirement for biosynthetic and glutamine assimilation reactions in High PI and 
BC3-128 due to higher protein production compared to Evans.  
Comparison of Set 2 and Set 3 (TP1) showed variations in metabolic fluxes and flux 
ratios within the genotype for High PI, BC3-128 and Evans. However, there were 
temperature fluctuations in the growth chamber where Set 3 plants were grown and could 
have directly influenced the changes. The variation between fluxes between the replicates 
could be attributed by a combination of factors such as temperature fluctuations in the Set 3 
growth chamber, biomass accumulation and composition or a difference in the NMR 
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intensities which directly reflect the intracellular fluxes. For Set 2 TP2, the pglp flux and ratio 
of the pglP relative to sucrose intake on a C mol basis was statistically similar between all 
three genotypes. The anaplerotic reactions such as meP, cytosolic ppc and malate transporters 
(malT1 and malT2) between cytosol, plastid and mitochondrion were flexible between 
genotypes as observed in the temperature study for Set 2 and Set 3. In particular, higher meP 
flux was observed when protein content was higher. The large variation in meP in the 
temperature study and higher flux through meP during increased protein production observed 
in the genotype study suggest that meP could be a possible target for genetic manipulation.  
Despite differences observed between replicates, certain metabolic trends remained 
consistent between the genotype study as well as the temperature study. The transketolase 
and transaldolase of the oxidative pentose phosphate pathway (oxPPP) fluxes were higher in 
the plastid than the cytosol and agreed with the emerging model of oxPPP in plant systems. 
The hexose isomerase flux was in the direction of F6P to G6P thereby feeding the oxPPP. 
There was substantial GABA shunt driving the glutamine assimilation into the system. The 
net pyruvate kinase flux in the cytosol and plastid was much higher than the meP feeding the 
plastidic Pyr pool. Thus, 13C MFA has been demonstrated to be an effective tool in 
understanding pathway interactions and identifying important reactions influencing protein 
and oil content in developing soybeans. A collaborative study to analyze gene expression 
data for Set 2 TP1 is under progress. The integration of the flux and transcript data for Set 2 
TP1 is proposed to better understand the underlying physiology of developing soybeans.  
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1. INTRODUCTION 
Genetic engineering marked the advent of modifying specific enzymatic reactions using 
recombinant DNA technology. Early genetic engineering manipulations showed that a single 
gene transformation can result in unexpected changes in the metabolic pathways and 
phenotypic behaviour. This emphasized the need for a systems-level understanding of the 
physiology. Consequently, the field of metabolic engineering emerged, which encouraged a 
systematic approach towards genetic manipulation of metabolic pathways to produce 
valuable chemicals or proteins (Stephanopoulos et al., 1998). A metabolic network was 
considered in its entirety as opposed to a single reaction thus leading towards a better 
understanding of the underlying physiology as well.  
The importance of metabolic fluxes as a fundamental determinant of cell physiology was 
promoted by metabolic engineering (Stephanopoulos, 1999). Metabolic flux is defined as the 
net rate of conversion of a precursor metabolite to a product in a metabolic pathway. The 
quantification of intracellular metabolite fluxes in a network of metabolic pathways is termed 
as metabolic flux analysis. Though metabolic flux analysis has been used in microbial 
systems extensively, its application in mammalian cells and plant systems has been recent.  
Metabolic flux analysis (MFA) 
The most basic approach of flux analysis, stoichiometric MFA, requires information 
about the reaction stoichiometry and extracellular measurements such as substrate intake, 
effluxes and biomass synthesis (Varma and Palsson, 1994; Stephanopoulos et al., 1998). 
Assuming pseudo-steady state conditions, balances around each intracellular metabolite are 
written and the equations are solved for the intracellular fluxes. However, with an increase in 
the complexity of the metabolic network under consideration, the number of extracellular 
measurements required also increases. Further, stoichiometric MFA fails in case of parallel 
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pathways, bidirectional reaction steps and metabolic cycles (Wiechert, 2001). The use of 
labeling (13C) came to be an attractive alternative to overcome the aforementioned limitations 
and provide additional constraints to solve for the intracellular fluxes. 
13C MFA involves feeding a biological system with a combination of labeled (13C) and 
unlabeled substrates. The selection of the type of labeled substrate- uniformly labeled at all 
carbon atom positions versus selectively labeled at particular carbon atoms is a critical 
parameter in 13C MFA (Szyperski, 1998). The use of uniformly labeled substrates has been 
acknowledged as a separate class of labeling experiments called the ‘biosynthetically 
directed fractional labeling’ experiments. Further, these experiments emphasized the use of 
proteinogenic amino acids to elucidate metabolism (Szyperski, 1995). The work in this thesis 
employs uniformly labeled substrates for 13C MFA.  
Figure 1.1 elucidates the information obtained from a biosynthetically directed fractional 
labeling experiment using a mixture of uniformly labeled and unlabeled six carbon substrate 
in a hypothetical pathway in a biological system. As seen in Figure 1.1, the label gets 
distributed among various metabolites in the pathway and also gets assimilated into biomass 
(indicated by AA in Figure 1.1) depending on the carbon skeleton rearrangement, network 
topology and the intracellular fluxes. At the end of the experiment, the biomass is 
fractionated into its major components such as protein, lipids and starch. To determine the 
intracellular fluxes, it is important to deduce the branchpoint ratios in various nodes in the 
system. The branchpoint ratio for example of metabolite A entering pathway (1) versus 
pathway (2) (Figure 1.1) can in turn be determined from the varying labeling pattern of the 
amino acid generated from metabolite H. These varying carbon labeling patterns (as 
demonstrated in Figure 1.1) are known as “isotopomers”, arising from a combination of the 
terms ‘isotope’ and ‘isomers’.  
Two techniques to detect the isotopomer abundances of the proteinogenic amino acids 
and starch are Nuclear Magnetic Resonance (NMR) spectroscopy and Mass Spectroscopy  
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Figure 1.1: Illustration of breakdown of labeled six carbon substrate into various reactions 
in a hypothetical pathway. The carbon skeleton rearrangement has been assumed as 
follows. The carbons do not undergo any rearrangement when they are being converted 
from A→B, B→C, C→H, H→AA (AA represents an amino acid produced from H). 1st 
carbon atom of A is evolved (as X) and the remaining five carbon atoms convert to D 
without any rearrangement. The first two carbon atoms of one molecule of D combine with 
another molecule of D to generate E; the remaining 3 atoms of first molecule of D are 
converted to F. E and F combine together as follows. The last four atoms of E convert to G 
without rearrangement; the first three atoms of E combine with the three atoms of F to 
generate the six carbon molecule B again.  
  
4 
 
(MS) (Szyperski, 1998; Schwender et al., 2003; Sriram et al., 2004). The two dimensional 
heteronuclear single quantum correlation spectroscopy (HSQC) NMR experiment detects the 
labeling pattern of adjacent carbon atoms in a metabolite (Szyperski, 1998). Contrastingly, in 
MS, the mass isotopomer fractions are detected which indirectly constraints the expected 
labeling pattern (Christensen and Nielsen, 1999).  The conversion of labeling data to flux 
data is non-linear and can be performed using analytical (Szyperski, 1995) or iterative 
techniques (Wiechert et al., 2001).  
The result of MFA is a metabolic flux map (Figure 1.2) which indicates the steady state 
fluxes through various reactions of the metabolic pathway. Such metabolic flux maps can be 
effectively used for comparing flux differences in genetic or environmental variants 
(Ratcliffe and Shachar-Hill, 2006). The comparisons between genetic or environmental 
variants can be carried out in terms of fluxes or flux ratios. The flux ratio can be used to 
analyse key nodes in the metabolic network, where there is a partitioning of the carbon into 
multiple branches. If the ratio of the carbon partitioning into multiple reactions at a node 
remains constant, irrespective of changes in the total incoming flux, then the node is said to 
be rigid (Figure 1.3). The node is flexible if the ratio of the carbon flow in the multiple 
branches changes with a change in the incoming flux (Figure 1.3). Hence, genetic 
manipulation of the reactions involved in a flexible node is likely to be more productive in 
channeling the precursor metabolite in the preferred direction (Stephanopoulos and Vallino, 
1991). Conversely, for rigid nodes, it is more difficult to break the intrinsic regulation of the 
node and hence would most likely require multiple genetic manipulations of the enzymes 
involved. Subsequently, once the effect of a genetic or environmental manipulation is 
analysed, further modifications can be suggested and tested to achieve the desired results 
(Nielsen, 1998). Thus the characterization of the cellular physiology can be achieved in an 
iterative manner (Nielsen, 1998).  
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Figure 1.2: Metabolic flux map for central carbon metabolism in developing soybean embryos 
using a single compartment model (Iyer, 2003).  
Figure 1.3: Analysis of the rigidity of a ‘node’ or a branchpoint.  
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Another important component of MFA is the statistical analysis of the calculated fluxes 
in order to perform an identifiability study of the metabolic network (Wiechert et al., 2001). 
This is necessitated by NMR measurement errors in the case of certain fluxes, which can 
translate to large standard deviations in the estimation of the flux and identifiability 
problems. In a metabolic network, the information about different parts of the pathway is 
obtained from measurements pertaining to that particular part of the pathway. For example, 
flux analysis of the transketolase and transaldolase reactions in the pentose phosphate 
pathway depend primarily on the labeling information obtained from the PEP family of the 
amino acids (example, Tyr). If the external measurements or the NMR data are not sufficient 
to estimate the fluxes or if the error in the measurements is large, then the fluxes become 
structurally unidentifiable. In a number of cases, this problem can be resolved by increasing 
the number of measurements or by providing the system with low noise level measurements. 
In some cases, however, the relationship between the NMR measurements and the fluxes 
are highly non-linear. In such cases, the fluxes become statistically unidentifiable and even a 
very low noise level in the NMR data can translate into large standard deviations of the 
corresponding fluxes. Thus, in the case of a statistically unidentifiable flux, the model cannot 
estimate the flux irrespective of redundant measurements pertaining to that flux (Wiechert et 
al., 2001). A statistical analysis of the NMR error translating into the fluxes can be carried 
out using Monte Carlo simulations in an error minimization subroutine (Sriram et al., 2004).  
The hypothetical pathways in Figures 1.1 and 1.2 are rather simplified as compared to 
reality. Plant metabolic networks are classical examples of complex pathways existing in 
nature. One of the major factors contributing to the complexity of plant networks is 
compartmentation. In plants, the same reaction pathway may occur in more than one 
compartment (for example, oxidative pentose phosphate pathway in cytosol and plastid 
(Kruger and von Schaewen, 2003)). Transporters facilitate the exchange of metabolites 
between compartments thus making intracellular transport processes important. Hence, the 
  
7 
 
quantification of fluxes in parallel compartments becomes vital (Shanks, 2005). Additionally, 
higher plants are separated on various levels such as the tissue (roots, stems, leaves) as well 
as cellular levels within a tissue. Furthermore, the topology of plant networks is often 
incomplete. 
13C MFA in plant systems 
Due to the aforementioned complexity of plant metabolic networks, application of 13C 
MFA in plants has been rather limited as compared to microbes. The few prior ‘flux’ labeling 
studies in plants have focused on either the identification of metabolic network topology 
(Krook et al., 1998; Glawischnig et al., 2002; Schwender et al., 2004) or flux quantification 
using analytical or a highly-simplified 13C NMR constrained analysis (Dieuaide-Noubhani et 
al., 1995; Rontein et al., 2002; Schwender et al., 2003). Nevertheless, plant systems biology 
has re-emphasized the importance of fluxes (Girke et al., 2003; Stitt and Fernie, 2003; 
Sweetlove et al., 2003) in achieving the in silico plant (Minorsky, 2003). Thus, it has become 
essential to promote the application of MFA to different plant systems. Towards this goal, a 
comprehensive flux analysis tool, NMR2Flux, was developed using recent mathematical 
advances from our research group (Sriram et al., 2004). NMR2Flux was used effectively to 
detect compartmentation of the pentose phosphate pathway in developing soybean 
cotyledons. NMR2Flux being a generic tool can be extended to other biological systems for 
example to study the carbon partitioning into protein, starch and oil kernels in corn kernels. 
The application of the tool NMR2Flux in elucidating carbon partitioning in an agronomically 
important plant system, namely soybeans forms the crux of this study.  
Soybean as an agronomically valuable plant system 
Soybean is a native crop of China and arrived in America in the early 1800’s. In 2003, 
the Unites States produced 34 % of the world’s total soybean production (ASA, 2005). 
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Soybeans are excellent sources of protein for animal feed. Soy protein also has applications 
in human food products such as tofu, soy milk and soy flour as well as industrial non-food 
applications such as textiles and plastics (Lusas, 2004). Soybeans are also important sources 
of isoflavones in human diet which are known to reduce cancer risk, heart disease risk, ease 
menopause symptoms and improve bone health (Stacey et al., 2004). Soybean oil is used in 
cooking, in making margarine and in industrial applications particularly biodiesel and 
lubricants (Lusas, 2004). Thus, the biomass composition of the soybean (especially protein 
and oil content) is a fundamental parameter in setting its market price.  
The biomass composition or what is defined as the “quality” of the soybean seed is 
dependent on factors such as genotype and environmental conditions such as growth 
temperature. Further, it has been observed that there is an inverse relationship between the 
protein and oil content (Wilson, 2004). Hence, any external influence which causes an 
increase in the protein production (% of biomass dry weight) often results in a decrease in the 
oil content (% of biomass dry weight). Additional correlations of these traits include the 
positive relationship between the oil content and the yield (bushels/acre) and the inverse 
relationship between the protein content and the yield (Wilson, 2004). The inverse 
relationship between protein and yield seriously limits the production of soybeans which are 
of high economic impact.  
Several research efforts have been made to address the problem of producing high 
quality (protein and oil) soybeans without compromising on the yield. Recently, a NSF-
sponsored workshop was held towards advancing soybean genomics research (Stacey et al., 
2004). Soybase (http://soybase.agron.iastate.edu/), an online database provides latest 
information on genetics, metabolism and pathology of soybeans. With the production of the 
recent Affymetrix chip for soybeans, the application of microarray (mRNA) data for 
comparing soybean variants is now a potential technique to study soybean metabolism.  
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The use of microarray data to study metabolism in plant systems is gaining popularity 
(Ruuska et al., 2002; Buckhout and Thimm, 2003). Metabolite profiling (Roessner et al., 
2001; Fiehn, 2002) and proteomics (Barbier-Brygoo and Joyard, 2004; Whitelegge, 2004) are 
other promising techniques to gain insight into plant metabolism. Further, the importance of 
integration of multiple techniques to acquire a systems-level understanding of physiology has 
been realised (Sanford et al., 2002; Hegde et al., 2003; Urbanczyk-Wochniak et al., 2003). 
13C MFA however, is a promising but unexploited tool in understanding regulation of carbon 
flow in plant systems.  
Our study employs NMR2Flux towards understanding central carbon metabolism in 
developing soybean embryos. Nodal analysis using metabolic flux maps can be effective in 
comparing genetic or environmental variants. This in turn would probably highlight the 
potential enzymes that can be targeted to channel carbon in the desired direction in soybeans. 
Towards this goal, comparison of environmental variants has been successfully performed. 
Using the methodology employed for the comparison of environmental variants, we have 
extended the work to also study genetic soybean variants. In the case of the genotype study, 
integration of two techniques MFA and transcriptomics is also suggested.  
Organization of thesis 
This chapter introduced the theoretical background and methodology of metabolic flux 
analysis and its importance in understanding preferred regulation of carbon flow in plant 
systems, particularly soybeans.  
Chapter 2 presents the literature review of metabolic flux analysis in biological systems, 
the state of the art of MFA in plants and the need for understanding carbon regulation in 
soybeans.  
Chapter 3 describes the metabolic network constructed for the central carbon metabolism 
in soybeans. The application of the flux analysis tool NMR2Flux (Sriram et al., 2004) to 
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study the effect of temperature on soybeans and subsequent analysis of the fluxes is 
explained. This chapter is a manuscript in preparation for The Plant Journal. 
Chapter 4 discusses the results of MFA of three soybean genotypes with varying levels 
of protein in an effort to identify the reactions responsible for an increased protein 
production. The flux data will be integrated with transcript data in collaboration with Dr. Eve 
Wurtele (Genetics, Development and Cell Biology at Iowa State University) and Dr. Julie 
Dickerson (Dept. of Electrical and Computer Engineering at Iowa State University). 
Chapter 5 summarizes the conclusions of the work performed in this thesis and presents 
ideas for future work. 
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2. LITERATURE REVIEW 
2.1 Soybeans 
Soybeans are used as a major source of edible vegetable oil and high quality protein. Soy 
proteins have a huge market as raw material for animal feed, other food products and 
industrial non food applications such as paper coating, textiles and plastics (Myers, 1993). 
Soybean oils can be used in food products as biodegradable lubricants in industry (Kinney, 
1998). Hence, soybeans with high protein and high oil content are highly desired. However, 
it is difficult to develop soybeans with high protein and high oil due to the inverse 
relationship between the two (Nakasathien et al., 2000). Consequently, increasing seed 
protein concentration without adversely affecting the yield and oil content becomes difficult 
(Cober and Voldeng, 2000). Further, the biomass composition of soybean is affected by the 
growth stage and genetic or environmental variations.  
The reproductive growth stage R5, R6 and R7 characterize beginning seed, full seed and 
beginning maturity, respectively. Dornbos et al. (1986) showed that the majority of the dry 
weight, protein, oil and total sugar accumulated between R5 and R7 respectively. The 
moisture content was found to decrease between R5 and R7 steadily (Dornbos and Mc 
Donald, 1986). Studies on the effect of day and night growth temperatures on the seed 
composition indicated that during the seed-fill and maturation period, protein concentration 
increased whereas oil decreased with increasing temperature (Gibson and Mullen, 1996). 
Another study with different soybean cultivars indicated that the oil concentration increased 
with increasing temperature (Piper and Boote, 1999). The oil concentration was found to be 
highest at a mean daily temperature of 28 oC. In environmental studies in Argentina, 
soybeans were grown under different conditions of latitude, longitude, altitude and 
temperature (Maestri et al., 1998). It was found that there was no important correlation 
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between the genotypes and environmental conditions. It was concluded that the selection of a 
genotype from their time of maturity was a more important factor.  
Additionally, studies have been carried out to understand the effect of varying carbon 
and nitrogen concentrations on growth of soybean embryos in vitro (Saravitz and Raper, 
1995). A decreased glutamine concentration affected both the protein and oil content whereas 
an increase in the glutamine concentration increased the protein content but not the oil 
content. An increase in sucrose concentration increased the dry weight and protein content as 
well but the protein content was lower at the maximum sucrose concentration of 150 mM 
because of enhanced dry weight (Saravitz and Raper, 1995). In another parallel study, it was 
observed that a minimal concentration of 17 mM of glutamine was sufficient for dry weight 
accumulation without the need for nitrogen accumulation (Hayati et al., 1996). From 
literature (Obendorf et al., 1983; Hayati et al., 1996), the concentrations of sucrose (146 mM) 
and glutamine (37 mM) were determined for the in vitro culture system of soybean in our 
study. Thus, genotypes, growth stage and environmental conditions are important factors 
influencing the final seed composition. However, the mechanism behind the carbon 
partitioning into various pathways remains unclear.  
We propose to use metabolic flux analysis (Stephanopoulos, 1999) as an analytical tool 
to study the interactions of the various pathways of central carbon metabolism in developing 
soybean cotyledons. The details of the methodology employed for quantification of fluxes 
and state of the art in quantification of metabolic fluxes in plant systems will be discussed in 
the following sections of this chapter.  
2.2 Metabolic flux analysis 
Metabolic flux analysis (MFA) involves the quantification of intracellular steady state 
fluxes in a cell, using metabolite balances and extracellular measurements. Metabolic flux 
maps generated from MFA quantify carbon flow through the reaction network (Ratcliffe and 
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Shachar-Hill, 2006), and thus are reflective of the cell physiology (Stephanopoulos et al., 
1998). MFA is significantly effective in comparing genetic or environmental variants as well 
as suggesting possible targets for genetic modification (Szyperski, 1995; Nielsen, 1998; 
Rijhwani et al., 1999).  
Stoichiometric MFA is the most basic approach of metabolic flux analysis and requires a 
thorough understanding of the reaction stoichiometry. Consequently, corresponding balances 
around each intracellular metabolite are written to generate a system of linear equations 
(Varma and Palsson, 1994; Stephanopoulos et al., 1998). If the model has J reactions and K 
internal metabolites, the number of degrees of freedom F, is given by F = J-K. If the number 
of supplied measurements is same as F, it is an exactly determined system; if greater than F, 
an overdetermined system; and if less than F, an underdetermined system. Exactly 
determined and overdetermined systems will have a unique solution for the distribution of 
fluxes through the metabolic network. In addition, for an overdetermined system, the 
additional measurements can be used to check the validity of the metabolic network. On the 
other hand, to solve an underdetermined system, cofactor balances (NADPH/ NADH) may 
need to be supplemented as additional constraints (Schmidt et al., 1998; Stephanopoulos et 
al., 1998). However, the NADPH, NADH and ATP balances are not closed in reality due to 
futile cycles and incomplete pathway knowledge. Stoichiometric MFA also fails in cases of 
parallel pathways and metabolic cycles (Wiechert, 2001). It is hence essential to provide 
further information and also elucidate flux distribution at branch points. For larger systems, 
the number of reactions increases and flux analysis becomes furthermore difficult as the 
number of measurements required correspondingly increases. Consequently, 13C labeling 
experiments can be used to complement stoichiometric balancing and extracellular 
measurements, thereby providing a rigorous alternative to traditional flux analysis.  
Carbon labeling experiments (CLE) involve feeding a combination of 13C/ 14C labeled 
substrates along with 12C substrates such as glucose or sucrose to the biological system of 
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interest. The selection of the type of labeled substrate i.e., selective or uniformly labeled is a 
fundamental component of experimental design (Schmidt et al., 1999). In addition, it is 
essential that the relative extents of the labeled and unlabeled substrate be decided a priori to 
get adequate information from the labeling data (Szyperski, 1995; Stephanopoulos et al., 
1998). In the case of selectively labeled substrates, a large percentage of labeling has to be 
used to obtain meaningful data (Park et al., 1999). On the other hand, when a mixture of 
uniformly labeled and unlabeled substrates is used, carbon bond-bond connectivities are 
traced as opposed to fractional enrichments. Hence, percentages of uniformly labeled 
substrate required are much lower (approximately 10%) for adequate labeling data 
(Szyperski, 1995). Once the type of labeled substrate and their extents are decided, the cells 
are cultured with the mixture of labeled and unlabeled substrate. The experiment is carried 
out at metabolic (the rates of change of intracellular metabolite concentrations are small as 
compared to intracellular fluxes) and isotopic (labeling patterns of the metabolites do not 
change with time) steady states. Finally, the biomass from the plant tissue is extracted and 
broken down into its corresponding components. Depending on the network topology and the 
intracellular fluxes, different labeling patterns of the metabolites will be reflected from the 
biomass components (for e.g. protein or starch sample), which can be detected using nuclear 
magnetic resonance (NMR) spectroscopy or gas chromatography-mass spectroscopy (GC-
MS) (Szyperski, 1995; Christensen and Nielsen, 1999; Klapa et al., 1999). The labeling data 
can be translated into flux information, using the concept of isotopomers (Schmidt et al., 
1997; Klapa et al., 1999).  
The terminology ‘isotopomers’ arises from a combination of the terms “isotope” and 
“isomers”, which represent various labeling patterns of a given metabolite. For example as 
shown in Figure 2.1, for a 3 carbon metabolite there are 23 = 8 isotopomers possible. Hence, 
for a metabolite with n carbons, there are 2n labeling patterns possible. Recently, the new 
concept of bondomers was introduced which can be used in case of single substrate 
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experiments only. Bondomers are similar to isotopomers except that the bonds instead of the 
carbon atoms are being followed (Sriram and Shanks, 2002; van Winden et al., 2002). 
Bondomers are molecules of the same metabolite, which have different bond integrities for 
different carbon-carbon bonds (Sriram and Shanks, 2004). The bond integrity of a covalent 
bond indicates whether the two carbon atoms under consideration arise from the same 
substrate or not. If they arise from the same substrate the bond integrity is 1, otherwise it is 0. 
The bondomer possibilities for a three carbon metabolite are indicated in Figure 2.2. For an n 
carbon molecule there are 2n-1 bondomers as opposed to 2n isotopomers. The use of 
bondomers thus reduces the computational time for flux analysis (van Winden et al., 2002).  
NMR is a non-intrusive technique, which can be used to detect the labeling patterns of 
the metabolites. In an NMR experiment, the spin of the 13C nucleus is detected. The variation 
in the frequency of resonance is called the chemical shift and is characteristic for each 
nucleus. A 1-dimensional (1D) proton spectrum gives the enrichments of all the protonated 
carbon present in the sample (Marx et al., 1996). The information in a 1D spectrum is in the 
form of a number of peaks, which may overlap and make the analysis difficult. However, 2-
dimensional (2D) NMR is more convenient as the peak is dispersed in 2 dimensions and 
there is less ambiguity in the assignment of the carbon atoms. The 2D correlation 
spectroscopy (COSY) experiment detects the interaction of protons directly attached to 
carbons. Since the detection is restricted to large one bond scalar coupling, only adjacent 
carbon atoms are detected and information about the origin of the carbon atoms of a 
metabolite is obtained. A 2D HSQC (Heteronuclear Single Quantum Correlation 
spectroscopy) experiment, which is a variation of the COSY experiment can also be carried 
out to detect the 13C-13C scalar couplings (Szyperski, 1998). In the HSQC experiment the 
magnetization is transferred from the proton to the carbon and then back to the proton. The 
indirect detection of carbon using highly abundant protons makes the HSQC experiment 
more sensitive (Szyperski, 1998). The multiplet patterns of carbon atoms obtained from the  
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Figure 2.1: Isotopomer possibilities for a three carbon metabolite. Black 
and unfilled circles indicate 13C and 12C atoms respectively. 
Figure 2.2: Bondomer possibilities for a three carbon metabolite. Black 
and grey lines indicate intact and biosynthetic bonds respectively. 
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HSQC spectrum is proportional to the isotopomer abundances (Figure 2.3).  
We have used 2D HSQC experiment to detect the labeling pattern between adjacent 
carbon atoms and 2D Total Correlation Spectroscopy (TOCSY) experiment to detect the 
enrichment of the carbon atoms of the amino acids. The labeling data is converted to fluxes 
by comparing the experimental data with simulated isotopomer abundances generated using 
isotopomer mapping matrices (IMM) (Schmidt et al., 1997). Assuming a set of intracellular 
fluxes, IMM uses the concept of isotopomer distribution vectors (IDV) and reaction 
stoichiometry to generate the simulated isotopomer abundances (Schmidt et al., 1997). The 
‘best’ set of intracellular fluxes satisfies the reaction stoichiometry and also shows the least 
mean square error between experimental and simulated isotopomer abundances.  
Isotopomer distributions were simulated for the first time and metabolic fluxes were 
quantified in an iterative manner in Escherichia coli using a simplified network topology and 
MATLAB as a platform (Schmidt et al., 1999). Simultaneously, a mathematical model was 
developed, which included only the physically realizable isotopomers and was solved in a 
non-iterative manner for systems of Escherichia coli, Pseudomonas AM1 and mammals 
using analytical solutions (Klapa et al., 1999; Park et al., 1999). The concept of cumomers 
(cumulative isotopomers) was later introduced to analytically solve isotopomer balances, 
which further decreased the computational time (Wiechert et al., 1999a). 13C-FLUX, a 
universal software framework was soon developed using the concept of cumomers for 
metabolic flux analysis (Wiechert et al., 2001).  The working of the framework was 
exemplified on a Cornyebacterium glutamicum system for the determination of the 
anaplerotic fluxes (Wiechert et al., 2001).  
The articles mentioned above were mainly on biological systems such as bacteria and 
yeast. The application of MFA in plants though has been recent, is steadily gaining emphasis 
(Ratcliffe and Shachar-Hill, 2006). 
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Figure 2.3: Relationship between isotopomers and multiplet pattern obtained from 
NMR. Only 4 out of the 8 isotopomers possible for a three carbon metabolite (Figure 
2.1) are shown here as NMR observes 13C atom only.  
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2.3 13C MFA in plant systems 
Plant metabolism is notably complex with compartmentation issues, branch points, futile 
cycling and anaplerotic reactions. Hence, mathematical models of plant systems are highly 
non-linear and their analysis complicated and computationally expensive. The mathematical 
complexity is the major challenge responsible for limiting the application of MFA in plant 
systems. In addition NMR, though an established technique has not been used to study plant 
metabolism to a large extent (Ratcliffe and Shachar-Hill, 2001). NMR as explained earlier is 
useful in detection of network topology and intracellular fluxes using a mathematical 
framework. The use of carbon labeling experiments however, have gradually been found 
suitable for the quantification of fluxes in complex eukaryotic systems like plants (Roscher et 
al., 2000).  
A retrobiosynthetic approach was employed to asses the labeling patterns of intracellular 
metabolites in Rubia tinctorum using a combination of 1D and 2D NMR experiments to give 
qualitative information about active pathways in biosynthesis of anthraquiniones (Eichiger et 
al., 1999). Similar qualitative studies for assessment of labeling patterns were carried out to 
gain insight into metabolism of amino acid and starch biosynthesis in developing maize 
kernels (Glawischnig et al., 2001, 2002). An in situ NMR spectroscopy experiment has also 
been carried out on Catharanthus roseus to study glycolysis and pentose phosphate pathway 
activities in primary metabolism (Rijhwani et al., 1999).  
One of the early applications of quantitative flux analysis using labeling studies was 
carried out in maize root tips. Enrichment data from 1D 13C and 1H experiments contributed 
towards quantifying fluxes in maize root tips using an analytical approach (Dieuaide-
Noubhani et al., 1995). 13C enrichment data has also been used for probing central carbon 
metabolism in tomato cell suspensions using a simplified metabolic network (Rontein et al., 
2002). For example, reversibilities of the pentose phosphate pathway were not considered in 
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the aforementioned study. The use of 13C isotopomer data in quantitative flux analysis of 
glycolysis and oxidative pentose phosphate pathway (oxPPP) in Brassica napus embryos was 
carried out recently (Schwender et al., 2003). The use of flux analysis in identification of 
network topology was more recently demonstrated in Brassica napus embryos (Schwender et 
al., 2004). The study characterized the role of Rubisco in the absence of Calvin cycle in 
improving the efficiency of carbon utilization during oil synthesis.  
A generic mathematical framework NMR2Flux for quantification of metabolic fluxes in 
plant systems using an integrated approach (Sauer, 2004) employing isotopomer balancing 
and global optimization routine was recently developed in our laboratory (Sriram et al., 
2004). The working of the tool NMR2Flux was demonstrated on developing soybean 
embryos. The metabolic network considered for flux analysis was more comprehensive and 
addressed issues such as compartmentation (for example, parallel pathways of glycolysis and 
oxPPP in cytosol and plastid) (Sriram et al., 2004). Other reactions considered were TCA 
cycle, anaplerotic shunts, γ-amino butyrate shunt etc. Further, statistical analysis of the 
quantified fluxes was carried out using random Monte-Carlo simulation methods.  
2.4 Integration of 13C MFA with other global analytical approaches 
The physiology in a cell can be mapped on various levels such as gene function, 
transcriptional regulation, protein expression, metabolite levels and pathway fluxes. The 
emerging field of plant systems biology has recently emphasized the potential of integrating 
the abovementioned various ‘omic’ techniques (metabolomics, proteomics etc.) for providing 
a detailed understanding of the plant physiology (Girke et al., 2003; Minorsky, 2003; 
Sweetlove et al., 2003; Sweetlove and Fernie, 2005; Kauffman et al., 2006). It would be 
advantageous to integrate transcript (mRNA) and metabolic flux data in soybean embryos to 
enhance our understanding of carbon partitioning in soybeans.  
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Microarrays  can be used to measure the mRNA expression of practically every gene in 
an organism (Schena et al., 1995), which can be used effectively towards understanding plant 
metabolism (Buckhout and Thimm, 2003). For example, the major accumulation of protein 
and oil in Arabidopsis thaliana seeds is between 5-13 days after flowering (DAF) (Ruuska et 
al., 2002). Ruuska et al. examined changes in gene expression in Arabidopsis thaliana seeds 
during the 5-13 DAF period using cDNA microarrays. A key conclusion of their study was 
that the carbon flow from the sucrose to oil involved an active glycolytic pathway to produce 
phosphoenol pyruvate (PEP). In such cases, MFA can be used to complement microarray 
data. If a large glycolytic flux is observed using MFA, the combination of both datasets will 
further strengthen the conclusion. Ruuska et al. (2002) also observed that the PEP was 
transported to the plastid where it was converted to pyruvate and then acetyl-CoA. The 
acetyl-CoA finally gets assimilated into oil. Thus, regulation of central carbon metabolism 
can be effectively understood. Other examples of application of microarrays in plants include 
exploring plant-pathogen interactions (Wan et al., 2002) and effect of water-deficit stress in 
Arabidopsis (Bray, 2002).  
Moreover, there has been a rapid advancement in the methodology and data analysis 
employed for the application of microarray chips in elucidating plant metabolism (Page et al., 
2003; Kennedy and Wilson, 2004). The soybean chip now available from Affymetrix 
(constructed from oligonucleotides) allows us to study the gene expression of over 37, 500 
transcripts simultaneously. The Affymetrix chips can be used for comparison of gene 
expression between the selected genotypes. The sample preparation for the Affymetrix chip 
and analysis of the transcript data will be carried out in collaboration with Dr. Eve Wurtele 
(Department of Genetics, Development and Cell Biology at Iowa State University and Dr. 
Julie Dickerson (Dept. of Electrical and Computer Engineering at Iowa State University). 
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The details of the development of the metabolic network for the soybean embryos and 
extension of our work to study the effects of varying temperature on carbon partitioning in 
soybean has been discussed in detail in the next chapter.    
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3. STUDY ON THE EFFECT OF TEMPERATURE ON 
DEVELOPING SOYBEAN COTYLDEONS 
Manuscript submitted to The Plant Journal 
3.1 Introduction 
Metabolic flux, the flow of carbon through metabolic networks (Ratcliffe and Shachar-
Hill, 2006), is a crucial indicator of cell physiology (Stephanopoulos, 1999). 13C metabolic 
flux analysis (13C MFA) is the organism-wide quantification of metabolic fluxes by using 
carbon labeling experiments and mathematical analysis of the labeling data. Metabolic flux 
maps, the outcomes of 13C MFA, indicate steady state fluxes through various reactions and 
pathways in the organism. A recent review (Ratcliffe and Shachar-Hill, 2006) has 
underscored the significance of 13C MFA and flux maps towards characterization of 
phenotype in plants.   
In plants, 13C MFA and flux maps can be applied to quantify fluxes in known pathways 
(Rontein et al., 2002; Schwender et al., 2003; Sriram et al., 2004), to assess fluxes through 
parallel pathways in separate compartments (Sriram et al., 2004), or to identify previously 
unknown pathways (Schwender et al., 2004). In plant metabolic engineering, systemic 13C 
MFA is an effective tool to assess the impact of an environmental or genetic perturbation on 
carbon flow. It provides insights on whether specific metabolic nodes are ‘rigid’ or ‘flexible’ 
(Stephanopoulos and Vallino, 1991) and thus, the degree of amenability of the node to 
metabolic engineering. Such results can suggest further manipulations, which on 
implementation can be followed by 13C MFA in an iterative manner to achieve an optimally 
engineered biological system (Nielsen, 1998). In plant systems biology, 13C MFA in 
combination with global profiling techniques such as proteomics, transcriptomics and 
metabolomics has significant potential for building predictive models of plant metabolism 
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(Girke et al., 2003; Minorsky, 2003; Sweetlove et al., 2003; Sweetlove and Fernie, 2005; 
Kauffman et al., 2006; Ratcliffe and Shachar-Hill, 2006).  
Although 13C MFA is an established technique to characterize prokaryotic systems, its 
entry into plant science is only recent. This is chiefly because the intricacy and extensive 
subcellular compartmentation of plant metabolism renders the mathematical techniques of 
13C MFA challenging and non-trivial for the casual user. In a recent publication (Sriram et 
al., 2004), we developed a generic flux analysis tool NMR2Flux incorporating recent 
advances in efficient flux evaluation (Wiechert and Wurzel, 2001; Sriram and Shanks, 2004). 
Together with an extensive two-dimensional (2D) nuclear magnetic resonance spectroscopy 
(NMR) based isotopomer dataset, extracellular and biomass synthesis fluxes measurements, 
and statistical analysis, we used NMR2Flux to quantify compartmented fluxes in developing 
soybean cotyledons (Sriram et al., 2004). This approach quantifies fluxes in a systemwide 
manner (Sauer, 2004) in contrast to previous approaches that employed local flux analysis 
around selected metabolic branchpoints (Dieuaide-Noubhani et al., 1995; Glawischnig et al., 
2001, 2002; Rontein et al., 2002; Schwender et al., 2003; Schwender et al., 2004).  
In this work, we report the application of NMR2Flux to investigate the effect of 
temperature on central carbon metabolism in developing soybean cotyledons. Soybean is a 
major source of high quality protein, edible oil, and food products, and also several industrial 
non food applications such as paper coating, textiles and plastics (Myers, 1993; Kinney, 
1998). It is difficult to develop soybeans with high protein and high oil, however, due to the 
inverse relationship between these two components (Nakasathien et al., 2000). Consequently, 
increasing seed protein concentration without adversely affecting the yield and oil content 
has been difficult to achieve (Cober and Voldeng, 2000).  
Studies on the effect of day and night growth temperatures on the seed composition 
indicated that during the seed-fill and maturation period, protein concentration increased 
whereas oil decreased with increasing temperature during the seed-fill and maturation period 
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(Gibson and Mullen, 1996). Another study with different soybean cultivars indicated that oil 
concentration increased with increasing temperature (Piper and Boote, 1999). Although 
various studies have indicated a significant response to temperature in developing soybean, 
the metabolic pathways contributing to the observed changes in biomass accumulation and 
composition are not understood clearly. Our study was designed to understand pathway 
interactions in response to temperature in developing soybean cotyledons, with the objective 
of understanding carbon regulation for improved protein and oil production. 
3.2 Results 
This study was designed to investigate temperature effects on fluxes through central 
carbon metabolism in developing soybean cotyledons. In most previous studies that 
documented temperature effects on protein and oil content in soybean (Westgate et al., 1995; 
Piper and Boote, 1999; Westgate et al., 2000; Pipolo et al., 2004), the optimum temperature 
for seed growth was about 27 °C. Growth temperature higher or lower than this optimum 
resulted in decreased protein accumulation, decreased oil accumulation, or both. In addition, 
temperature treatments imposed during the early stage of cotyledon development, when cells 
are being formed, had a larger impact on final seed composition (Howell and Cartter, 1953; 
Bils and Howell, 1963). Therefore, we created two related cases for this study: one to 
determine whether 13C MFA could distinguish temperature effects on seed metabolism, and a 
second to investigate whether growth temperature during cell formation limited the capacity 
for metabolic flux later in seed development. For Case 1, cotyledons were collected from 
plants growing under moderate conditions (27°C/20°C - M), in a growth chamber and 
cultured in vitro at varying temperatures (35°C/27°C- H, 27°C/20°C- M and 20°C/12°C- L). 
These treatments are designated MH, MM and ML respectively. For Case 2, plants were 
grown under high temperature, moderate temperature or low temperature condition during 
seed development and cotyledons were cultured at the same temperature at which they were 
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growing. These treatments are designated as HH, MM and LL respectively. In both cases, the 
cotyledons were selected for uniform initial size of 50 mg fresh weight in all temperature 
treatments to ensure that they were in the same stage of metabolic development. Metabolic 
flux was analyzed during the middle of the seed-fill period, when biomass, protein and oil 
were accumulating rapidly. The intent was to determine how a temperature change when 
introduced during incubation in vitro affected metabolic fluxes compared to the same 
temperature treatment imposed during seed formation and development.  
3.2.1 Treatment effects on biomass and composition 
The MM temperature condition was best suited for maximal relative protein content (as 
a fraction of dry weight) of the cotyledons (Table 3.1). To contrast the metabolic rates of 
different temperature treatments against this optimal condition, we compared the fluxes of 
the different temperature conditions relative to the MM temperature condition. Table 3.1 
presents biomass composition and dry weight accumulation data for both Case 1 and Case 2.  
The soybean cotyledons displayed a trend towards increased dry weight accumulation at 
higher temperatures. In Case 1, dry weight accumulation was greatest for MH condition (55.2 
mg/cotyledon) and lowest for ML condition (17.9 mg/cotyledon). The relative protein 
content of the cotyledons was highest in the MM condition, whereas the relative lipid content 
was highest in the MH condition and the relative starch content was highest in ML condition. 
In Case 2, protein and starch percentage of the biomass were highest for the MM condition, 
whereas lipid percentage was highest for HH condition. The dry weight accumulation was 
maximum for the HH condition (56.0 mg/cotyledon) and lowest for LL condition (18.9 
mg/cotyledon). Interestingly, the ML condition accumulated less dry weight than the LL 
condition. The biomass accumulation was comparable between MH and HH condition. The 
protein and lipid as a percentage of biomass was greater for the MH than the HH condition. 
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Table 3.1: Comparison of biomass constituents for Case 1 and Case 2 
Temperature Growth/Incubator
study temperature Protein Starch Oil
MH 29.3±0.54 5.5±0.18 18.4±0.71
MM 31.7±0.32 6.3±0.12 15.6±0.59
ML 30.7±1.51 7.8±0.24 13.6±0.67
HH 26.3±1.34 5.2±0.58 16.7±2.93
MM 31.7±0.32 6.3±0.12 15.6±0.59
LL 28.2±0.66 5.7±0.27 11.6±0.49
MM was the optimum temperature for protein accumulation and was common between both cases.
20oC/12oC (L) 20oC/12oC (L) 18.9±0.79Case 2
35oC/27oC (H) 35oC/27oC (H) 56.0±4.17
27oC/20oC (M) 27oC/20oC (M) 41.3±7.05
Case 1
27oC/20oC (M) 35oC/27oC (H) 55.2±3.44
27oC/20oC (M) 27oC/20oC (M) 41.3±7.05
27oC/20oC (M) 20oC/12oC (L) 17.9±0.22
temperature temperature (mg/cotyledon)
Growth Incubator Dry weight growth % of biomass
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On the basis of this data, we observed that the growth temperature during cell formation had 
a dominant influence on the biomass accumulation and composition. Additionally, we also 
expected increased intake of carbon and increased carbon flow through metabolic pathways 
at higher temperatures compared to lower temperatures.  
3.2.2 NMR2Flux 
As explained above, the effect of temperature was apparent in the accumulation of 
biomass as well as the biomass composition. This formed the background for using 13C MFA 
to detect changes in central carbon metabolism contributing to the observed biomass 
variation. The program NMR2Flux was developed (Sriram et al., 2004) and used to solve for 
the metabolic fluxes from the isotopomer data and biomass information.  
It is essential that a metabolic network mimicking the underlying physiology be 
proposed to convert the labeling data to intracellular fluxes. With such a network, mass 
balances around each intracellular metabolite are written to generate a system of linear 
equations assuming pseudo-steady state. The fluxes in a reaction network are thus 
stoichiometrically related to each other and are expressed in terms of flux parameters. The 
selection of flux parameters is important to solve the metabolic network (Sriram et al., 2004). 
Some potential candidates for flux parameters are the independent reactions of the network 
(Stephanopoulos et al., 1998), reversibilities of key reactions and also scrambling extents of 
parallel reactions (Szyperski, 1995). Product effluxes, substrate consumption and biomass 
synthesis are additional essential extracellular measurements required for accounting for 
complete carbon balance and thereby provide a better estimate of the intracellular fluxes. 
Further, labeling data which give key information about branchpoints are important inputs. In 
the event that the labeling data does not satisfy the proposed reaction network, certain 
reactions may need to be added or removed from the proposed network to satisfy the labeling 
data. 
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Figure 3.1 represents the modeling methodology employed in the program NMR2Flux. 
The tool (NMR2Flux) chooses an initial set of flux parameters (independent net fluxes, 
reversibilities and scrambling extents) that are stoichiometrically feasible (Stephanopoulos et 
al., 1998; Sriram et al., 2004). From the feasible set of flux parameters, the remaining fluxes 
can be calculated. The metabolite balances from the stoichiometric network coupled with the 
carbon skeleton rearrangements (from biochemistry) are fundamental in enumerating the 
isotopomers of the metabolites in the network. In NMR2Flux, the feasible fluxes are 
converted to isotopomer distributions using an efficient Boolean function mapping method 
that was recently developed (Sriram and Shanks, 2004) coupled with explicit solution 
methods (Wiechert and Wurzel, 2001). The ‘best’ set of intracellular fluxes satisfies the 
reaction stoichiometry and also shows the least mean square error between experimental and 
simulated isotopomer abundances. Further, a statistical analysis was carried out which 
accounts for the NMR error and converts them to confidence intervals of the fluxes using 
random Monte Carlo simulation methods (Sriram et al., 2004). The application of 
NMR2Flux to the temperature study is discussed below.  
3.2.3 13C Metabolic Flux Analysis 
The soybean cotyledons from both Case 1 and Case 2 were fractionated into protein, oil 
and starch respectively. The protein and starch fractions of cotyledons were hydrolyzed to 
prepare respective NMR samples. Two-dimensional (2D) heteronuclear single quantum 
correlation spectroscopy (HSQC) spectra (of protein and starch samples) (Figure 3.2) and 2D 
Total Correlation spectroscopy (TOCSY) spectra (protein sample) were acquired. Cross-
peaks on these spectra displayed peak splitting along the 13C dimension; the intensities of the 
multiplets formed were proportional to isotopomer abundances of metabolites in the sample 
(Harris, 1983; Sriram et al., 2004). Isotopomer abundances measured from these spectra are 
listed in Appendix I. Measurements of extracellular fluxes (carbon source intake, acid  
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Figure 3.1: Flux evaluation methodology employed in NMR2Flux. Figure adapted from 
Sriram et al. (2004). 
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Figure 3.2: 2D [13C, 1H] HSQC spectrum of the protein hydrolysate. The peaks represent 
carbon atoms of amino acids and levulinic acid (from glycosylated protein) in the protein 
hydrolysate. 1D slice of Proδ and Aspα are shown to represent the multiplet pattern of 
the isotopomer. 
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effluxes and biomass synthesis) are listed in Appendix II. 
Our previous work (Sriram et al., 2004) demonstrated how 13C MFA can be used as a 
powerful tool for identifying active pathways and also segregating parallel pathways in 
multiple compartments and thereby iteratively constructing a metabolic network using the 
MM temperature condition as a case study. The metabolic network constructed for the central 
carbon metabolism in developing soybean cotyledons is shown in Figure 3.3. The metabolic 
network consists of three compartments; cytosol, plastid and mitochondrion. There are 
parallel pathways of glycolysis and oxidative pentose phosphate pathway (oxPPP) in the 
cytosol (pglC) and plastid (pglP). The mitochondrion comprised of the TCA cycle and 
glyoxylate shunt. The glutamine assimilation reactions are considered in the plastid and the 
γ-aminobutyric acid (GABA) shunt in the cytosol and mitochondrion. Anaplerotic shunts 
such as malic enzyme are present in the plastid and mitochondrion and the 
phosphoenolpyruvate carboxylase (ppc) in the cytosol respectively. The biosynthetic 
pathways of protein, lipid and starch are considered in their respective compartments. We 
have not included the fixation of evolved CO2 by the Rubisco flux (Schwender et al., 2004) 
as our isotopomer experimental design cannot  ‘identify’ (Wiechert et al., 2001) a possible 
flux through the Rubisco pathway. The reactions included were determined from biochemical 
texts (Dey and Harborne, 1997; Singh, 1998), online databases (Soybase and KEGG 
encyclopedia) and literature (Chollet et al., 1996; Casati et al., 1999).  
3.2.4 Metabolic trends observed in Case 1 and Case 2  
13C MFA of the five temperature conditions was carried out using the tool NMR2Flux. 
The NMR multiplet intensities of experimental and simulated data for all the five 
temperature conditions compared well (except for the outlier Leuδ1 points; Figure 3.4). 
Further analysis of the intracellular fluxes and flux ratios are discussed below. The metabolic 
flux map for the MM temperature condition (Figure 3.3) depicts the metabolic trends 
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Figure 3.3: Metabolic network representing central carbon metabolism in soybean 
embryos. This figure also represents the metabolic flux map for MM temperature 
condition. The thickness of the arrows is proportional to the relative fluxes 
(standardized with respect to 100 mol of sucrose intake). Appendix IV lists all 
relative fluxes for the MM temperature condition. Intracellular metabolites are shown 
in white ovals, and gray ovals represent sink metabolites (amino acids, nucleotides 
etc.). Metabolic pathways are color coded as follows- Glycolysis and sucrose 
metabolism: dark red; oxPPP: pale blue; anaplerotic pathways: mauve; glutamate 
assimilation: brown; TCA cycle: orange; biosynthetic fluxes: gray; pyr 
dehydrogenase: blue-gray and transport fluxes: black (Sriram et al., 2004). 
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Figure 3.4: Comparison of experimental and simulated NMR intensities of 
amino acids from protein hydrolysate and levulinic acid from starch and 
protein hydrolysate of MM temperature condition. Leu δ1 is shown as black 
circles (Sriram et al., 2004). 
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discussed below. As observed by Sriram et. al. (2004), parallel pathways of glycolysis and 
oxPPP were distinguished between the cytosol and the plastid. The T3P pools in the plastid 
and cytosol rapidly exchanged between the two compartments. The hexose isomerase flux 
was in the direction of F6P → G6P, channeling carbon flow through the oxPPP in a cyclic 
manner. The flux through oxPPP was considerable in both the cytosol and plastid but higher 
in the plastid (pglP). The flux through non-oxidative reactions of the oxPPP catalyzed by 
transketolase (tkt) and transaldolase (tal) were much greater in the plastid compared to the 
cytosol. Flux from T3P to F6P was substantial in the plastid (where it is catalyzed by 
fructose-1,6-bisphosphatase, f16bpP) but negligible in the cytosol (where it is catalyzed by 
pyrophosphatase). Large enrichments of the γ2 carbon atom of Val and δ2 atom of Leu 
(Appendix I) indicated that the plastidic pyruvate (Pyr) pool was generated mainly from 
sucrose. This result implies negligible fixation of CO2 from photosynthetically derived T3P 
or dilution by glutamine which is supplied as a nitrogen source. However, the carboxylation 
by Rubisco bypass reaction cannot be identified by our NMR dataset.   
Table 3.2 summarizes the flux ratios of key reactions in both Case 1 and Case 2. Some 
common trends observed among all the temperature conditions are listed below. The 
contribution of the plastidic malic enzyme (meP) reaction to the Pyr pool was substantially 
less than the overall pyruvate kinase (pyktotal) flux in the glycolytic pathway. The flux 
through the cytosolic PEP carboxylase reaction (ppc) was also negligible compared to the net 
pyk flux but considerable compared to the flux through pyruvate dehydrogenase (pdh) in the 
mitochondrion. The glyoxylate shunt, which is associated with lipid catabolism, was 
negligible in both cases as expected as the cotyledons predominantly accumulate lipids and 
proteins. There was substantial flux through the GABA shunt. Thus our metabolic flux map 
establishes compartmentation for primary metabolism, delineates extent of flux through 
parallel reactions in multiple compartments and elucidates compartment interactions 
including the direction of transport of various metabolites. Together this information reveals 
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Table 3.2: Comparison of flux ratios (using mean flux values) and NADPH production by pglP versus plastidic 
NADPH consumption for Case 1 and Case 2. The numbers in bold indicate that they are not statistically different 
from the MM temperature condition. Superscripts c, p and m represent cytosol, plastid and mitiochondrion 
respectively. Superscript total indicates sum of cytosol and plastidic fluxes. 
Temp. → HH MM LL MH MM ML
Flux ratio ↓
Glycolysis/Suc intake 0.50 ± 0.03 0.56 ± 0.04 0.47 ± 0.04 0.52 ± 0.03 0.56 ± 0.04 0.55 ± 0.05
pglc/Suc intake 0.37 ± 0.22 0.48 ± 0.22 0.34 ± 0.20 0.57 ± 0.22 0.48 ± 0.22 0.17 ± 0.17
pglp/Suc intake 0.65 ± 0.29 0.57 ± 0.26 0.77 ± 0.24 0.59 ± 0.23 0.57 ± 0.26 0.53 ± 0.24
Glycolysis/pgl(c+p) 0.53 ± 0.22 0.58 ± 0.22 0.45 ± 0.16 0.46 ± 0.13 0.58 ± 0.22 0.90 ± 0.44
pyktotal/mep 15.89 ± 8.81 37.5 ± 16.4 10.85 ± 2.03 11.41 ± 2.13 37.5 ± 16.4 7.82 ± 3.03
pyktotal/ppcc 11.63 ± 1.40 8.83 ± 0.86 12.05 ± 1.23 11.14 ± 0.79 8.83 ± 0.86 5.53 ± 1.14
pdhm/ppcc 1.91 ± 0.41 2.60 ± 0.34 5.24 ± 0.53 3.15 ± 0.28 2.60 ± 0.34 3.07 ± 0.50
pdhp/ppcc 9.01 ± 1.30 5.52 ± 0.85 6.88 ± 1.31 8.01 ± 0.91 5.52 ± 0.85 3.07 ± 0.84
pdhp/mep 12.04 ± 5.68 23.02 ± 9.65 6.10 ± 0.94 8.12 ± 1.10 23.02 ± 9.65 4.23 ± 1.45
respiration/ 0.38 ± 0.02 0.43 ± 0.02 0.48 ± 0.03 0.46 ± 0.02 0.43 ± 0.02 0.48 ± 0.04
Suc intake
pgl P contribution to 1.05 0.98 1.07 1.05 0.98 1.6
NADPH consumption
Ratio Ratio
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the quantitative nature of partitioning of carbon into multiple branches at various nodes of 
primary carbon metabolism. 
3.2.5 Absolute and relative fluxes for Case 1 and Case 2  
The absolute flux data (µmol day-1 cotyledon-1) for all the metabolic steps are listed in 
Appendix III for Case 1 and Case2. The temperature imposed during in vitro culture had the 
expected effect on cotyledon growth and metabolism. There was more sucrose consumed and 
more amino acids, lipids and starch synthesized in the HH, MH and MM conditions than in 
the ML and LL temperature conditions (Table III-1 and III-2 in Appendix III). Also, most 
absolute fluxes for HH and MH condition were greater than the MM temperature condition. 
Conversely, the absolute fluxes were lesser for the ML and LL condition compared to the 
MM temperature condition. Thus, greater carbon uptake and carbon flow occurred through 
the central carbon metabolism with an increase in temperature. Figure III-1 (Appendix III) 
illustrates the absolute flux map for the MH compared to the MM temperature condition.  
Although absolute fluxes indicate the most active pathways, relative fluxes give better 
insight into the regulation of the reaction network because the total substrate entering into the 
system is constant across the different temperature conditions. To that end, the relative fluxes 
were standardized with respect to 100 mol of sucrose intake. All comparisons made 
henceforth are in terms of relative flux values and analyzed with respect to the MM 
temperature condition. Table IV-1 and IV-2 in Appendix IV lists the relative fluxes of the 
metabolic network (standardized with respect to 100 mol of sucrose intake) for Case 1 and 
Case 2. Figure IV-1 (Appendix IV) represents the relative flux map for the MH temperature 
conditions relative to the MM temperature condition.   
Nodal analysis was carried out to analyze the partitioning of the carbon into multiple 
branches in both Case 1 and Case 2. The ‘flexibility’ or ‘rigidity’ of a node can be insightful 
in identifying preferred direction of carbon flow and regulation of metabolism 
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(Stephanopoulos and Vallino, 1991). To elucidate, if the ratio of the carbon partitioning into 
multiple reactions at a node remains constant, irrespective of changes in the total incoming 
flux, then the node is said to be ‘rigid’. Hence, genetic manipulation of the reactions involved 
in a flexible node is likely to be more productive in channeling the precursor metabolite in 
the preferred direction (Stephanopoulos and Vallino, 1991). Conversely, for rigid nodes, it is 
more difficult to modify the intrinsic regulation of flux through the node, and hence would 
likely require multiple genetic manipulations of the enzymes involved. For example, the ratio 
of the pglP/glycolysis flux on a C mol basis (Appendix V) in the plastid was statistically 
different for both Case 1 (MH and ML) and Case 2 (HH and LL) compared to the MM 
temperature condition (Table 3.2). This indicates that the pglP/glycolysis node is flexible; this 
metabolic node alters the direction of carbon flow to meet the metabolic demand of 
downstream reactions (Stephanopoulos and Vallino, 1991). Two other significant results that 
were observed from nodal analysis of the temperature conditions; the rigidity of the 
important pglP node with respect to the sucrose intake and the flexibility of the anaplerotic 
reactions contributing to the Pyr node which is the crossroad for partitioning of carbon into 
protein and lipid synthesis.  
3.2.6 Ratio of the pglP flux to the total sucrose intake  
The pglP reaction is a source of reductant (NADPH) for lipid and protein biosynthesis, 
glutamine assimilation and for countering oxidative stress within the plastid (Hauschild and 
von Schaewen, 2003). Flux through pglP was substantial for both Case 1 and Case 2 
cotyledons. The ratio of the pglP flux to the total sucrose intake rate on a C mol basis was not 
statistically different [approximately 56 % (± 24%)] for either MH or ML compared to the 
MM temperature condition (Case 1) (Table 3.2). This finding indicates that the relative 
amount of carbon entering pglP remained ‘rigid’ relative to sucrose intake regardless of 
temperature in vitro (Figure 3.5(A)). In contrast, pglP flux to sucrose intake ratio on a C mol 
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Figure 3.5: Plastidic oxPPP node for the (A) MH and (B) HH temperature condition. The thickness of the arrows 
is proportional to the relative fluxes (standardized with respect to 100 mol of sucrose intake). Green and red 
arrows indicate that the flux is greater or lower than the MM (optimum) temperature condition respectively. 
Appendix IV lists the relative fluxes with standard deviations for the temperature treatments. Table 3.2 lists the 
flux ratios of key nodes for the temperature treatments. 
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basis varied among the LL, MM and HH temperature treatments tested in Case 2 (Table 3.2). 
This latter result implies that carbon flow through the pglP reaction can be ‘flexible’ in 
response to the growth conditions early in the seed development. The relative flux maps for 
the pglP node for these treatments are shown in Figure 3.5.  
3.2.7 Carbon partitioning at plastidic Pyr node  
An important node in the central carbon metabolism that signifies the focal point of 
carbon partitioning into protein and oil is the Pyr pool in the plastid. The inverse relationship 
between protein and oil is a fundamental limitation towards generating high protein and high 
oil content soybeans (Cober and Voldeng, 2000). Hence we analyzed metabolic flux through 
the plastidic Pyr node to understand the regulation of carbon allocation towards these two 
primary biomass components in the seed (protein and oil).  
The primary reactions that direct carbon flux into the plastidic Pyr pool are the pyruvate 
kinase (pyk) and plastidic malic enzyme (meP) reactions. The plastidic Pyr is then channeled 
into the biosynthesis of protein and oil. Figure 3.6 depicts the Pyr node for the ML 
temperature condition with key flux values. The pyktotal flux was much greater than the meP 
flux (Table 3.2). For Case 1 (MH and ML), the pyktotal flux decreased and the meP flux 
increased relative to the MM condition. This result is shown graphically in Figure 3.6 for the 
ML treatment and Figure 3.7 for MH treatment. The flux values through specific enzymes 
relative to the MM are presented in Appendix IV. The pyktotal fluxes for the MH and ML 
were 5-8 % less than the MM temperature condition. The meP flux for the MH treatment was 
177% of MM and for the ML treatment it was 325 % of MM values (Table 3.3). Thus for 
Case 1, the meP flux varied dramatically in response to temperature; there was much less 
variation in pyktotal flux.  
We also considered how temperature treatments affected flux through the ppc reaction in 
the cytosol and the malate (Mal) transporter from mitochondrion to cytosol (malT1). These 
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Figure 3.6:  Plastidic Pyr node for the ML temperature condition. The thickness of the arrows is proportional to 
the relative fluxes (standardized with respect to 100 mol of sucrose intake). Green and red arrows indicate that the 
flux is greater or lower than the MM (optimum) temperature condition respectively. Flux values of key metabolic 
reactions are indicated in the figure. Appendix IV lists all relative fluxes with standard deviations for the ML 
temperature condition. Table 3.2 lists the flux ratios of key nodes for the temperature treatments. 
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two components are responsible for directing carbon flow from the cytosol to the plastid 
(malT2) (Figure 3.6). The malT2 transporter replenishes OAA and Pyr pool in the plastid by 
directing the carbon flow into the plastidic malate dehydrogenase (mdhP) and meP reactions 
(Figure 3.6). Flux through cytosolic ppc increased approximately 50 % (Table 3.3) under the 
ML condition relative to MM (Figure 3.6). Additionally, in the MM and ML temperature 
conditions, OAA produced from the ppc reaction was converted to Mal. The Mal in the 
cytosol apparently met with 2 fates; some was transported into the mitochondrion to feed the 
TCA cycle, and the remaining was transported to the plastid (Figure 3.6). The MH 
temperature condition, however, decreased flux through cytosolic ppc reaction about 25 % 
(Table 3.3) relative to MM (Figure 3.7) which effectively reversed the net flux through the 
malT1 transporter relative to the MM condition. In MH cotyledons, net Mal transport was 
from the mitochondrion to the cytosol and then to the plastid (Figure 3.7).  
In Case 2 the pyktotal flux for HH and LL was approximately 11 to 12 times greater than 
the meP flux (Table 3.2). Figure 3.8 depicts the Pyr node for the HH temperature condition 
with key flux values. The pyktotal flux decreased whereas the meP increased for the HH and 
LL relative to the MM temperature condition. Similar to Case 1, the percentage change in 
flux was greater for meP than for pyktotal (Table 3.3). Furthermore, the direction of the Mal 
transporters were from the mitochondrion to cytosol and then to the plastidic Mal pool for 
both HH and LL temperature conditions. Thus, the anaplerotic reactions and the Mal 
transporters contributing carbon to the plastidic Pyr node varied largely in response to the 
temperature treatments, with the meP, malT1 and malT2 responding to the greatest extent to 
temperature.  
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Figure 3.7:  Plastidic Pyr node for the MH temperature condition. The thickness of the arrows is proportional to 
the relative fluxes (standardized with respect to 100 mol of sucrose intake). Green and red arrows indicate that the 
flux is greater or lower than the MM (optimum) temperature condition respectively. Flux values of key metabolic 
reactions are indicated in the figure. Appendix IV lists all relative fluxes with standard deviations for the MH 
temperature condition. Table 3.3 lists the flux ratios of key nodes for the temperature treatments. 
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Table 3.3: Comparison of percentage change between relative flux values through 
various reactions contributing to the plastidic Pyr node. Red and green indicate a  
decrease and increase as compared to MM temperature condition respectively.  
Appendix IV lists the relative fluxes with standard deviations for the  
  
temperature treatments.  
      
        
 
Flux HH MH ML LL 
  
 
through Percentage change 
  
 
     
  
 
pyktotal -7.74 -4.84 -7.94 -14.08 
  
 
ppcc -29.55 -25.01 52.87 -36.85 
  
 
me
m
 -70.04 -8.19 139.19 21.38 
  
 
me
p
 117.17 177.29 325.62 163.31 
  
 
malT2 47.63 71.61 135.25 66.96 
  
 
     
  
 
OAA to protein -4.69 -7.84 -7.89 -5.52 
  
 
Pyr to protein -15.78 -18.52 -12.53 -14.65 
  
 
Pyr to lipid 14.78 9.80 -18.85 -21.75 
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Figure 3.8:  Plastidic Pyr node for the HH temperature condition. The thickness of the arrows is proportional to 
the relative fluxes (standardized with respect to 100 mol of sucrose intake). Green and red arrows indicate that the 
flux is greater or lower than the MM (optimum) temperature condition respectively. Flux values of key metabolic 
reactions are indicated in the figure. Appendix IV lists all relative fluxes with standard deviations for the HH 
temperature condition. Table 3.3 lists the flux ratios of key nodes for the temperature treatments. 
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3.3 Discussion 
3.3.1 Applying 13C MFA to soybean cotyledons 
The metabolic architecture responsible for the changes in physiology caused by 
temperature was examined in this study using carbon labeling experiments and a recently 
developed generic 13C MFA tool NMR2Flux (Sriram et al., 2004). The assumption of steady 
state conditions in the labeling studies of soybean embryos was verified. The cotyledon 
volume was approximately 0.3 ml and the intracellular sucrose concentration in a soybean 
cotyledon was found from literature to be approximately 37 mM (Lichtner and Spanswick, 
1981). For the HH temperature condition, the sucrose uptake rate was 1.6 µmol h-1 cotyledon-
1
. The residence time of sucrose was calculated to be 7 h. Isotopic steady state is attained 
within five residence times and thus was estimated to be 35 h which was much less than the 
labeling time (6 d) in culture. Isotopic steady state also was verified for all the temperature 
treatments (data not shown). 
We observed that simulated and experimental isotopomer abundances compared well 
except for Leuδ1 (Figure 3.4). According to well established biochemical pathways for their 
synthesis, the multiplet intensities of Leuδ1, Valγ1
 
and Alaβ peaks should agree with each 
other, as they reflect the same carbon atom of the precursor metabolite Pyr (Szyperski, 1998). 
However, a discrepancy between the Leuδ1 and Valγ1/Alaβ peaks at all temperature 
conditions was observed (Figure 3.9). The consistency between Val γ1 and Alaβ peaks 
indicates that Leuδ1 discrepancy would not affect the fluxes of the primary carbon 
metabolism. Rather, this isotopomeric discrepancy suggests that one or more of the 
intermediate reactions in the biosynthesis of Leu from 2-oxoisovalerate (Dey and Harborne, 
1997) might be reversible. Similar discrepancy between the Leuδ1 and Valγ1/Alaβ peaks has 
been detected in another biological system (Catharanthus roseus) being studied in our lab 
(unpublished data). The carboxylation by Rubisco bypass cannot be identified by our  
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Figure 3.9: Comparison of Leu δ1, Val γ1 and Ala β. (A) Carbon skeleton rearrangement 
of pyruvate to Leu, Val and Ala. As seen, Leu δ1, Val γ1 and Ala β reflect the same 
carbon atom of pyruvate. Figure in 3.6 (A) is modified from literature (Szyperski, 1998). 
(B) Comparison of NMR intensities of Leu δ1, Val γ1 and Ala β for MM temperature 
condition. Leu δ1 varies significantly from Val γ1 and Ala β. 
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isotopomer dataset. However, this does not affect the results reported in this  paper. This is 
because for all the temperature conditions our evaluated fluxes accounted for the 
experimental isotopomer abundances well. 
3.3.2 Dominant effect of the early development temperature 
Growth temperature is a key parameter influencing the biomass and composition of the 
soybean seed (Dornbos and Mullen, 1992; Gibson and Mullen, 1996; Kane et al., 1997). In  
Case 1, the early development temperature in the growth chamber was maintained the same 
before the cotyledons were transferred to the in vitro culture at varying conditions (MH, MM 
and ML; Table 3.1). However, in Case 2 the temperature in the growth chamber and in the in 
vitro culture was maintained the same but at varying levels (HH, MM, LL; Table 3.1). The 
effect of the temperature during in vitro culture on the biomass composition was more 
pronounced (Table 3.1) when a temperature change was imposed (Case 1), compared to 
those grown at a constant temperature (Case 2). The ratio of pglP flux to total sucrose intake 
on a C mol basis was rigid in Case 1 but flexible in Case 2 in response to temperature in 
vitro. Together these results indicate that the growth temperature during early development 
stage temperature has a dominant influence on establishing constraints for primary 
metabolism.  
The pglP flux is an important source of reductant for lipid and protein biosynthesis, 
glutamine assimilation and countering oxidative stress by maintaining the redox potential in 
the plastid (Hauschild and von Schaewen, 2003). The NADPH requirement in the plastid was 
completely satisfied by pglP flux for all the temperature conditions (Table VI-1 in Appendix 
VI illustrates this for the MH temperature treatment). Additionally, the production of 
NADPH by pglP flux was 1.6 times the NADPH requirement for the plastidic biosynthetic 
and glutamine assimilation reactions for the LL temperature condition. The greater NADPH 
production was attributed to a 36% greater pglP flux in LL compared to the MM temperature 
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condition. The increase in the pglP flux could result from decreased glycolytic carbon flux 
(~15 %) observed in the LL condition relative to the MM temperature condition. The 
increase in pglP flux could also be a response to the cold stress to maintain the redox state of 
the plastid. This possibility is consistent with observed increases in glucose 6-phosphate 
dehydrogenase (enzyme important in the oxPPP) activities in cold-treated rape plants 
(Maciejewska and Bogatek, 2002). 
3.3.3 Crossroad for protein and oil partitioning 
The plastidic Pyr node in the metabolic network provides a focal point for carbon 
partitioning into protein and oil in soybeans. The overall glycolytic flux catalyzed by 
pyruvate kinase (pyktotal) was much greater than meP for both Case 1 and Case 2 (Table 3.2). 
Our results corroborate the observations in B. napus embryos, in which the label incorporated 
into fatty acids was primarily from glycolysis; negligible carbon was derived from Mal 
(Schwender et al., 2003). Our results illustrate that the activity of the cytosolic ppc and meP 
varies greatly depending on the temperature conditions. Further, the large variation in the 
fluxes around the plastidic Pyr node indicates that this metabolic node is ‘flexible’.  
The importance of ppc activity in regulating carbon partitioning in soybean seeds has 
been previously emphasized (Smith et al., 1989). Moing et al. (2004), however, questioned 
whether ppc influenced the direction of carbon flux based on metabolite profiling of 
Arabidopsis transformants. Our direct measurements of carbon flux through the anaplerotic 
reactions (cytosolic ppc and meP) indicate they have a fundamental impact on carbon 
partitioning into protein and oil in soybeans.  
3.4 Summary 
Flux analysis is a powerful technique for analyzing interaction among multiple 
metabolic compartments inherent in plant systems. Our detailed study on the effects of 
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temperature on the fluxes of central carbon metabolism in developing soybean cotyledons 
show that the early development temperature is dominant in regulating certain metabolic 
aspects of the system, which was reflected in the rigidity of the important pglP node.13C MFA 
has also proven useful in identifying regulatory nodes for carbon partitioning within the 
system. Our results indicate that temperature has a large impact on the direction of flux 
through cytosolic ppc and meP. It would be advantageous to integrate flux analyses with 
other global analytical approaches such as metabolomics, transcriptomics and proteomics to 
elucidate key metabolic engineering targets for channeling of carbon into protein and lipid in 
soybean cotyledons.  
3.5 Experimental Procedures 
3.5.1 Soybean cotyledon culture 
Soybeans (Glycine max cv. Evans) were grown in controlled environment chambers 
under conditions optimal for seed production and growth: 27°C/20°C day/night temperature, 
14 hour photoperiod, with high output fluorescent lamps providing approximately 500 µmol 
photons m-2 sec-1 of photosynthetically active radiation at the upper leaves. Sufficient water 
and nutrients were applied to the soil to ensure vigorous plant growth. At 10 days after 
flowering (DAF) and prior to rapid seed growth, the growth temperature was adjusted to one 
of the three conditions- 35°C day/27°C night (H-high), 27°C/20°C (M-medium) and 
20°C/12°C (L-low). These conditions were maintained for the duration of seed development. 
Ten days later (20 DAF), pods were harvested from the central nodes and cotyledons isolated 
under aseptic conditions for in vitro culture. The cotyledons were approximately 50 mg fresh 
weight and selected for uniform initial size. They were cultured aseptically for six days in 
separate 25 ml Erlenmeyer flasks containing 4 ml liquid medium. The medium comprised of 
146 mM sucrose (10% U-13C sucrose from Isotec, Miamisburg, OH) and 37 mM glutamine 
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as the only carbon sources and was replaced every three days. The flasks were gently shaken 
at 100 r.p.m. and maintained at one of the three temperatures (H, M, L) within Percival 
incubators at approximately 100 µmol photons m-2 sec-1 light intensity. In all, there were five 
temperature treatments. Cotyledons collected from plants grown at 35°C/27°C, were 
incubated at 35°C/27°C (HH).  Cotyledons sampled from plants growing at 27°C/20°C were 
incubated at one of three temperatures: 35°C/27°C (MH), 27°C/20°C (MM), or 20°C/12°C 
(ML).  Cotyledons from plants growing at 20°C/12°C were incubated at 20°C/12°C (LL).  
All temperature treatments were performed in triplicate. Cotyledons were harvested after 6 
days in culture, rinsed with distilled water, frozen in liquid nitrogen and lyophilized at -50oC 
and 0.133 mbar for 72 h. The lyophilized cotyledons were finely ground for further 
processing. 
3.5.2 Biomass quantification and fractionation 
Biomass growth was quantified by measuring fresh and dry weights of the cotyledon. 
The total lipid content was quantified gravimetrically using hexane extraction. Protein in the 
defatted pellet was separated from non-protein nitrogen by precipitation in 240 g kg-1 
trichloroacetic acid and quantified by microkjeldahl procedures. Soluble sugars from the 
defatted pellet were extracted in 800 g kg-1 ethanol at 60oC for 20 min. The extraction was 
repeated four times. Successively, starch in the remaining pellet was digested in 100 mM 
citrate buffer containing amyloglucosidase in the ratio 0.025mg: 1 mg of dry weight. Starch 
content was quantified using the starch assay kit (Sigma, St. Louis, MO). Sucrose and 
glutamine consumption from the medium was measured using HPLC.  
3.5.3 Protein and starch hydrolysis, and NMR sample preparation 
The protein and starch were vacuum hydrolyzed in hydrolysis tubes (Pierce Endogen, 
Rockford, IL) using 6N constant boiling hydrochloric acid (HCl) (Sigma, St. Louis, MO). 
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The acid was added in the ratio 0.5 ml HCl:1 mg protein/starch. The tube was evacuated, 
purged with N2 to remove residual air and re-evacuated. The sample (starch/protein) was 
hydrolyzed for 4 h at 150oC in a heat block. The acid in the hydrolysate was removed with a 
Rapidvap evaporator (Labconco, Kansas city, MO). The residue was reconstituted in 2 ml of 
de-ionized water and lyophilized for 72 h. The sample was reconstituted in 500 µl of 
deuterium oxide and transferred into an NMR tube. The sample pH was adjusted to 0.75-1.0 
using deuterium chloride. Amino acids in the samples were quantified by HPLC (Protein 
facility, Department of Biochemistry, Biophysics and Molecular Biology at Iowa State 
University) using a reverse phase C18 silica column, with detection at 254 nm (Figure II-1 in 
Appendix II).  
3.5.4 NMR spectroscopy 
[13C, 1H] Heteronuclear Single Quantum Correlation (HSQC) spectroscopy and [1H, 1H] 
Total Correlation Spectroscopy (TOCSY) were performed on a Bruker Avance DRX 500 
MHz spectrometer (NMR facility, Department of Biochemistry, Biophysics and Molecular 
Biology at Iowa State University) at 298 K. The reference zero p.p.m. was set by the methyl 
signal of dimethylsilapentanesulfonate (Sigma, St. Louis, MO) as an internal standard. The 
resonance frequency of 13C and 1 were 125.7 MHz and 499.9 MHz. The number of scans 
ranged from 16 to 32 and was inversely proportional to the concentration of the NMR 
samples. The spectral width was 5028.05 Hz and 5482.26 Hz along the 13C (F1) and 1H (F2) 
dimension respectively. Peak aliasing was used to minimize the sweep width in the 13C 
dimension.  The number of complex datapoints were 1024 (1H) and 900 (13C). While 
acquiring the TOCSY spectra, the DIPSI-2 sequence was used for isotropic mixing; with a 
mixing time of 76 ms. Additionally, 2-D HSQC spectra were obtained using a J-scaling 
factor of 6 in F1 dimension (Willker et al., 1997).  NMR spectra were acquired and 
processed by using the Xwinnmr (Bruker) software. The HSQC and TOCSY spectra were 
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analyzed by using the free software NMRview (Johnson and Blevins, 1994). Deconvolution 
of multiplet intensities was carried out using software written in our lab (Sriram et al., 2004) 
based on the spectral processing, first proposed by van Winden et al, 2001 (van Winden et 
al., 2001). Peak assignments were verified using 2-D [1H, 1H] TOCSY and 3-D [13C, 1H, 1H] 
TOCSY analyses on a 100% 13C-labeled protein samples. 
3.5.6 Flux evaluation methodology and computer program 
Fluxes were quantified by using the generic flux evaluation software NMR2Flux 
reported by Sriram et. al. (2004). The working of the tool NMR2Flux was demonstrated by 
employing the MM temperature condition as a case study (Sriram et al., 2004). NMR2Flux 
employs isotopomer balancing and a global optimization routine to calculate a 
stoichiometrically feasible set of fluxes that best explains the observed isotopomer 
measurements. Approximately 300 simulations were performed for each temperature 
condition. Statistical analysis using the JMP software (SAS Institute, Cary, NC) was carried 
out to determine the standard deviations of the fluxes and reversibilities. The student’s t-Test 
(P < 0.05) was performed to compare the means of different temperature conditions. The 
error in the isotopomer measurements were used to perform random Monte Carlo simulations 
to generate probability distributions for the fluxes (Press et al., 1992). For the mathematical 
details, the reader is referred to our previous work (Sriram et al., 2004).  
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4. STUDY ON PATHWAY INTERACTIONS IN THREE 
GENOTYPES OF DEVELOPING SOYBEAN COTYLEDONS 
WITH DIFFERING PROTEIN CONTENT 
4.1 Introduction 
A comprehensive mathematical framework (NMR2Flux) for metabolic flux analysis has 
been developed in our lab and has been effective in elucidating various aspects of central 
carbon metabolism in developing soybean embryos (Sriram et al., 2004). For example, the 
fluxes through the non-oxidative reactions of the oxidative pentose phosphate pathway 
(oxPPP) catalyzed by the transketolase and transaldolase enzymes were found to be much 
higher in the plastid than in the cytosol for soybean embryos. This result supports the current 
emerging model of the oxPPP in which the non-oxidative enzymes of the oxPPP are mainly 
restricted to the plastid (Kruger and von Schaewen, 2003). Another example in soybean 
embryos was the plastidic fructose-1, 6-bisphosphatase (f16bpP) flux catalyzing the 
conversion of T3P to F6P. The f16bpP flux was substantial in the plastid but negligible in the 
cytosol (where it was catalyzed by pyrophosphatase). The f16bpP reaction had to be added to 
the metabolic network to explain the labeling data from starch hydrolysate. f16bpP was not 
expected to be active in soybean embryos as it participates mainly in starch synthesis in 
photosynthetic systems (Heldt, 1997). However, it has been previously reported in pea 
embryos (Entwistle and ap Rees, 1990). Thus as demonstrated by the f16bpP reaction, MFA 
is helpful in identifying active pathways in biological systems.  
As described in detail in Chapter 3, the tool NMR2Flux was employed to study the 
effects of temperature on the biomass composition of the soybean embryos. The temperature 
study indicated that the fluxes through cytosolic phosphoenolpyruvate carboxylase (ppc), 
plastidic malic enzyme (meP) and the malate transporters varied considerably among the 
temperature treatments. The meP and ppc enzymes and malate transporters malT1 and malT2 
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contribute to the Pyr pool in the plastid, which is the metabolic crossroad of protein versus 
oil formation in soybean embryos. Hence, these reactions maybe potential targets towards a 
better understanding of the carbon flow into protein and lipid in soybeans. Chapter 3 
investigated the importance of the effect of temperature on soybean composition. Similarly, 
the genotype of the soybean is also a critical factor influencing the biomass composition of 
the developing embryo (Piper and Boote, 1999; Carter et al., 2004). However, the interaction 
between various pathways responsible for the physiological changes between genotypes is 
unknown. The application of the tool NMR2Flux to study the central carbon metabolism 
among three soybean genotypes that differ in protein accumulation forms the crux of the 
second part of this thesis. 
Comparison of soybean genotypes 
Two parent lines of soybeans, Evans (Lambert and Kennedy, 1975) and PI 153296 
(http://www.ars-grin.gov/cgi-bin/npgs/html/acchtml.pl?1136705, donated to the USDA-
GRIN database from Belgian Department of Agriculture) exhibited considerable difference 
in seed accumulation (Figure 4.1). The progeny of Evans and High-Protein PI 153296 (High 
PI) when back crossed three times with Evans yielded a series of (nearly isogenic lines - ~94 
% identical genes) back-crossed lines with either higher or lower accumulation of protein 
compared to Evans. These experiments were carried out previously in growth chambers in 
Dr. Westgate’s laboratory (Department of Agronomy, Iowa State University). One such 
back-crossed line displaying higher protein accumulation and importantly high yield is the 
BC3-128 genotype (Figure 4.1). The BC3-128 was also nearly isogenic to Evans and as a 
plant, grew as well as Evans in the fields.  
Soybeans with increased protein and yield are highly desired but are difficult to develop 
due to the inverse relationship between the two (Cober and Voldeng, 2000). Hence, the BC3-
128 is a potential candidate towards understanding carbon partitioning into biomass 
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Figure 4.1: (A) Protein accumulation and (B) dry weight data for Evans, High PI 
153.296 and BC3-128 (Preliminary experiments previously performed in growth 
chambers at Dr. Westgate’s laboratory, Dept. of Agronomy at Iowa State 
University). 
 
(A) 
(B) 
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constituents in soybeans. Thus the above discussed three genotypes, out of which two are 
parent lines (Evans and High PI), have been chosen to probe the regulation of central carbon 
metabolism using 13C MFA. There are mainly two linear growth regions (between 20-35 
days after flowering (DAF) and 35-45 DAF) for the three genotypes during embryo 
development (Figure 4.1). Additionally, it is observed that the difference in the accumulation 
of protein is more pronounced in the later stage of development (T4 and T5 in Figure 4.1). 
Metabolic flux analysis assumes metabolic quasi-steady state (Stephanopoulos et al., 1998) 
and hence two time points representing both linear growth regions are chosen for this study. 
The time points are in the region between 20-35 DAF and 35-45 DAF. At the second time 
point where the endogenous quantities of biomass constituents is higher, it is also essential to 
take into account the isotopic dilution (Szyperski, 1998). Thus, we propose to compare three 
genotypes during development at two different time points (between 20-35 DAF and 35-45 
DAF).  
4.2 Results and Discussion 
This study was designed to understand the variations in pathway interactions of central 
carbon metabolism between three soybean genotypes- Evans, High PI and back crossed BC3-
128 exhibiting large variations in protein content. The three soybean genotypes were grown 
in a growth chamber at an optimum temperature of 27°C/20°C day/night temperature 
(Westgate et al., 1995; Piper and Boote, 1999; Westgate et al., 2000; Pipolo et al., 2004) and 
cultured in vitro (where the 13C label was introduced) at the same temperature. Three 
different sets of all three genotypes were grown in the growth chamber. The first set (Set 1) 
was to assess the reproducibility of the available growth curve data (Figure 4.1). Set 2 and 
Set 3 served as replicates for the 13C MFA studies. The pods were harvested for in vitro 
cultures at two different times- one during the early stage of development (~ 20 days after 
flowering (DAF)-Time point 1) and one further along development (~32-35 DAF-Time 
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point 2). The intent was to understand the regulation of central carbon metabolism between 
the three genotypes and along development.  
4.2.1 Replication of growth curve for all three genotypes 
Figure 4.2 represents the comparison of growth curves (dry weight) from the May 2003 
experiment and Set 1 for all three genotypes. For High PI and BC3-128, the growth curves 
are in very good agreement with each other. For Evans, the difference between Set 1 and the 
May 2003 growth curve around 30-40 DAF is most likely a sampling error. As the Evans 
plant grows tall, the cotyledons at the different nodes along the plant are at different stages of 
development. Hence, care had to be taken to make sure that the seeds are harvested from 
nodes in the central region of the plant where they are in the same stage of development. 
Thus, the growth curves data match well between the May 2003 experiment and Set 1. The 
three genotypes were again grown in separate chambers (Set 2 and Set 3) for the in vitro 
culture experiment.  
4.2.2 Genotype effects on biomass and composition (Set 2) 
Seeds from Set 2 and Set 3 were selected for uniform initial size of approximately 40-45 
mg dry weight for Time point 1 and approximately 140-150 mg dry weight for Time point 2 
for all three genotypes (Figure 4.3). Only one cotyledon from the dicotyledon seed was 
cultured in vitro. There were four cotyledons for each 13C in vitro culture for all three 
genotypes. The dry weight accumulation was higher in culture compared to the plant (Figure 
4.3). The comparison of genotypes was carried out using the two-sample t-Test using the 
JMP software (version 6.0.0). The t-Test compares whether the means of two different 
sample sets are statistically different or not. The significance test is carried out using an alpha 
value of 0.05 which implies that even if the means are statistically similar, there is a 5% 
chance for a statistical difference. Figure 4.4 compares the dry weight growth rate between 
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Figure 4.2: Replication of growth curves for (A) High PI (B) BC3-128 and (C) Evans. Set 
1 was data collected from plants grown in the growth chamber in April 2005 and previous 
experiment data represented data from May 2003 experiment.   
(A) 
(B) 
(C) 
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Figure 4.3(A): Comparison of culture sampling and growth with the plant growth data 
for High PI genotype. The cotyledons grew much better in culture compared to the 
plant. 
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Figure 4.3(B): Comparison of culture sampling and growth with the plant growth data 
for BC3-128 genotype. The cotyledons grew much better in culture compared to the 
plant. 
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Figure 4.3(C): Comparison of culture sampling and growth with the plant growth data 
for all three genotypes. The cotyledons grew much better in culture compared to the 
plant. 
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genotypes at both time points for 13C culture. For Set 2 Time point 1 (Set 2 TP1), there was 
no statistical difference between the growth rates of all three genotypes. For Set 2 Time point 
2 (Set 2 TP2), the growth rate for the High PI line was statistically different from Evans and 
BC3-128. The growth rates for BC3-128 and Evans were however, statistically not different 
from each other for Set 2 TP2 (Figure 4.4). The sucrose consumption of Set 2 TP1 was 
statistically different for High PI compared to Evans and BC3- 128. The sucrose 
consumption was not statistically different between Evans and BC3-128 for Set 2 (TP1 and 
TP2). Glutamine was used as a nitrogen source in the experiment. Glutamine consumption 
rates were statistically different between all three genotypes for Set 2 (Figure 4.4). There 
were no common trends observed between sucrose and glutamine consumption rates and dry 
weight growth rate between the three genotypes. The comparison of the biomass constituents 
is discussed below. 
The comparison of protein accumulation between the culture (Set 2) and plant data is 
shown in Figure 4.5. For the culture data, the total protein content was analyzed using a CHN 
analyzer in the Chemistry facility at Iowa State University. For the protein data from the 
plant (May2003 experiment), the total protein content was estimated using microKjehldahl 
procedures. For Set 2 TP1, when the cotyledons were harvested off the plant for the in vitro 
culture, the trend displayed by the protein (% of DW) was the same as the plant data with 
High PI being the highest, followed by BC3-128 and then Evans. However, the protein 
percentages itself were higher than expected values (Figure 4.5) at around 21 DAF indicating 
that the cotyledons may have been further along in development for all three genotypes. 
After 6 days in culture, it was observed that the aforementioned trend remained same with 
High PI being the highest followed by BC3-128 and Evans. The protein percentages however 
dropped (Figure 4.5) owing to higher dry weight accumulation in culture compared to the 
plant (Figure 4.3). When the absolute protein (mg) was compared between culture and plant, 
the trends displayed were similar (Figure 4.5). The total protein (mg) was approximately  
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Figure 4.4: Comparison of (A) dry weight growth rate and corresponding (B) sucrose 
and (C) glutamine consumption rates for all three genotypes (Set 2 and Set 3) 
(A) 
(B) 
(C) 
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Figure 4.5: Comparison of protein accumulation- (A) % of DW and (B) absolute 
protein (mg) between culture (Set 2) and plant data. 
(A) 
(B) 
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same for all three genotypes before culture and after 6 days, the protein accumulation was 
highest in High PI, followed by BC3-128 and then Evans. For Set 2 TP2, we observed that 
the protein % dropped after 6 days in culture owing to increased dry weight accumulation in 
culture compared to the plant. However, as seen in Set 2 TP1, the trend remained same with 
High PI being the highest followed by BC3-128 and then Evans.  
For Set 2 TP2 absolute protein (mg), we observed that the BC3-128 accumulated more 
protein than High PI as they grow better even in the plant. The difference in protein 
accumulation between culture and plant was more pronounced for Set 2 TP2. The difference 
is again attributed to a higher dry weight accumulation rate in culture compared to plant 
(Figure 4.3). Figure 4.6 and 4.7 represent the lipid and starch accumulation data for Set 2 
respectively. The absolute lipid (mg) displayed similar trend to that observed by the plant. 
For Set 2 TP2 however, the lipid accumulation was more pronounced due to increased dry 
weight accumulation in culture compared to that in plant. For absolute starch (mg), Set 2 TP2 
displayed the same trend as that of the plant. However, Set 2 TP1 displayed a much higher 
starch accumulation for BC3-128 compared to the plant. Thus, for Set 2 the biomass 
constituents displayed similar trends for absolute protein and lipid amounts compared to the 
plant for both TP1 and TP2. A variation was however observed for starch accumulation.  
4.2.3 Genotype effects on biomass and composition (Set 3) 
Figure 4.3 shows that the dry weight accumulation was higher in culture compared to 
that in plant for Set 3. The growth rate for Set 3 TP1 was statistically significantly different 
between BC3-128 compared to High PI and Evans whereas the growth rate was statistically 
similar between High PI and Evans. For Set 3 TP2, the growth rate was statistically same for 
all three genotypes. The sucrose consumption rate mimicked the trend observed for growth 
rate for Set 3 TP1. For Set 3 TP2, there was a statistical difference between High PI and 
BC3-128 whereas no statistical difference was observed between High PI and Evans and 
  
67 
(B) 
Figure 4.6: Comparison of lipid accumulation- (A)% of DW and (B) absolute lipid 
(mg) between culture (Set 2) and plant data. 
 
(A) 
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(B) 
(A) 
Figure 4.7: Comparison of starch accumulation- (A)% of DW and (B) absolute 
starch (mg) between culture (Set 2) and plant data. 
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between Evans and BC3-128. Glutamine consumption varied between all three genotypes for 
Set 3 TP1. For Set 3 TP2, there was no statistical difference in glutamine consumption rates 
observed between High PI and Evans but BC3-128 varied compared to Evans and High PI. 
Thus, sucrose consumption rate exhibited the trend displayed by the growth rate for all three 
genotypes for Set 3 TP1. For Set 3 TP2, sucrose and glutamine consumption rates exhibited 
the trend displayed by the growth rate for High PI and Evans.  
The comparison of protein accumulation data (% of DW and absolute (mg)) between Set 
3 and plant is shown in Figure 4.8. For Set 3 TP1, when the cotyledons were harvested off 
the plant for the in vitro culture, the trend displayed by the protein (% of DW) was the same 
as the plant data with High PI being the highest, followed by BC3-128 and then Evans. 
However, the protein percentages itself were higher than what was expected (Figure 4.8) at 
around 21 DAF indicating that the cotyledons may have been further along in development 
for all three genotypes (similar to Set 2 TP1). After 6 days in culture, the protein percentages 
however dropped (Figure 4.8) owing to higher dry weight accumulation in culture compared 
to the plant (Figure 4.3). The final protein % after 6 days in culture was very similar for all 
three genotypes (~ 36 % of DW- Figure 4.8). Though the seeds were harvested around 21 
DAF for all three genotypes, dry weight of Evans was higher than that of High PI and BC3-
128 (Figure 4.3). The average temperature that was usually maintained in the growth 
chamber was around 27oC for a 14 hour photo period and 20oC in darkness mimicking the 
night temperature. The temperature controller in the growth chamber did not function 
properly during July 19 to July 20, 2005. The average temperature in the growth chamber 
was approximately 27oC in the growth chamber and no lower night temperature. The 
sampling for Evans culture (Set 3 TP1) was carried out on July 22nd, 2005. The higher 
temperature in the growth chamber just before the sampling possibly explains the higher dry 
weight of Evans at 21 DAF. The High PI line would not be affected by this temperature 
change as both cultures of High PI Set 3 (TP1 and TP2) had been carried out before July 15th,  
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(A) 
(B) 
Figure 4.8: Comparison of protein accumulation- (A)% of DW and (B) absolute 
protein (mg) between culture (Set 3) and plant data. 
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2005. The BC3-128 was harvested for the culture (Set 3 TP1) on August 5th 2005, much later 
than the temperature change. The absolute protein (mg) trend observed was not similar to 
that of the plant. Evans exhibited the largest protein accumulation followed by BC3-128 and 
High PI. For Set 3 TP2, when the cotyledons were harvested from the plant, they exhibited 
the right trend with High PI being the highest, followed by BC3-128 and then Evans. The 
temperature in the growth chamber was affected again from August 11th to August 12th, 2005 
resulting in an average temperature of approximately 26oC in the growth chamber and no 
lower night temperature. The BC3-128 was harvested from the plant for culture (Set 3 TP2) 
on August 16th, 2005. At the end of 6 days in culture, BC3-128 exhibited largest protein % 
(of DW) followed by High PI and Evans. The absolute protein amounts (mg) displayed the 
right trend of protein accumulation with BC3-128 being highest (owing to larger BC3-128 
seeds than High PI), followed by High PI and Evans. However, there was a considerable gap 
(~ 6 days) in sampling between Evans 38 DAF) and BC3-128/High PI (32 DAF) for Set 3 
TP2.  
The absolute lipid accumulation (mg) displayed the right trend as that of the plant for Set 
3 (TP1 and TP2), with Evans being the highest followed by the BC3-128 and High PI (Figure 
4.9). The absolute starch accumulation (mg) also looked similar to the plant data for Set 3 
TP1. For Set 3 TP2, the accumulation of lipid and starch was much higher compared to the 
plant owing to the higher growth rate in culture compared to plant (Figure 4.3). Thus, the Set 
3 TP1 displayed different trend in protein accumulation but similar trends in starch and lipid 
accumulation compared to the plant. For Set 3 TP2, the trends displayed for protein, starch 
and lipid were similar to the plant but were much higher due to faster growth in culture 
compared to the plant.  
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(A) 
(B) 
Figure 4.9: Comparison of lipid accumulation- (A)% of DW and (B) absolute lipid 
(mg) between culture (Set 3) and plant data. 
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(A) 
(B) 
Figure 4.10: Comparison of starch accumulation- (A)% of DW and (B) absolute 
starch (mg) between culture (Set 3) and plant data. 
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4.2.4 13C Metabolic flux analysis 
The protein and starch fractions from the soybean cotyledons of all three genotypes, 
High PI, Evans and the back-crossed line BC3-128 were acid hydrolyzed to prepare the 
NMR samples. We carried out two-dimensional Heteronuclear Single Quantum Correlation 
spectroscopy (2D HSQC) analysis on the protein and starch samples of all three genotypes 
from Set 2 (TP1 and TP2) and Set 3 TP1. Set 3 TP2 was disregarded from the flux analysis 
due to the difference in sampling time between Evans (38 DAF) and HighPI/BC3-128 (32 
DAF). We expect that this difference would most likely be responsible for different stages of 
development in the genotypes and hence would not be a true representative of the study. The 
NMR intensities obtained from the HSQC spectrum for protein and starch data provided 
information about the intracellular fluxes (Szyperski, 1995). Additionally, extracellular 
measurements such as substrate uptake rates (sucrose and glutamine), acid effluxes and 
fluxes contributing to biomass synthesis were also required to constrain the flux analysis 
(Wiechert, 2001). The input data including NMR intensities and external fluxes have been 
summarized in Appendix VII and VIII respectively. The assumption of steady state 
conditions in the labeling studies of soybean embryos was verified. For Evans genotype, Set 
2 TP1, the sucrose uptake rate was 3.42 µmoles h-1 cotyledon-1. Assuming the cotyledon to 
be a continuously stirred tank reactor (CSTR) with a volume of approximately 0.3 ml and the 
intracellular sucrose concentration to be approximately 37 mM (Lichtner and Spanswick, 
1981), the residence time of sucrose was calculated to be 3.3 hours. Isotopic steady state is 
attained within five residence times and thus was estimated to be 16 hours which was less 
than the experimental time (six days) in the labeled in vitro culture. Isotopic steady state was 
also verified for all genotypes for Set 2 and Set 3 TP1 (data not shown). 
The metabolic reaction network representing the central carbon metabolism in soybean 
cotyledons was the same as that in the temperature study. There are parallel pathways of 
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glycolysis and oxidative pentose phosphate pathway in the cytosol and the plastid. The TCA 
cycle is in the mitochondrion and glutamine assimilation reaction in the plastid. γ-
aminobutyric acid shunt (GABA shunt) shuttles glutamine and α-ketoglutarate between the 
plastid, cytosol and the mitochondrion. T3P, G6P and P5P transporters allow the exchange of 
the corresponding metabolites between the cytosol and the plastid. Anaplerotic reactions such 
as malic enzyme (cytosol and plastid) and PEP carboxylase enzyme (ppc) in cytosol are also 
included. There is a malate shuttle which allows transport between mitochondrion and 
cytosol (malT1) and from cytosol to plastid (malT2). The biosynthetic reactions of protein, 
starch and lipid synthesis are assumed in the respective compartments as known from 
literature. We have not included the fixation of evolved CO2 by the Rubisco flux (Schwender 
et al., 2004) as our isotopomer NMR data did not  ‘identify’  the flux through the Rubisco 
pathway (Wiechert et al., 2001). The reactions included were verified from biochemical texts 
(Dey and Harborne, 1997; Singh, 1998), online databases (Soybase and KEGG encyclopedia) 
and literature (Chollet et al., 1996; Casati et al., 1999).  
Using the input NMR intensities, external flux data and the metabolic network explained 
above, we carried out MFA using the tool NMR2Flux (Sriram et al., 2004) in order to 
understand the pathway interactions responsible for the varied protein accumulation between 
the three genotypes for Set 2 (TP1 and TP2) and Set 3 TP1. The results of the flux analysis 
are described in detail in the following sections. 
4.2.5 Common metabolic trends observed among the three genotypes (Set 2/Set 3)  
13C MFA of all three genotypes High PI, Evans and back-crossed line BC3-128 (Set 2 
and Set 3 TP1) was carried out using the tool NMR2Flux. The NMR multiplet intensities of 
experimental versus simulated data compared well between each other for all three genotypes 
(Appendix IX). The experimental isotopomer abundance of Leu δ1 varies considerably from 
Val γ1 and Alaβ though they all represent carbon atom 3 of their precursor metabolite Pyr. 
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This result was observed in our temperature study data (Chapter 3) and in another plant 
system Catharanthus roseus being studied in our lab (unpublished data). Though the exact 
reason for this is unknown, it is likely that there are reversible or additional reactions are 
involved in the biosynthesis of Leu. The removal of the isotopomer abundance of Leu δ1 
from the NMR input data does not affect the metabolic fluxes as demonstrated in Appendix 
X. The observed pathway interactions and direction of carbon flow through the various 
branches of central carbon metabolism which were common to Set 2 (TP1 and TP2) and Set 
3 TP1 are discussed below (Figure 4.11).  
As observed in our temperature study experiment, parallel pathways of glycolysis and 
oxPPP were distinguished between the cytosol and the plastid. The hexose isomerase flux 
was in the direction of F6P → G6P, channeling carbon flow through the oxPPP in a cyclic 
manner. The flux through non-oxidative reactions of the oxPPP catalyzed by the 
transketolase (tkt) and transaldolase (tal) enzymes were much greater in the plastid compared 
to the cytosol. The f16bpP, which catalyzes the conversion of T3P to F6P was higher in the 
plastid than the cytosol. The glyoxylate shunt, which is associated with lipid catabolism, was 
negligible in both cases as expected as the cotyledons predominantly accumulate lipids and 
proteins. There was substantial flux through the GABA shunt. These results illustrate the 
general trend in the carbon flow through primary metabolism.  
However, to understand the differences in carbon regulation between the genotypes, 
comparisons have been made in terms of relative fluxes, where the total substrate entering 
into the system is assumed constant through all three genotypes. To that end, relative fluxes 
were standardized with respect to 100 mol of sucrose intake. Absolute and relative fluxes 
have been summarized in Appendix XI and XII for all three genotypes (Set 2 (TP1 and TP2) 
and Set 3 TP1) respectively. Another important parameter that helps in distinguishing the 
genotypes is the flux ratios of various branchpoints in the reaction network. The ‘flexibility’ 
or ‘rigidity’ of a node can be insightful in identifying preferred direction of carbon flow and  
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Figure 4.11: Metabolic flux map representing central carbon metabolism in BC3-128 
genotype (Set 2 TP1). The thickness of the arrows is proportional to the relative fluxes 
(standardized with respect to 100 mol of sucrose intake). Table in Appendix lists all 
relative fluxes for the BC3-128 Set 2 TP1. Intracellular metabolites are shown in white 
ovals, and gray ovals represent sink metabolites (amino acids, nucleotides etc.). Metabolic 
pathways are color coded as follows- Glycolysis and sucrose metabolism: dark red; 
oxPPP: pale blue; anaplerotic pathways: mauve; glutamate assimilation: brown; TCA 
cycle: orange; biosynthetic fluxes: gray; pyr dehydrogenase: blue-gray and transport 
fluxes: black. 
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regulation of metabolism (Stephanopoulos and Vallino, 1991). To elucidate, if the ratio of the 
carbon partitioning into multiple reactions at a node remains constant, irrespective of changes 
in the total incoming flux, then the node is said to be ‘rigid’. Hence, genetic manipulation of 
the reactions involved in a flexible node is likely to be more productive in channeling the 
precursor metabolite in the preferred direction (Stephanopoulos and Vallino, 1991). 
Conversely, for rigid nodes it is more difficult to modify the intrinsic regulation of flux 
through the node, and hence would require multiple genetic manipulations of the enzymes 
involved. The results of the nodal analysis and comparison of relative fluxes between 
genotypes has been discussed in detail below. 
4.2.6 Pathway interactions in Set 2 TP1 
The comparisons between the three genotypes have been made as follows- High PI with 
Evans, High PI with BC3-128 and Evans with BC3-128. The metabolic fluxes and flux ratios 
that are statistically similar are discussed first. Comparing High PI with BC3-128, we 
observed that flux through the hexose isomerase reaction in the cytosol (hxiC) was 
statistically similar to each other (Table 4.1). Furthermore, the total flux through the hexose 
isomerase reaction (cytosol and plastid- hxitotal) was also statistically similar to each other. 
Comparison of flux ratios indicate that the partitioning of the flux into the total oxPPP 
(cytosol and plastid- oxPPPtotal) with respect to the net glycolytic pathway (cytosol and 
plastid) as denoted by the ratio oxPPPtotal/glycolysistotal on a C mol basis was statistically 
similar between BC3-128 and High PI (Table 4.1). The ratio of respiration relative to the 
total sucrose intake for both High PI and BC3-128 was statistically similar as well. Table 4.1 
summarizes the results stated above.  
There were no reactions that were statistically similar between Evans and BC3-128. 
When Evans and High PI were compared, we observe that flux through the oxidative pentose 
phosphate pathway in the cytosol (pglC) was statistically similar (Table 4.1). Additionally,  
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Table 4.1: Comparison of relative flux values (Standardized w.r.t. 100 mol of sucrose intake) 
and flux ratios (C mol basis) for Set 2 TP1 for all three genotypes. Subscript f indicates net 
flux in the forward direction; Superscript c, p or m represents cytosol, plastid and 
mitochondrion respectively. Bold faced indicates the values are statistically similar. 
Statistical analysis was carried out using student’s t-Test (p< 0.05). 
 
Set 2 TP1 Relative fluxes (Standardized w.r.t. 100 mol of 
sucrose intake) or flux ratios (C mol basis) 
Fluxes and Flux ratios High PI BC3-128 Evans 
hxif C -99.0±14 -98±10 -103±25 
hxif total -187±47 -193±37 -140±32 
pglC 105±37 145±21 116±19 
pglP 157±49 127±37 109±25 
G6P transporter 76±37 38±21 78±28 
pyktotal 211±16 217±12 252±11 
ppc 24±3 28±2 29±2 
malT1 (m to c) -6±5 -16±3 -20±2 
me
M
 24±8 16±10 7±10 
me
P 14±2 9±2 8±1 
Glutamine consumption 39±2 32±2 38±3 
gad 170±39 178±37 227±44 
oxPPP/glycolysistotal 2.2±0.6 2.2±0.4 1.6±0.3 
pyktotal/meP 15.7±2.7 25.7±8.3 34.0±4.9 
resp/sucrose intake 0.7±0.03 0.7±0.03 0.8±0.03 
pglP contribution to 
NADPH consumption  
~107% ~95% ~76% 
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the G6P transporter from the cytosol to the plastid also was the same between High PI and 
Evans. High PI line produces the most protein, followed by the BC3-128 and then Evans in 
Set 2 TP1 (Figure 4.5). The Pyr pool in the plastid is the focal point for carbon partitioning 
into protein and oil in soybean cotyledons. The reactions feeding into the Pyr pool are the net 
pyk flux from the glycolytic pathway (pyktotal) and the plastidic malic enzyme (meP). 
Furthermore, the reactions contributing to the meP are the cytosolic PEP carboxylase reaction 
(ppc) enzyme, and the malate transporters (malT1 and malT2) that help in the exchange of 
malate pools in the cytosol, mitochondrion and plastid.  
The ratio of the oxPPPtotal relative to the glycolysistotal on a C mol basis (Table 4.1) was 
statistically similar in BC3-128 and High PI indicating a larger flux through the oxPPPtotal 
compared to the glycolytic pathway. In case of Evans, this ratio was lower indicating 
comparatively higher flux through the glycolytic pathway. The pyktotal flux was considerably 
higher than the meP enzyme for all three genotypes (Table 4.1). However, for High PI the 
contribution of the meP into the Pyr pool was the highest (Table 4.1). For Evans, the 
contribution of meP was the lowest. In case of BC3-128, the contribution of meP was more 
than Evans but less than High PI. Previously, El-Shora and ap Rees (1991) have also 
observed in suspension culture of soybeans that the meP activity was higher in tissues with 
increased biosynthetic activity, particularly linking it to amino acids. The activity of the 
malic enzyme has been associated usually with replenishing of metabolites required for 
biosynthesis or combating stress (Casati et al., 1999). Thus, the meP could potentially be an 
important influencing parameter in channeling of carbon flux into protein and oil in 
soybeans. This result additionally corroborates with the high variation in meP that we 
observed with response to temperature in our previous study.  
The flux through the ppc enzyme was lowest for High PI followed by BC3-128 and 
Evans. However, the variation in ppc enzyme was less pronounced than the meP (Table 4.1). 
In our temperature study, we observed a larger variation in ppc activity in response to 
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temperature. The malate transporter between the cytosol and mitochondrion (malT1) 
channeled more flux from cytosol to mitochondrion in case of Evans, followed by BC3-128 
and then High PI. However, the reversibility of malT1 was very high (~ 99%) indicating 
there was a rapid exchange between the two pools.  
The plastidic oxPPP flux (pglP) is an important source of reductant for lipid and protein 
biosynthesis, glutamine assimilation and countering oxidative stress by maintaining the redox 
potential in the plastid (Hauschild and von Schaewen, 2003). The flux through pglP 
contributed to > 94 % of the NADPH consumption in the plastid for biosynthetic reactions 
and glutamine assimilation for High PI and BC3-128 (Table 4.1). For Evans, pglP contributed 
to ~76 % of NADPH consumed. There was an increased consumption of NADPH in case of 
Evans due to higher GABA shunt (gad) driving glutamine assimilation (Table 4.1).  
Compared to the temperature study, the sucrose consumption rate was higher (2-3 times) 
in our genotype study. However, during the temperature study the incubator chamber was 
maintained at 27oC/20oC (day/night) whereas the culture was maintained at 26oC in the 
incubator chamber for the genotype study. Further, the sucrose consumption rate was 
measured by HPLC using the Aminex-87K column for Set 2 TP1 and was calculated from 
literature (Bennett et al., 1994) for the MM condition (Appendix II). The increased sucrose 
consumption was complemented with higher glutamine assimilation for all three genotypes. 
Though the growth rate across genotypes was considerably higher than that in plant (Figure 
4.3), the increased sucrose and glutamine consumption rates were not compensated with an 
equal increase in the biomass constituents. The result was higher rates of evolved CO2 among 
all three genotypes compared to the plant (Table 4.2). Table 4.2 delineates all the reactions 
that produce CO2 for all three genotypes (Set 2 TP1). The TCA cycle has high interaction 
with the GABA shunt and drives the glutamine assimilation into biomass synthesis. The TCA 
cycle reactions and GABA shunt contribute to ~41 % of the CO2 evolved for BC3-128. The  
other major contributors to the evolved CO2 are the oxPPPtotal (~30 %) and the pyruvate 
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Table 4.2: Reactions contributing to evolved CO2 for Set 2 TP1.  
 
% of net CO2 evolved (Set 2 TP1) 
Reaction 
High PI  BC3-128 Evans 
pdhM 
pdhP 
26.1 % 25.6 % 26.3 % 
glycine 0.5 % 0.3 % 0.2 % 
pglP 
pglC 
29.2 % 30.1% 23.2 % 
me
M 
me
P 
4.3 % 2.8% 1.5 % 
cs 
αkgdh 
gad 
40 % 41.1% 48.7 % 
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dehydrogenase (pdhtotal) reaction that converts Pyruvate to acetyl-CoA (~26%) for BC3-128. 
The contribution of these main reactions to the evolved CO2 was similar for High PI as well 
(Table 4.2). For Evans the contribution of TCA and GABA shunt driving glutamine 
assimilation was higher (~49%) and was compensated by a lower oxPPP contribution 
(~23%).  
4.2.7 Pathway interactions in Set 3 TP1 
Table 4.3 lists the comparisons between the three genotypes (Set 3 TP1) for some key 
fluxes. Comparing High PI with BC3-128, we observed that the carbon flux through the 
GABA shunt driving the glutamine assimilation (gad) was statistically similar to each other 
(Table 4.3). Comparing Evans and BC3-128, no reaction was statistically similar. 
Comparison of Evans and High PI showed statistical similarity between oxPPPtotal and the 
total hexose isomerase (hxitotal) enzyme. The ratio of the flux through oxPPPtotal relative to 
sucrose intake on a C mol basis was statistically similar as well between High PI and Evans.  
As elaborated previously, the Pyr pool is the focal point of carbon partitioning into 
protein and lipid in soybeans. The pyktotal flux was considerably higher than the meP for all 
three genotypes. The pyktotal was highest in High PI followed by BC3-128 and Evans. The 
flux through the meP was lowest in High PI followed by BC3-128 and Evans. This 
observation reflects the fact that the total protein and lipid accumulation also showed the 
reverse trend in Set 3 TP1 compared to Set 2 TP1, with Evans being the highest, followed by 
BC3-128 and then High PI.  
The fluxes that contribute to the meP are the malate transporters (malT1 and malT2) and 
the ppc enzyme. The flux through the ppc enzyme was comparable between Evans and High 
PI and higher in BC3-128 (Table 4.3). The direction of the malate transporter (malT1) was 
from cytosol to the mitochondrion with a high reversibility (> 98%) indicating there was a 
rapid exchange between the two pools similar to Set 2 TP1. The malT1 flux was lowest for  
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Table 4.3: Comparison of relative flux values (Standardized w.r.t. 100 mol of sucrose intake) 
and flux ratios (C mol basis) for Set 3 TP1 for all three genotypes. Subscript f indicates net 
flux in the forward direction; Superscript c, p or m represents cytosol, plastid and 
mitochondrion respectively. Bold faced indicates the values are statistically similar. 
Set 3 TP1 Relative fluxes (Standardized w.r.t. 100 mol of 
sucrose intake) or flux ratios (C mol basis) 
Fluxes and Flux ratios High PI BC3-128 Evans 
hxif C -96±17 -104±14 -93±15 
hxif total -141±36 -194±36 -144±45 
oxPPPtotal 216±36 273±36 214±44 
pyktotal 223±12 209±11 204±15 
ppc 29±2 36±2 28±3 
malT1 (m to c) -21±3 -27±3 -15±4 
me
P
 5±1 7±1 9±2 
citrate synthase (cs) 198±15 208±15 140±17 
Glutamine consumption 33±2 29±2 34±7 
gad 210±37 206±36 108±51 
oxPPPtotal/glycolysistotal 1.7±0.4 2.2±0.4 1.8±0.5 
oxPPPtotal/Sucrose intake 1.1±0.2 1.4±0.2 1.1±0.2 
pyktotal/meP 50±14 31±4 26±11 
resp/sucrose intake 0.7±0.03 0.8±0.03 0.6±0.03 
pglP contribution to NADPH 
consumption  
~95% ~115 % ~140% 
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Evans, followed by High PI and then BC3-128. The flux through the pglP contributed to 95 
% of the NADPH consumption in the plastid for biosynthetic reactions and glutamine 
assimilation for High PI and completely satisfied NADPH consumption for BC3-128 (Table 
4.3). For Evans, pglP contributed to ~144 % of NADPH consumed. The decreased 
consumption of NADPH in case of Evans was due to lower GABA shunt (Table 4.3).  
Table 4.4 delineates all the reactions that produce and consume CO2 for Set 3 TP1. The 
TCA cycle has high interaction with the GABA shunt and drives the glutamine assimilation 
into biomass synthesis. The TCA cycle reactions and GABA shunt contribute to ~46 % of the 
CO2 evolved for High PI. The other major contributors to the evolved CO2 are the oxPPPtotal 
(~24 %) and pdhtotal (~27 %). The contribution of these main reactions to the evolved CO2 for 
BC3-128 are; TCA cycle and GABA shunt (~44 %) followed by oxPPP (~28 %) and the 
pdhtotal (~24 %). For Evans the contribution of TCA and GABA shunt is 41 % and is 
compensated by a higher oxPPPtotal (~29 %) and pdhtotal (~28 %).  
4.2.8 Comparison of pathway interactions between Evans- MM (from temperature 
study) and Set 2 TP1 and Set 3 TP1 
For the Evans genotype, Set 2 TP1 and Set 3 TP1 are representatives of the same stage 
of development of the soybean cotyledon (~20 days after flowering). From the temperature 
work, the MM soybean data also represents the same stage of development of the soybeans 
and temperature condition (27oC day/20oC night) as the genotype work. Hence a comparison 
of the metabolic fluxes of these three conditions (MM, Set2 TP1 and Set 3TP1) of Evans has 
been performed. Table 4.5 summarizes the biomass growth and composition data for Evans 
(MM, Set2 TP1 and Set 3TP1). The net biomass accumulation was comparable between MM 
and Set 2 TP1. However the protein and lipid accumulation was higher in MM than Set 2 
TP1 whereas starch accumulation was lower in MM than Set 2 TP1. Set 3 TP1 showed 
higher biomass accumulation compared to MM and Set 2 TP1. The temperature controller in  
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Table 4.4: Reactions contributing to evolved CO2 for Set 3 TP1.  
 
% of net CO2 evolved (Set 3 TP1) 
Reaction 
High PI BC3-128 Evans 
pdhM 
pdhP 
26.5 % 23.8 % 27.6 % 
Glycine 0.4 % 0.2 % 0.7 % 
pglP 
pglC 
23.6 % 27.6 % 28.6 % 
me
M 
me
P 
3.7 % 3.9 % 2.5 % 
cs 
αkgdh 
gad 
45.8 % 44.4 % 40.6 % 
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Table 4.5: Comparison of total biomass growth and composition data for Evans (Set 2 TP1 
and Set 3 TP1 and MM from temperature study).  
Biomass dry weight growth and composition  
(mg cotyledon-1 for Evans) 
For 6 days 
Set 2 TP1 MM Set 3 TP1 
Growth 38.6±7.9 41.0±7.1 46.2±1.2 
Protein accumulation 11.6±2.6 13.1±2.3 16.5±0.3 
Lipid accumulation 5.0±1.2 6.4±0.6 6.7±0.1 
Starch accumulation 4.5±0.8 2.6±0.4  4.1±0.02 
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Figure 4.12: Comparison of amino acid composition between Evans Set 2 TP1, Set 3 
TP1 and MM from temperature study. 
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the growth chamber did not function properly few days (July 19 to July 20, 2005) before the 
sampling of Evans (Set 3 TP1) for in vitro culture was carried out (July 22nd, 2005). The seed 
weight of Evans was hence higher than usual (Figure 4.3(C)) for its development stage (20 
DAF) during the culture harvest.  
The increased temperature in the growth chamber prior to culture may also be 
responsible for the higher growth rate in Set 3 TP1 compared to Set 2 TP1 and MM. The 
protein accumulation was correspondingly higher in Set 3 TP1 due to increased biomass 
accumulation. The sucrose and glutamine consumption rates varied greatly between the three 
datasets. However, during the temperature study the incubator chamber was maintained at 
27oC/20oC (day/night) whereas the culture was maintained at 26oC in the incubator chamber 
for the genotype study. Further, the sucrose consumption rate was measured by HPLC using 
the Aminex-87K column for Set 2 TP1 and Set 3TP1 and was calculated from literature 
(Bennett et al., 1994) for the MM condition. The calculation is explained in detail in 
Appendix II. Though the biomass accumulation was comparable between MM and Set 2 
TP1, the sucrose consumption rate was almost 3 times higher in case of Set 2 TP1 than MM. 
This difference was also reflected in the respiration (as a % of sucrose intake) with the 
respiration being high in Set 2 TP1 than MM (Table 4.6). In case of Set 3 TP1, the sucrose 
intake was higher than MM but lower than Set 2 TP1.   
The amino acid profile for MM, Set 2 TP1 and Set 3 TP1 (Figure 4.12) demonstrates 
that the mol fraction (of total protein) of glutamine family of amino acids (Glx, Pro and Arg) 
was highest in Set 2 TP1, followed by Set 3 TP1 and then MM. The mol fraction of OAA 
family of amino acids (Asp, Thr, Met, Lys and Ile) was comparable between MM and Set 3 
TP1 but lower in Set 2 TP1. Appendix XIII lists the comparison of input NMR intensity 
fractions for MM, Set 2 TP1 and Set 3 TP1. There was a large difference in NMR intensities 
between Set 2 TP1 and MM for most peaks. Thus, the intracellular metabolism was 
obviously different between MM and Set 2 TP1 despite comparable biomass accumulation. 
  
89 
Table 4.6: Comparison of absolute flux data in µmole day-1cotyledon-1 for Evans Set 2 TP1, 
Set 3 TP1 and MM from temperature study.  
Evans   
Absolute fluxes  
(µmole day-1cotyledon-1) 
Fluxes 
Set 2 TP1 MM φ Set 3 TP1 
Sucrose intake* 83±3  54±5 
Glutamine intake * 29±1  24±1 
Sucrose intake 82±4 29±0.3 60±3 
Glutamine intake 31±2 14±1 20±5 
resp/sucrose intake 0.8±0.03 0.4±0.02 0.6±0.03 
pyktotal 208±17 55±4 121±12 
me
p 6±1 2±1 5±1 
ppc 24±2 6±1 17±2 
malT1 (m to c) -16±2 -2±1 -9±3 
oxPPPtotal 185±24 60±13 127±26 
hxitotal -115±26 -39±13 -86±26 
Glu to protein 4.9±0.1 4.7±0.0 6.4±0.2 
OAA to protein 3.5±0.2 2.3±0.0 6.1±0.5 
Pyr to protein 6.8±0.1 8.2±0.0 8.9±0.2 
AcoA to lipid 25.6±0.6 32.7±0.0 34.5±1.8 
AcoA to protein 1.2±0.1 1.6±0.0 1.7±0.1 
* indicates measured sucrose and glutamine consumption values 
φ 
 indicates sucrose values was calculated from literature 
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There was considerable variation observed between the isotopomer abundances of the 
OAA and Pyr family of amino acids between Set 3 TP1 and MM. Additionally, the levulinic 
acid peaks from the protein and starch spectrum varied between Set 3 TP1 and MM 
(Appendix XIII). Between Set 2 TP1 and Set 3 TP1, the OAA and levulinic acid peaks from 
the protein spectrum exhibit considerable difference. Thus the NMR isotopomer abundances 
suggest that there was a difference in the metabolism between Set 3 TP1 and MM and 
between Set 3 TP1 and Set 2 TP1. The absolute fluxes for some key pathways for Set 2 TP1, 
MM and Set 3 TP1 have been summarized in Table 4.6.   
4.2.9 Comparison of pathway interactions between Set 2 and Set 3 (TP1) For High PI 
and BC3-128 
The comparison of flux data for Set 2 TP1 and Set 3 TP1 for High PI is discussed below. 
High PI Set 3 TP1 grew better than Set 2 TP1 in culture (Table 4.7). The total protein and 
starch accumulation was however comparable between High PI Set 2 and Set 3 TP1 
indicating a lower protein and starch content (% of biomass) in Set 3 TP1 than Set 2 TP1. 
The total lipid accumulation was lower in Set 3 TP1 compared to Set 2 TP1. Table 4.7 
summarizes the biomass growth and composition data for High PI (TP1). The higher growth 
rate was accompanied by a higher sucrose consumption for High PI Set 3 TP1 relative to Set 
2 TP1 (Table 4.8). However, the glutamine intake relative to sucrose intake is lower in Set 3 
TP1 than Set 2 TP1. 
Figure 4.13 demonstrates that the amino acid profile for High PI Set 2 and Set 3 TP1 
compare well with each other. In case of OAA family of amino acids, the lower Asp % in Set 
3 TP1 (denoted by Asx) is compensated by a higher Thr in Set 3 TP1. Though the net starch 
accumulation was comparable between High PI Set 2 and Set 3 TP1, the NMR intensities of 
levulinic acid peaks from starch hydrolysate of High PI Set 2 and Set 3 TP1 vary 
considerably (Appendix VII). In addition, from a carbon flux perspective, total carbon 
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Table 4.7: Comparison of total biomass growth and composition data for High PI (Set 2 TP1 
and Set 3 TP1).  
Biomass dry weight growth and composition  
(mg cotyledon-1 for High PI TP1) 
For 6 days 
Set 2 TP1 Set 3 TP1 
Growth 39.4±5.0 45±0.6 
Protein accumulation 14.8±2.1 14.4±0.5 
Lipid accumulation 6.8±0.8 4.9±0.2 
Starch accumulation 4.5±0.6 4.8±0.2 
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Figure 4.13: Comparison of amino acid composition between High PI Set 2 TP1 and 
Set 3 TP1. 
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Table 4.8: Comparison of absolute flux data (µmole day-1cotyledon-1) and relative flux data 
(standardized w.r.t. 100 mol of sucrose intake) for High PI (Set 2 TP1 and Set 3 TP1).  
High PI   
Absolute fluxes  
(µmole day-1cotyledon-1) 
Relative fluxes standardized 
w.r.t. 100 mol of sucrose 
intake 
Fluxes 
Set 2 TP1 Set 3 TP1 Set 2 TP1 Set 3 TP1 
Sucrose intake* 51±6 60±3   
Glutamine intake * 19±2 20±1   
Sucrose intake 54±2 65±3 100±0.0 100±0.0 
Glutamine intake 21±1 22±1 39±2 33±2 
resp/sucrose intake 0.7±0.03 0.7±0.03 0.7±0.03 0.7±0.03 
pyktotal 115±11 145±11 212±16 223±12 
me
p 8±1 3±1 14±2 5±1 
ppc 13±2 19±2 24±3 29±2 
malT1 (m to c) -3±2 -13±2 -6±5 -21±3 
oxPPPtotal 143±24 140±24 263±47 216±36 
hxitotal -102±24 -91±24 -188±47 -141±36 
Glu to protein 5.8±0.1 6.1±0.1 10.7±0.5 9.4±0.4 
OAA to protein 4.7±0.2 4.4±0.2 8.6±0.6 6.8±0.4 
Pyr to protein 8.1±0.1 8.1±0.1 14.9±0.8 12.6±0.6 
AcoA to lipid 33.9±0.8 24.5±1.5 62.4±3.8 37.9±3.1 
AcoA to protein 1.5±0.1 1.5±0.1 2.7±0.3 2.3±0.2 
* indicates measured sucrose and glutamine consumption values 
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entering into Glu, OAA and Pyr family of amino acids and into lipid relative to sucrose 
intake was higher in case of Set 2 TP1 than Set 3 TP1 (denoted by relative fluxes in Table 
4.8). Correspondingly, the relative flux through the meP is almost 3 times higher in Set 2 TP1 
than Set 3 TP1. Thus, the difference in metabolic fluxes in case of High PI Set 2 and Set 3 
TP1 seems to be influenced by the relative accumulation of biomass constituents such as 
protein and lipid. 
Table 4.9 summarizes the biomass growth and composition data for BC3-128. The 
biomass accumulation was higher for Set 2 TP1 than Set 3 TP1. Correspondingly, total 
protein, lipid and starch accumulation were also higher in Set 2 TP1 than Set 3 TP1 (Table 
4.9). The amino acid composition comparison is shown in Figure 4.14. The glutamine family 
of amino acids (Glx, Arg and Pro) was higher in Set 2 TP1 than Set 3 TP1. The total OAA 
family of amino acids (Asp, Thr, Met, Lys and Ile) was lower in Set 2 TP1 than Set 3 TP1. 
However, the large difference in Asp % between Set 2 and Set 3 was compensated to an 
extent by higher Thr % in Set 2 TP1 relative to Set 3 TP1 Figure 4.14).   
The measured and simulated sucrose and glutamine consumption rates compare well 
with each other for BC3-128 Set 2 and Set 3 (Table 4.10). The lower biomass accumulation 
in Set 3 TP1 was reflected by a higher respiration in case of Set 3 TP1 than Set 2 TP1 (Table 
4.10). The NMR isotopomer abundances of Tyr δ and Starch peaks which have a direct 
impact on the oxPPP and glycolysis node in the plastid was different in BC3-128 Set 2 and 3 
(TP1) (Appendix VII). Correspondingly, the relative flux through the oxPPPtotal was much 
higher for Set 3 TP1 than Set 2 TP1. From the biomass composition data (Table 4.9), we 
observe that protein, starch and lipid accumulation were higher in Set 2 TP1 than Set 3 TP1, 
with the difference in lipid accumulation being the largest. The pyktotal flux that channels 
carbon to Pyr pool and the meP were higher in Set 2 TP1 than Set 3 TP1. The malT1 
transporter channels lower carbon from cytosol to mitochondrion making more carbon  
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Table 4.9: Comparison of total biomass growth and composition data for BC3-128 (Set 2 
TP1 and Set 3 TP1).  
Biomass dry weight growth and composition  
(mg cotyledon-1 for BC3-128 TP1) 
For 6 days 
Set 2 TP1 Set 3 TP1 
Growth 42.3±6.5 37.6±5.0 
Protein accumulation 13.2±2.4 12.5±1.7 
Lipid accumulation 8.3±1.6 3.2±0.7 
Starch accumulation 5.5±0.8 4.7±0.5 
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Figure 4.14: Comparison of amino acid composition between BC3-128 Set 2 TP1 
and Set 3 TP1. 
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Table 4.10: Comparison of absolute metabolic flux data in µmole day-1cotyledon-1 and 
relative flux data (standardized w.r.t. 100 mol of sucrose intake) for BC3-128 (Set 2 TP1 and 
Set 3 TP1).  
BC3-128   
Absolute fluxes  
(µmole day-1cotyledon-1) 
Relative fluxes standardized 
w.r.t. (100 µmole day-
1cotyledon-1 of sucrose intake)  
Fluxes 
Set 2 TP1 Set 3 TP1 Set 2 TP1 Set 3 TP1 
Sucrose intake* 77±3 74±6.0   
Glutamine intake * 25±1.0 22±2   
Sucrose intake 78±3 72±4 100.0±0.0 100.0±0.0 
Glutamine intake 25±1 21±1 32±2 29±2 
Resp/sucrose intake 0.7±0.03 0.8±0.03 0.7±0.03 0.8±0.03 
pyktotal 170±13 151±13 217±12 208±11.0 
me
p 7±1 5±1 9±2 7±1 
ppc 22±2 26±3 28±2 36±2 
malT1 (m to c) -13±3 -19±3 -16±3 -27±3 
oxPPPtotal 212±28 198±28 185±24 273±36 
hxitotal -151±28 -179±14 -193±37 -194±36 
Glu to protein 5.7±0.1 5.0±0.1 7.3±0.3 6.9±0.4 
OAA to protein 3.9±0.3 3.5±0.1 5.0±0.4 4.8±0.3 
Pyr to protein 7.5±0.1 6.5±0.1 9.6±0.4 6.9±0.4 
AcoA to lipid 41.3±1.4 17.3±1.2 52.9±2.7 24.0±2.0 
AcoA to protein 1.3±0.1 1.2±0.1 1.7±0.1 1.7±0.1 
* indicates measured sucrose and glutamine consumption values
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available in the form of malate to be shuttled to the plastid. CO2 fixation by ppc enzyme (Pyr 
→ OAA) was correspondingly lower in Set 2 TP1 (Table 4.10).  
4.2.10 Pathway interactions in Set 2 TP2 
For Set 2 TP2 absolute protein (mg), we observed that the BC3-128 accumulated more 
protein than High PI as the BC3-128 cotyledons grew better than High PI as seen even in the 
plant (Figure 4.5). Evans accumulated the lowest total protein. As the seeds were further 
along in development (32-35 DAF), they were bigger and hence we accounted for the 
endogeneous dilution for all three genotypes. Approximately, 15-20% dilution was observed 
among the three genotypes, which was included in the NMR2Flux program. Comparison of 
experimental and simulated intensities for High PI indicated that singlet and double doublet 
peak of LVA 5 of starch hydrolysate did not compare well with each other (Appendix IX). 
The discrepancy maybe a result of improper deconvolution as the resolution of the peak was 
not very good (Appendix IX). For Evans, the His δ peak did not compare well (Appendix 
IX). It is possible that this is a spectrum artifact with His being in extremely low quantities in 
the protein hydrolysate. For BC3-128, there was good comparison between experimental and 
simulated intensities.  
We observed that the pglP flux was statistically not different between all three genotypes 
and oxPPPtotal flux was statistically similar between High PI and BC3-128. Correspondingly, 
the ratio of the flux through pglP compared to the total sucrose intake was statistically similar 
between all three genotypes and oxPPPtotal compared to the total sucrose intake on a C mol 
basis was statistically similar between High PI and BC3-128 (Table 4.11). Additionally, flux 
through the non-oxidative reactions of the oxPPP catalyzed by tktA, tal and tktB in the plastid 
were also statistically not different between Evans and High PI. Comparing Evans and BC3-
128, the GABA shunt reactions driving glutamine assimilation (gad) was statistically similar. 
Further, the ratio of the oxPPPtotal relative to glycolysistotal on a C mol basis was statistically  
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Table 4.11: Comparison of relative flux values (Standardized w.r.t. 100 mol of sucrose 
intake) and flux ratios (C mol basis) for Set 2 TP2 for all three genotypes. Subscript f 
indicates net flux in the forward direction; Superscript c, p or m represents cytosol, plastid 
and mitochondrion respectively. Bold faced indicates the values are statistically similar. 
Set 2 TP2 Relative fluxes (Standardized w.r.t. 100 mol of 
sucrose intake) or flux ratios (C mol basis) 
Fluxes and Flux ratios High PI BC3-128 Evans 
hxif P -113±56 -120±46 -102±45 
hxif total -225±55 -213±47 -208±44 
pglP 163±65 169±55 176±52 
oxPPPtotal 297±55 290±47 279±45 
pyktotal 187±19 196±14 182±12 
ppc 15±2.0 36±3 38±4 
malT1 (m to c) 17±3 -16±3 -22±4 
me
P
 26±2 17±2 12±2 
citrate synthase (cs) 111±19 177±17 147±19 
Glutamine consumption 50±3.0 33±2 54±3 
gad 136±35 184±48 183±35 
oxPPPtotal/glycolysistotal 2.9±0.8 2.5±0.6 2.5±0.6 
pglP/Sucrose intake 0.8±0.3 0.9±0.3 0.9±0.3 
oxPPPtotal/Sucrose intake 1.5±0.3 1.5±0.2 1.4±0.2 
pyktotal/meP 7.1±0.9 11.8±1.5 16.3±4.1 
resp/sucrose intake 0.7±0.03 0.8±0.03 0.7±0.03 
pglP contribution to 
NADPH consumption  
1.12 1.22 1.07 
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similar between BC3-128 and Evans. The above mentioned ratio was lower (~2.5) in BC3-
128 and Evans indicating lower carbon through the oxPPP when compared to High PI (~2.9). 
Analyzing the plastidic Pyr pool which is the crossroad for protein and oil partitioning, we 
observed that pyktotal was much higher than meP for all three genotypes. The pyktotal was 
comparable between High PI and Evans but higher in BC3-128 (Table 4.11). As observed in 
Set 2 TP1, the meP was highest for High PI, BC3-128 and then followed by Evans. The ppc 
and malT1 transporter are directly linked with channeling flux into meP. The ppc flux was 
comparable between BC3-128 and Evans and was more than two times higher than ppc in 
High PI (Table 4.11). Correspondingly, malT1 transported flux from the cytosol to 
mitochondrion in case of Evans and BC3-128. However, for High PI, the lower ppc was 
complemented with a change in the direction of the malT1 for High PI; it transported malate 
from the mitochondrion to the cytosol. Thus, the flexibility of these anaplerotic reactions and 
the malT1 transporter has been observed again for Set 2 TP2. 
The pglP flux satisfied NADPH consumption in the plastid for all three genotypes (Table 
4.11). The respiration rate relative to the sucrose intake in C mole basis was ~ 65% for High 
PI but higher for BC3-128 and Evans (Table 4.11). As observed in Set 2 TP1, the TCA cycle 
and glutamine assimilation reactions contributed to approximately 45% of the evolved CO2, 
and the remaining was a combination of contribution from oxPPPtotal and pdhtotal.  
 4.3 Summary 
13C MFA of three genotypes High PI, BC3-128 and Evans with varying levels of protein 
production was performed. High PI produced the maximum protein on the plant followed by 
BC3-128 and then Evans. The analysis was carried out at two different stages of 
development (around 21 DAF and around 32-25 DAF) for one set (Set 2) and for only 21 
DAF for another set (Set 3). Comparisons of metabolic fluxes were performed between 
genotypes and between Set 2 and Set 3. The common metabolic trends in Set 2 and Set 3 
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included higher activity of the non-oxidative part of the oxPPP (catalyzed by tktA, tktB and 
tal) in the plastid than cytosol, substantial GABA shunt, negligible glyoxylate shunt and the 
hexose isomerase (hxi) reaction channeling carbon from F6P to G6P, thus feeding the oxPPP. 
The rate of CO2 evolution observed was high (~60-75%) due to higher sucrose and glutamine 
uptake from the culture media.  
The flexibility of the anaplerotic reactions catalyzed by cytosolic ppc, meP and malT1 
and malT2 transporters shuttling malate between cytosol, mitochondrion and plastid was 
observed again similar to our temperature study. In particular, a considerable increase in meP 
was observed during increased protein accumulation. For Set 2 TP2, the pglP flux and ratio of 
pglP flux to the sucrose intake on a C mol basis was statistically similar between all three 
genotypes. We did not observe rigidity in the same nodes in Set 2 and Set 3 between 
genotypes. For example, though we observed no statistical difference in the flux through 
oxPPPtotal relative to glycolysistotal (on a C mol basis) between High PI and BC3-128 for Set 
2, we did not observe this rigidity in Set 3. Further analysis indicated that there was a 
difference in isotopomer abundances of starch peaks in case of High PI and BC3-128 
between Set 2 and Set 3 which are important in estimating the oxPPP flux. Thus, despite 
being grown under similar conditions, comparisons of Set 2 and Set 3 (21 DAF) displayed 
considerable variation between the same genotype. However, during the duration of growth 
in the growth chamber, there were temperature fluctuations in the growth chamber for Set 3, 
which could have affected BC3-128 and Evans. For High PI, the seeds were harvested for 
culture before the temperature fluctuation set in. The variation between Set 2 and Set 3 (TP1) 
was thus a result of a combination of factors such as difference in the intracellular fluxes (as 
observed from the NMR intensities), biomass accumulation, biomass composition and the 
temperature fluctuation in the growth chamber. 
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4.4 Experimental Procedures 
4.4.1 Soybean cotyledon culture 
Three soybean (Glycine max) genotypes (Evans, High PI and backcrossed line (BC3-
128)) were grown in controlled environment chambers under conditions optimal for seed 
production and growth- 27°C/20°C day/night temperature, 14 hour photoperiod, with high 
output fluorescent lamps providing approximately 500 µmol photons m-2 sec-1 of 
photosynthetically active radiation at the upper leaves. Sufficient water and nutrients were 
applied to the soil to ensure vigorous plant growth. These conditions were maintained for the 
duration of seed development. Seeds were sampled at 10 day intervals to plot the growth 
profile for all three genotypes. This represented Set1 of our experiment.  
In another growth chamber the three genotypes were grown with the conditions 
maintained exactly similar to Set 1. This represented Set 2 of our experiment. In Set2, 21 
DAF (Time point 1), pods were harvested from the central nodes and four cotyledons were 
isolated under aseptic conditions for 13C in vitro culture. The cotyledons were approximately 
20-25 mg dry weight and selected for uniform initial size. They were cultured aseptically for 
six days in separate 25 ml Erlenmeyer flasks containing 4 ml liquid medium. The medium 
comprised of 146 mM sucrose (10% U-13C sucrose from Isotec, Miamisburg, OH) and 37 
mM glutamine as the only carbon sources and was replaced every three days. The flasks were 
gently shaken at 100 r.p.m. and maintained at 26°C day/night temperature within Percival 
incubators at approximately 100 µmol photons m-2 sec-1 light intensity. Cotyledons were 
harvested after 6 days in culture, rinsed with distilled water, frozen in liquid nitrogen and 
lyophilized at -50oC and 0.133 mbar for 72 h. The lyophilized cotyledons were finely ground 
for further processing. The procedure for the in vitro culture was repeated for all three 
genotypes around 32-38 DAF (Time point 2) to represent the latter stage in development. 
The cotyledons at this stage were sampled for a uniform initial size of approximately 70 mg 
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dry weight. In a third growth chamber (Set 3), the three genotypes were grown and the in 
vitro culture experiment was repeated approximately at 21 DAF (Time point 1) and 32-38 
DAF (Time point 2) during the course of development.  
4.4.2 Biomass quantification and fractionation 
Biomass growth was quantified by measuring fresh and dry weights of the cotyledon. 
The total lipid content was quantified gravimetrically using hexane extraction. Protein in the 
defatted pellet was isolated using phosphate buffer (150 mM, pH 7.2) containing 14mM β-
mercaptoethanol. The total protein content was measured using a PE2100 CHN analyzer 
(Department of Chemistry, Iowa State University) on a small fraction of biomass sample 
before lipid extraction. Soluble sugars from the defatted pellet were extracted in 800 g kg-1 
ethanol at 60oC for 20 min. The extraction was repeated four times. Successively, starch in 
the remaining pellet was digested in 100 mM citrate buffer containing amyloglucosidase 
enzyme in the ratio 0.025mg: 1 mg of dry weight. Starch content was quantified using the 
starch assay kit (Sigma, St. Louis, MO). Sucrose and glutamine consumption from the 
medium was measured using HPLC using the Aminex HPX-87K column (BioRad, Hercules, 
CA).  
4.4.3 Protein and starch hydrolysis, and NMR sample preparation 
The protein and starch were vacuum hydrolyzed in hydrolysis tubes (Pierce Endogen, 
Rockford, IL) using 6N constant boiling hydrochloric acid (HCl) (Sigma, St. Louis, MO). 
The acid was added in the ratio 0.5 ml HCl:1 mg protein/starch. The tube was evacuated, 
purged with N2 to remove residual air and re-evacuated. The sample (starch/protein) was 
hydrolyzed for 4 h at 150oC in a heat block. Rapidvap evaporator (Labconco, Kansas city, 
MO) was used to evaporate the acid in the hydrolysate. The residue was reconstituted in 2 ml 
of de-ionized water and lyophilized for 72 h. The sample was reconstituted in 500 µl of 
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deuterium oxide and transferred into an NMR tube. The sample pH was adjusted to 0.75-1.0 
using deuterium chloride. Amino acids in the samples were quantified by HPLC (Protein 
facility, Department of Biochemistry, Biophysics and Molecular Biology at Iowa State 
University) using a reverse phase C18 silica column, with detection at 254 nm.  
4.4.4 NMR spectroscopy 
[13C, 1H] Heteronuclear Single Quantum Correlation (HSQC) spectroscopy was 
performed on a Bruker Avance DRX 500 MHz spectrometer (NMR facility, Department of 
Biochemistry, Biophysics and Molecular Biology at Iowa State University) at 298 K. The 
reference zero ppm was set by the methyl signal of dimethylsilapentanesulfonate (Sigma, St. 
Louis, MO) as an internal standard. The resonance frequency of 13C and 1H were 125.7 MHz 
and 499.9 MHz. The number of scans was 16 for all NMR samples. The spectral width was 
5028.05 Hz and 5482.26 Hz along the 13C (F1) and 1H (F2) dimension respectively. Peak 
aliasing was used to minimize the sweep width in the 13C dimension.  The number of 
complex datapoints were 1024 (1H) and 900 (13C). Additionally, 2-D HSQC spectrum was 
obtained using a J-scaling factor of 6 in F1 dimension (Willker et al., 1997).  NMR spectra 
were acquired and processed by using the Xwinnmr (Bruker) software. The HSQC spectrum 
was analyzed by using the free software NMRview (Johnson and Blevins, 1994). 
Deconvolution of multiplet intensities was carried out using software written in our lab 
(Sriram et al., 2004) based on the spectral processing, first proposed by van Winden et al, 
2001 (van Winden et al., 2001). Peak assignments were verified using 2-D [1H, 1H] TOCSY 
and 3-D [13C, 1H, 1H] TOCSY analyses on a 100% 13C-labeled protein samples. 
4.4.5 Flux evaluation methodology and computer program 
Fluxes were quantified by using the generic flux evaluation software NMR2Flux 
reported by Sriram et. al. (Sriram et al., 2004). NMR2Flux employs isotopomer balancing 
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and a global optimization routine to calculate a stoichiometrically feasible set of fluxes that 
best explains the observed isotopomer measurements. Statistical analysis using the JMP 
software was carried out to determine the standard deviations of the fluxes and reversibilities. 
The error in the isotopomer measurements were used to perform random Monte Carlo 
simulations to generate probability distributions for the fluxes (Press et al., 1992). For the 
mathematical details, the reader is referred to our previous work (Sriram et al., 2004).  
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5. CONCLUSIONS AND FUTURE DIRECTIONS 
Conclusions 
13C MFA of developing soybean cotyledons was performed to explore the response of 
central carbon metabolism to two parameters; temperature and genotype effects. The 
temperature study demonstrated that the early development temperature is dominant in 
regulating certain metabolic aspects of the system, which was reflected in the rigidity of the 
important pglP node. Further the temperature during growth and incubation had a large 
impact on the flux through cytosolic ppc and meP and the malate transporters (malT1 and 
malT2) that channeled malate between cytosol, mitochondrion and plastid. The interaction 
between meP, cytosolic ppc, malT1 and malT2 was influenced by the metabolic demand for 
protein and lipid synthesis.  
The genotype study re-emphasized the results observed for cytosolic ppc, meP and 
malT1 and in particular an increase in meP flux was observed during increased protein 
accumulation. For Set 2 TP1, the flux ratio of oxPPPtotal relative to glycolysistotal was 
statistically similar (~2.2) between High PI and BC3-128 compared to a lower flux ratio in 
Evans (~1.6). The oxPPP is important for supplying NADPH for biosynthetic and glutamine 
assimilation reactions in the plastid. The higher flux through oxPPP could be a direct result 
of increased protein synthesis in High PI and BC3-128 compared to Evans. Though two 
experiments (Set 2 and Set 3) were carried out under the same conditions consecutively for 
all three genotypes thereby serving as replicates, considerable variation in fluxes were 
observed between the genotypes. However, there were temperature fluctuations in Set 3 
growth chamber which could have influenced Evans and BC3-128 directly. High PI was 
cultured before the temperature fluctuation set in. Thus the variation in metabolic fluxes 
within the same genotype between Set 2 and Set 3 (TP1) was influenced by a combination of 
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factors such as difference in intracellular fluxes (reflected on the NMR intensities), biomass 
accumulation and biomass composition and the temperature fluctuations in Set 3 growth 
chamber.  
Despite differences observed between replicates Set 2 and Set 3, certain trends observed 
remained the same. Both the temperature and genotype study demonstrated that the non-
oxidative part of the oxPPP catalyzed by tktA, tal and tktB was higher in the plastid than the 
cytosol which agrees with the model proposed for oxPPP in plant systems (Kruger and von 
Schaewen, 2003). The pyktotal flux was consistently higher than meP for all three genotypes. 
There was substantial GABA shunt driving glutamine assimilation reaction and hexose 
isomerase reaction channeled flux from F6P to G6P. Thus, 13C MFA can be beneficial to 
elucidate primary metabolism and understand the interactions between key pathways of plant 
systems.  
Future directions 
For the genotype study, in addition to 13C cultures, 12C cultures have been performed to 
study the mRNA expression levels of developing soybeans at Set 2 TP1. We observe that the 
ratio of the flux through the oxPPPtotal relative to glycolysistotal on a C mol basis is similar in 
High PI and BC3-128 (Set 2 TP1). It would be interesting to evaluate if the gene expression 
data mimics the flux data. Other key results include the flux ratio of plastidic malic enzyme 
to net pyruvate kinase flux being the highest in High PI, followed by BC3-128 and then 
Evans, indicating an increased flux through the meP for the highest protein producing line 
(High PI) which can be compared against the gene expression data.  
Thus, one approach of integrating the flux and gene expression data is to directly 
compare and contrast the trends between the two datasets. However, gene expression data 
could also lead us to more information about other enzymes linked to the reaction under 
consideration. For example, if we observe the expression of pyruvate dehydrogenase (pdh) 
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and find correlations between multiple other enzymes with pdh, the possibilities of those 
enzymes being a part of a regulatory network with pdh can be explored. The comparison of 
two analytical approaches could thus potentially further strengthen our conclusions and 
explain the regulatory aspects of carbon metabolism in soybeans.  
The current metabolic network is comprehensive for the isotopomer dataset that we have 
from the protein and starch hydrolysate. Though, we do not observe photosynthetic carbon 
fixation (observable from high Val γ2/ Leu δ2 enrichments), our NMR isotopomer dataset 
cannot ‘identify’ the Rubisco bypass flux that has been observed recently in Brassica napus 
embryos (Schwender et al., 2004). Schwender et. al. (2004) carried out elegant labeling 
experiments using U-13C labeled alanine and 1-13C alanine to distinguish the CO2 being 
refixed by Rubisco without the Calvin cycle versus the flux flowing through the glycolytic 
pathway towards protein and  particularly lipid synthesis in Brassica napus. The light 
intensity used during in vitro culture of Brassica napus embryos was in the range of 10-100 
µmol photons m-2 sec-1and was similar to what we used in our soybean embryo culture (100 
µmol photons m-2 sec-1). Schwender et. al. concede that the light intensity used during in 
vitro culture is much higher than what is available to the plant (Schwender et al., 2004) and 
hence the activity of Rubisco bypass in the plant could potentially be much lower than in 
vitro. For the genotype study, since we will have gene expression data from the soybean 
culture experiment, the Rubisco activity from the gene expression data can potentially clarify 
whether the Rubisco bypass reaction could be functional in soybeans. If we do see Rubisco 
activity, experiments to identify the activity of the Rubisco pathway in developing soybeans 
have to be planned. Thus, metabolic flux analysis can be employed as an iterative tool to 
identify new pathways and increase the rigor of the constructed metabolic network. The 
extension of the tool NMR2Flux to study transgenic soybeans has been discussed below.  
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Understanding lignin biosynthesis in glyphosate-resistant soybeans 
Transgenic soybeans, resistant to the herbicide glyphosate were planted widely since 
2000 (Reddy, 2001) despite lower yield as compared to conventional soybean lines (Elmore 
et al., 2001). Another side effect observed in glyphosate-resistant (GR) soybeans was higher 
stem splitting at higher temperatures which is attributed to an increased lignin synthesis 
(Pline-Srnic, 2005). The higher stem splitting is highly disadvantageous as it makes the crop 
susceptible to environmental stress. To understand the increased lignin content in GR 
soybeans, 13C MFA using NMR2Flux can be applied to explore the pathway interactions in 
primary metabolism.  
The enzyme 5-enolpyruvlyshikimate 3-phosphate synthase (EPSP synthase) is an 
important enzyme in the shikimate pathway responsible for channelling of carbon into 
aromatic amino acids phenylalanine, tyrosine and tryptophan and secondary metabolites such 
as lignins, flavonoids etc. The herbicide glyphosate primarily targets EPSP synthase and is 
hence modified in glyphosate-resistant soybeans. The current central carbon metabolic 
network for soybeans can be modified to include the detailed shikimate pathway (Figure 5.1). 
The total flux through the shikimate pathway can be calculated from the contribution of all 
three amino acids towards protein and secondary metabolites (such as lignin in the case of 
Phe) using analytical estimates of protein and lignin content. As it has been observed that a 
larger amount of lignin is produced in glyphosate-resistant soybeans, the total flux through 
the shikimate pathway would be correspondingly higher.  
In addition, NMR can be used to analyse the lignin fractions to study the corresponding 
monolignol structures (Ralph et al., 1999; Ralph et al., 2001). As the monolignols in the 
lignin polymer are essentially derivatives of Phe without any carbon skeleton rearrangement, 
NMR of the lignin fraction would not be able to completely elucidate the details of the 
monolignol biosynthetic pathway (Boerjan et al., 2003; Szyperski, 1995). However, any  
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Figure 5.1: Metabolic reaction network indicating the modified shikimate acid 
pathway represented by a dashed grey line 
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differences in the monolignol derivatives that are produced in the GR as compared to the 
conventional soybean lines can be detected (Ralph et al., 2001). 
The total flux calculated for the shikimate pathway combined with the NMR intensities 
of Phe in the protein (Sriram et al., 2004) and lignin fraction (Ralph et al., 2001) would 
provide constraints for the shikimate pathway in the reaction network. These measurements 
need to be supplemented with NMR intensities of the remaining amino acids, starch fraction, 
biomass composition and external flux measurements (Sriram et al., 2004). As the primary 
metabolism is highly interconnected, an increase in the carbon flow towards lignin 
biosynthesis may be directly reflected by a change in other reactions contributing to biomass 
synthesis. Thus, the interactions of the important pathways of central carbon metabolism may 
be able to explain lower yields observed. 
Extension to other plant systems 
Research is currently being carried out towards metabolite profiling of Arabidopsis 
thaliana, headed by Dr. Basil Nikolau at Iowa State University. Dr. Eve Wurtele’s lab is 
working on analyzing gene expression data of A. thaliana from all over the world. The focus 
is on integration of metabolite profiling and gene expression data for A. thaliana at the 
VRAC facility, at Iowa State University. Sterile culture of A. thaliana seedlings has been 
performed previously in our laboratory. Using the existing methodology for 13C MFA in our 
lab, the extension of the culture experiment to include 13C label can be planned on A. 
thaliana. Performing 13C MFA of A. thaliana will potentially add an additional dimension to 
its existing physiological information. 
Glawischnig et. al. semi-quantitatively analyzed isotopomer abundances from protein 
and lipid fractions of maize kernels grown in in vitro culture containing uniformly labeled 
glucose or acetate (Glawischnig et al., 2001). In a separate study, they analyzed the 
isotopomer abundances of the starch fraction of maize kernels, indicating significant 
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interactions of glycolysis, pentose phosphate pathway and glucogenesis (Glawischnig et al., 
2002). With the efficient 2D HSQC experiment and NMR2Flux, it would be beneficial to 
explore the central carbon metabolism in maize kernels in a system-wide manner. Once the 
metabolic network is established for maize kernels, it can be used to study various mutants 
and elucidate the effect of mutations on primary carbon metabolism.  
Thus, 13C MFA can be applied to different plant systems to study pathway interactions 
and compartmentation issues thereby elucidating important aspects of the plant physiology 
using the tool NMR2Flux. The disadvantage of 13C MFA usually arises from the limitation of 
using liquid cultures to introduce the label efficiently and economically into the plant system 
of interest. Once the methodology is established for a particular plant system, it can be 
extended to compare its genetic and/or environmental variants as demonstrated in this study. 
The importance of metabolic fluxes is steadily gaining emphasis in plant systems biology and 
it would be advantageous to integrate 13C MFA with other global analytical approaches such 
as proteomics, transcriptomics and metabolomics to give an overall correct picture of cellular 
physiology.   
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Table I-1: Relative multiplet intensities of amino acids from protein and glucosyl units from starch hydrolysates with their standard
deviations (SDs) from 2-D [13C, 1H] HSQC spectrum. s indicates singlet, d1 and d2 indicate the first and second doublet and dd indicates
the double doublet. Bold faced carbon atom in Isotopomer indicates labeled carbon atom, normal font indicates unlabeled carbon atom and x
indicates unknown labeling state of the carbon atom. Subscripts p, c and m for precursor indicates the compartments plastid, cytosol and
mitochondrion  in which they are present. RI  and SD denote relative intensity and standard deviation respectively.
Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD RI SD RI SD Precursor Isotopomer
Protein Gly α (s) 0.473 0.001 0.523 0.005 0.458 0.005 0.375 0.016 0.367 0.003 T3P/GOx [12x]
Protein Gly α (d) 0.527 0.001 0.477 0.005 0.542 0.005 0.625 0.016 0.633 0.003 T3P/GOx [12x]
Protein Ser α (s) 0.313 0.005 0.344 0.008 0.272 0.008 0.169 0.070 0.234 0.020 Ser [123]
Protein Ser α (d1) 0.259 0.005 0.250 0.008 0.211 0.008 0.060 0.070 0.157 0.020 Ser [123]
Protein Ser α (d2) 0.121 0.005 0.144 0.008 0.127 0.008 0.162 0.070 0.118 0.020 Ser [123]
Protein Ser α (dd) 0.307 0.005 0.261 0.008 0.390 0.008 0.609 0.070 0.491 0.020 Ser [123]
Protein Ser β (s) 0.592 0.010 0.590 0.008 0.497 0.015 0.331 0.028 0.419 0.011 Ser [x23]
Protein Ser β (d) 0.408 0.010 0.410 0.008 0.503 0.015 0.669 0.028 0.581 0.011 Ser [x23]
Protein Ala α (s) 0.196 0.009 0.236 0.008 0.196 0.010 0.189 0.055 0.152 0.030 Pyr [123]
Protein Ala α (d1) 0.033 0.009 0.030 0.008 0.023 0.010 0.030 0.055 0.029 0.030 Pyr [123]
Protein Ala α (d2) 0.162 0.009 0.181 0.008 0.206 0.010 0.142 0.055 0.133 0.030 Pyr [123]
Protein Ala α (dd) 0.609 0.009 0.553 0.008 0.573 0.010 0.639 0.055 0.686 0.030 Pyr [123]
Protein Ala β (s) 0.246 0.001 0.271 0.002 0.244 0.002 0.242 0.009 0.238 0.003 Pyr [x23]
Protein Ala β (d) 0.754 0.001 0.729 0.002 0.756 0.002 0.758 0.009 0.762 0.003 Pyr [x23]
Protein Ile γ2 (s) 0.252 0.004 0.284 0.002 0.242 0.002 0.237 0.012 0.212 0.004 Pyrp [x23]
Protein Ile γ2 (d) 0.748 0.004 0.717 0.002 0.759 0.002 0.764 0.012 0.788 0.004 Pyrp [x23]
Protein Leu δ1 (s) 0.334 0.005 0.374 0.001 0.357 0.005 0.332 0.009 0.314 0.004 Pyrp [x23]
Protein Leu δ1 (d) 0.666 0.005 0.626 0.001 0.643 0.005 0.668 0.009 0.686 0.004 Pyrp [x23]
Protein Val α (s) 0.346 0.010 0.370 0.008 0.354 0.027 0.341 0.039 0.336 0.011 Pyrp [12x]·[x2x]
Protein Val α (d1) 0.557 0.010 0.499 0.008 0.558 0.027 0.563 0.039 0.549 0.011 Pyrp [12x]·[x2x]
Protein Val α (d2) 0.000 0.010 0.042 0.008 0.053 0.027 0.000 0.039 0.026 0.011 Pyrp [12x]·[x2x]
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD RI SD RI SD Precursor Isotopomer
Protein Val α (dd) 0.098 0.010 0.090 0.008 0.034 0.027 0.096 0.039 0.088 0.011 Pyrp [12x]·[x2x]
Protein Val γ1 (s) 0.225 0.002 0.259 0.002 0.235 0.002 0.239 0.009 0.253 0.003 Pyrp [x23]
Protein Val γ1 (d) 0.775 0.002 0.742 0.002 0.765 0.002 0.761 0.009 0.747 0.003 Pyrp [x23]
Protein Val γ2 (s) 0.865 0.002 0.881 0.002 0.882 0.002 0.878 0.009 0.903 0.003 Pyrp [x2x]·[xx3]
Protein Val γ2 (d) 0.135 0.002 0.119 0.002 0.118 0.002 0.122 0.009 0.097 0.003 Pyrp [x2x]·[xx3]
Protein Leu δ2 (s) 0.880 0.001 0.889 0.008 0.877 0.001 0.881 0.007 0.872 0.003 Pyrp [x2x]·[xx3]
Protein Leu δ2 (d) 0.120 0.001 0.112 0.008 0.123 0.001 0.120 0.007 0.128 0.003 Pyrp [x2x]·[xx3]
Protein Phe α (s) 0.181 0.009 0.242 0.009 0.205 0.012 0.186 0.070 0.176 0.030 PEPp [123]
Protein Phe α (d1) 0.016 0.009 0.017 0.009 0.035 0.012 0.067 0.070 0.015 0.030 PEPp [123]
Protein Phe α (d2) 0.167 0.009 0.162 0.009 0.151 0.012 0.155 0.070 0.124 0.030 PEPp [123]
Protein Phe α (dd) 0.636 0.009 0.579 0.009 0.608 0.012 0.592 0.070 0.685 0.030 PEPp [123]
Protein Phe β (s) 0.214 0.012 0.220 0.012 0.161 0.011 0.158 0.040 0.188 0.023 PEPp [x23]·[x2x]
Protein Phe β (d1) 0.744 0.012 0.688 0.012 0.750 0.011 0.610 0.040 0.716 0.023 PEPp [x23]·[x2x]
Protein Phe β (d2) 0.000 0.012 0.000 0.012 0.014 0.011 0.000 0.040 0.000 0.023 PEPp [x23]·[x2x]
Protein Phe β (dd) 0.042 0.012 0.092 0.012 0.074 0.011 0.232 0.040 0.095 0.023 PEPp [x23]·[x2x]
Protein Tyr α (s) 0.170 0.014 0.227 0.013 0.208 0.017 0.183 0.070 0.179 0.032 PEPp [123]
Protein Tyr α (d1) 0.011 0.014 0.037 0.013 0.000 0.000 0.000 0.070 0.018 0.032 PEPp [123]
Protein Tyr α (d2) 0.173 0.014 0.129 0.013 0.180 0.017 0.000 0.070 0.119 0.032 PEPp [123]
Protein Tyr α (dd) 0.646 0.014 0.608 0.013 0.612 0.017 0.817 0.070 0.684 0.032 PEPp [123]
Protein Tyr β (s) 0.151 0.021 0.186 0.012 0.155 0.028 0.064 0.072 0.134 0.035 PEPp [x23]·[x2x]
Protein Tyr β (d) 0.695 0.021 0.718 0.012 0.737 0.028 0.725 0.072 0.759 0.035 PEPp [x23]·[x2x] + [x23]·[x2x]
Protein Tyr β (t) 0.153 0.021 0.097 0.012 0.109 0.028 0.212 0.072 0.108 0.035 PEPp [x23]·[x2x]
Protein Leu α (s) 0.218 0.009 0.247 0.010 0.225 0.009 0.285 0.041 0.237 0.013 ACoA p /Pyrp [1 2 ] ·[x2x]
Protein Leu α (d1) 0.695 0.009 0.654 0.010 0.709 0.009 0.685 0.041 0.680 0.013 ACoA p /Pyrp [ 12 ] ·[x2x]
Protein Leu α (d2) 0.026 0.009 0.030 0.010 0.032 0.009 0.016 0.041 0.000 0.013 ACoA p /Pyrp [1 2 ] ·[x2x]
Protein Leu α (dd) 0.061 0.009 0.069 0.010 0.033 0.009 0.014 0.041 0.083 0.013 ACoA p /Pyrp [ 12 ] ·[x2x]
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD RI SD RI SD Precursor Isotopomer
Protein Leu b (s) 0.843 0.016 0.808 0.007 0.815 0.007 0.814 0.036 0.840 0.016 ACoA p /Pyrp [x2] ·[x2x].[x2x]
Protein Leu b (d) 0.157 0.016 0.192 0.007 0.185 0.007 0.187 0.036 0.160 0.016 ACoA p /Pyrp [x 2 ] ·[x2x].[x2x]
+[x2]·[x2x].[x2x]
Protein Leu b (t) 0.000 0.016 0.000 0.007 0.000 0.000 0.000 0.036 0.000 0.016 ACoA p /Pyrp [x 2 ] ·[x2x].[x2x]
Protein His α (s) 0.187 0.008 0.223 0.008 0.242 0.025 0.194 0.041 0.187 0.025 P5Pp [xx345]
Protein His α (d1) 0.026 0.008 0.045 0.008 0.000 0.000 0.000 0.041 0.011 0.025 P5Pp [xx345]
Protein His α (d2) 0.182 0.008 0.175 0.008 0.162 0.025 0.174 0.041 0.123 0.025 P5Pp [xx345]
Protein His α (dd) 0.606 0.008 0.557 0.008 0.596 0.025 0.632 0.041 0.679 0.025 P5Pp [xx345]
Protein His β (s) 0.326 0.012 0.381 0.013 0.321 0.007 0.378 0.059 0.325 0.019 P5Pp [x234x]
Protein His β (d1) 0.054 0.012 0.000 0.013 0.019 0.008 0.000 0.059 0.000 0.019 P5Pp [x234x]
Protein His β (d2) 0.535 0.007 0.523 0.007 0.551 0.008 0.622 0.059 0.563 0.019 P5Pp [x234x]
Protein His β (dd) 0.085 0.007 0.096 0.007 0.108 0.007 0.000 0.059 0.112 0.019 P5Pp [x234x]
Protein His δ2 (s) 0.582 0.005 0.574 0.007 0.513 0.008 0.498 0.029 0.481 0.014 P5Pp [12xxx]
Protein His δ2 (d) 0.418 0.005 0.426 0.007 0.487 0.008 0.502 0.029 0.519 0.014 P5Pp [12xxx]
Protein Tyr δ1 (s) 0.194 0.008 0.224 0.006 0.214 0.008 0.182 0.016 0.184 0.009 PEP p /E4Pp [x2 3 ] ·[1xxx]
Protein Tyr δ2 (s) PEP p /E4Pp [x2x] ·[43xx]
Protein Tyr δ1 (d) 0.718 0.008 0.702 0.006 0.692 0.008 0.707 0.016 0.711 0.009 PEP p /E4Pp [x 23 ] ·[1xxx] + [x2 3 ] ·[1xxx]
Protein Tyr δ2 (d) PEP p /E4Pp [x 2 x] ·[43xx] + [x2x] ·[43xx]
Protein Tyr δ1 (t) 0.088 0.008 0.074 0.006 0.094 0.008 0.111 0.016 0.105 0.009 PEP p /E4Pp [x 23 ] ·[1xxx]
Protein Tyr δ2 (t) PEP p /E4Pp [x 2 x] ·[43xx]
Protein Tyr ε1 (s) 0.468 0.008 0.453 0.008 0.462 0.006 0.454 0.013 0.438 0.009 PEP p /E4Pp [xx3] ·[12xx]
Protein Tyr ε2 (s) E4Pp [x234]
Protein Tyr ε1 (d) 0.192 0.008 0.217 0.008 0.190 0.006 0.199 0.013 0.191 0.009 PEP p /E4Pp [xx 3 ] ·[12xx] + [xx3] ·[12xx]
Protein Tyr ε2 (d) E4Pp [x234] + [x234]
Protein Tyr ε1 (t) 0.340 0.008 0.330 0.008 0.348 0.006 0.348 0.013 0.371 0.009 PEP p /E4Pp [xx 3 ] ·[12xx]
Protein Tyr ε2 (t) E4Pp [x234]
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD RI SD RI SD Precursor Isotopomer
Protein Arg β (s) 0.827 0.040 0.795 0.048 0.830 0.053 0.713 0.050 0.735 0.088 Glup [x234x]
Protein Arg β (d) 0.173 0.040 0.206 0.048 0.170 0.053 0.287 0.050 0.265 0.088 Glup [x234x] + [x234x]
Protein Arg β (t) 0.000 0.040 0.000 0.048 0.000 0.000 0.000 0.050 0.000 0.088 Glup [x234x]
Protein Arg δ (s) 0.590 0.006 0.617 0.008 0.663 0.012 0.552 0.048 0.561 0.015 Glup [xxx45]
Protein Arg δ (d) 0.410 0.006 0.383 0.008 0.337 0.012 0.448 0.048 0.439 0.015 Glup [xxx45]
Protein Glu β (s) 0.763 0.013 0.821 0.017 0.820 0.054 0.815 0.026 Glu [x234x]
Protein Glu β (d) 0.237 0.013 0.179 0.017 0.180 0.054 0.185 0.026 Glu [x234x] + [x234x]
Protein Glu β (t) 0.000 0.013 0.000 0.000 0.000 0.054 0.000 0.026 Glu [x234x]
Protein Glu γ (s) 0.594 0.004 0.595 0.005 0.694 0.009 0.548 0.030 0.546 0.040 Glu [xx345]
Protein Glu γ (d1) 0.035 0.004 0.032 0.005 0.016 0.009 0.000 0.030 0.000 0.040 Glu [xx345]
Protein Glu γ (d2) 0.372 0.004 0.373 0.005 0.290 0.009 0.361 0.030 0.394 0.040 Glu [xx345]
Protein Glu γ (dd) 0.000 0.004 0.000 0.005 0.000 0.000 0.091 0.030 0.060 0.040 Glu [xx345]
Protein Pro γ (s) 0.562 0.027 0.564 0.018 0.639 0.029 0.495 0.121 0.536 0.048 Glup [xx345]
Protein Pro γ (d) 0.438 0.027 0.436 0.018 0.361 0.029 0.505 0.121 0.464 0.048 Glup [xx345] + [xx345]
Protein Pro γ (t) 0.000 0.027 0.000 0.018 0.000 0.000 0.000 0.121 0.000 0.048 Glup [xx345]
Protein Pro δ (s) 0.566 0.022 0.581 0.017 0.641 0.036 0.468 0.138 0.477 0.074 Glup [xxx45]
Protein Pro δ (d) 0.434 0.022 0.420 0.017 0.359 0.036 0.532 0.138 0.523 0.074 Glup [xxx45]
Protein Asp α (s) 0.456 0.008 0.451 0.006 0.433 0.010 0.383 0.046 0.430 0.017 OAA [123x]
Protein Asp α (d1) 0.146 0.008 0.131 0.006 0.087 0.010 0.141 0.046 0.143 0.017 OAA [123x]
Protein Asp α (d2) 0.220 0.008 0.256 0.006 0.283 0.010 0.215 0.046 0.173 0.017 OAA [123x]
Protein Asp α (dd) 0.178 0.008 0.162 0.006 0.197 0.010 0.261 0.046 0.254 0.017 OAA [123x]
Protein Asp β (s) 0.445 0.008 0.424 0.003 0.406 0.010 0.436 0.017 0.482 0.007 OAA [x234]
Protein Asp β (d1) 0.290 0.008 0.323 0.003 0.343 0.010 0.259 0.017 0.257 0.007 OAA [x234]
Protein Asp β (d2) 0.113 0.008 0.109 0.003 0.082 0.010 0.140 0.017 0.149 0.007 OAA [x234]
Protein Asp β (dd) 0.153 0.008 0.144 0.003 0.169 0.010 0.166 0.017 0.112 0.007 OAA [x234]
Protein Ile α (s) 0.583 0.016 0.614 0.010 0.596 0.013 0.608 0.113 0.622 0.030 OAA p /Pyrp [1 2 xx] ·[x2x]
Protein Ile α (d1) 0.316 0.016 0.301 0.010 0.287 0.013 0.392 0.113 0.299 0.030 OAA p /Pyrp [ 12 xx] ·[x2x]
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD RI SD RI SD Precursor Isotopomer
Protein Ile α (d2) 0.102 0.016 0.086 0.010 0.060 0.013 0.000 0.113 0.016 0.030 OAA p /Pyrp [1 2 xx] ·[x2x]
Protein Ile α (dd) 0.000 0.016 0.000 0.010 0.058 0.013 0.000 0.113 0.064 0.030 OAA p /Pyrp [ 12 xx] ·[x2x]
Protein Ile γ1(s) 0.646 0.045 0.646 0.029 0.660 0.032 0.585 0.100 0.671 0.072 Pyrp/OAA p [x2x]·[xx 3 4]
Protein Ile γ1(d) 0.354 0.045 0.354 0.029 0.340 0.032 0.416 0.100 0.329 0.072 Pyrp/OAA p [x2x]·[xx 3 4]  + [x2x]·[xx 34 ]
Protein Ile γ1(t) 0.000 0.045 0.000 0.029 0.000 0.000 0.000 0.100 0.000 0.072 Pyrp/OAA p [x2x]·[xx 34 ]
Protein Ile δ (s) 0.689 0.005 0.729 0.005 0.732 0.007 0.696 0.041 0.713 0.013 OAAp [xx34]
Protein Ile δ (d) 0.312 0.005 0.271 0.005 0.268 0.007 0.304 0.041 0.287 0.013 OAAp [xx34]
Protein Met γ (s) 0.697 0.027 0.701 0.031 0.730 0.033 0.642 0.158 0.708 0.058 OAAp [xx34]
Protein Met γ (d) 0.304 0.027 0.299 0.031 0.270 0.033 0.359 0.158 0.293 0.058 OAAp [xx34]
Protein Thr α (s) 0.348 0.013 0.407 0.008 0.403 0.050 0.445 0.036 OAAp [123x]
Protein Thr α (d1) 0.148 0.013 0.192 0.008 0.122 0.050 0.230 0.036 OAAp [123x]
Protein Thr α (d2) 0.247 0.013 0.199 0.008 0.225 0.050 0.070 0.036 OAAp [123x]
Protein Thr α (dd) 0.257 0.013 0.202 0.008 0.250 0.050 0.255 0.036 OAAp [123x]
Protein Thr γ2 (s) 0.684 0.004 0.706 0.005 0.709 0.006 0.678 0.029 0.685 0.036 OAAp [xx34]
Protein Thr γ2 (d) 0.316 0.004 0.295 0.005 0.291 0.006 0.322 0.029 0.315 0.036 OAAp [xx34]
Protein Lys γ (s) 0.663 0.032 0.659 0.017 0.655 0.023 0.564 0.084 0.627 0.055 OAA p /Pyrp [xx3 4 ] ·[xx3]
Protein Lys γ (d) 0.338 0.032 0.341 0.017 0.345 0.023 0.436 0.084 0.373 0.055 OAA p /Pyrp [xx 34 ] ·[xx3] + [xx3 4 ]·[xx 3 ]
Protein Lys γ (t) 0.000 0.032 0.000 0.017 0.000 0.000 0.000 0.084 0.000 0.055 OAA p /Pyrp [xx 34 ] ·[xx3]
Protein Lys β (s) 0.318 0.013 0.257 0.014 0.235 0.013 0.137 0.046 0.314 0.035 OAA p /Pyrp ½{[x2 3 4]  + [x23]·[xxx4] }
Protein Lys β (d) 0.683 0.013 0.628 0.014 0.660 0.013 0.561 0.046 0.686 0.035 OAA p /Pyrp ½{[x 23 4]  + [x2 34 ] +
OAA p /Pyrp  [x23]·[xxx4]  + [x23]·[xxx 4 ] }
Protein Lys β (t) 0.000 0.013 0.115 0.014 0.106 0.013 0.302 0.046 0.000 0.035 OAA p /Pyrp ½{[x 234 ]  + [x23]·[xxx 4 ] }
Protein Lys δ (s) 0.259 0.006 0.263 0.007 0.250 0.008 0.245 0.029 0.246 0.014 OAA p /Pyrp ½{[x2 3 4]  + [x23]·[xxx4] }
Protein Lys δ (d) 0.642 0.006 0.631 0.007 0.642 0.008 0.597 0.029 0.635 0.014 OAA p /Pyrp ½{[x 23 4]  + [x2 34 ]  +
 [x23]·[xxx4] + [x23]·[xxx 4 ] }
Protein Lys δ (t) 0.099 0.006 0.106 0.007 0.108 0.008 0.157 0.029 0.119 0.014 OAA p /Pyrp ½{[x 234 ]  + [x23]·[xxx 4 ] }
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD RI SD RI SD Precursor Isotopomer
Protein Lys ε (s) 0.333 0.003 0.340 0.004 0.318 0.005 0.346 0.027 0.344 0.010 OAA p /Pyrp ½{[x23] + [x 2 3x] }
Protein Lys ε (d) 0.667 0.003 0.661 0.004 0.682 0.005 0.654 0.027 0.657 0.010 OAA p /Pyrp ½{[x23] + [x 23 x] }
Protein HMF 1 (s) 0.279 0.007 0.345 0.010 0.271 0.010 0.285 0.008 0.227 0.005 G6Pc/F6Pc [12xxxx]
Protein HMF 1 (d) 0.722 0.007 0.655 0.010 0.729 0.010 0.715 0.008 0.773 0.005 G6Pc/F6Pc [12xxxx]
Protein LVA 2 (s) 0.214 0.005 0.252 0.005 0.207 0.005 0.141 0.005 0.209 0.005 G6Pc/F6Pc [x234xx]
Protein LVA 2 (d1) 0.063 0.005 0.043 0.005 0.085 0.005 0.074 0.005 0.053 0.005 G6Pc/F6Pc [x234xx]
Protein LVA 2 (d2) 0.033 0.005 0.038 0.005 0.029 0.005 0.013 0.005 0.023 0.005 G6Pc/F6Pc [x234xx]
Protein LVA 2 (dd) 0.693 0.005 0.667 0.005 0.678 0.005 0.772 0.005 0.715 0.005 G6Pc/F6Pc [x234xx]
Protein LVA 3 (s) 0.136 0.008 0.174 0.008 0.139 0.005 0.192 0.008 0.116 0.007 G6Pc/F6Pc [xx3456]
Protein LVA 3 (d1) 0.004 0.008 0.000 0.008 0.011 0.005 0.000 0.008 0.001 0.007 G6Pc/F6Pc [xx3456]
Protein LVA 3 (d2) 0.002 0.008 0.001 0.008 0.007 0.005 0.000 0.008 0.000 0.007 G6Pc/F6Pc [xx3456]
Protein LVA 3 (d3) 0.004 0.008 0.004 0.008 0.000 0.005 0.001 0.008 0.000 0.007 G6Pc/F6Pc [xx3456]
Protein LVA 3 (dd1) 0.067 0.008 0.008 0.008 0.000 0.005 0.000 0.008 0.002 0.007 G6Pc/F6Pc [xx3456]
Protein LVA 3 (dd2) 0.001 0.008 0.001 0.008 0.000 0.005 0.000 0.008 0.002 0.007 G6Pc/F6Pc [xx3456]
Protein LVA 3 (dd3) 0.015 0.008 0.140 0.008 0.118 0.005 0.522 0.008 0.126 0.007 G6Pc/F6Pc [xx3456]
Protein LVA 3 (qd) 0.688 0.008 0.670 0.008 0.741 0.005 0.284 0.008 0.753 0.007 G6Pc/F6Pc [xx3456]
Protein LVA 5 (s) 0.161 0.005 0.139 0.005 0.132 0.005 0.081 0.005 0.135 0.005 G6Pc/F6Pc [xxx456]
Protein LVA 5 (d1) 0.026 0.005 0.009 0.005 0.000 0.005 0.003 0.005 0.004 0.005 G6Pc/F6Pc [xxx456]
Protein LVA 5 (d2) 0.000 0.005 0.047 0.005 0.020 0.005 0.031 0.005 0.033 0.005 G6Pc/F6Pc [xxx456]
Protein LVA 5 (dd) 0.813 0.005 0.805 0.005 0.848 0.005 0.886 0.005 0.829 0.005 G6Pc/F6Pc [xxx456]
Starch HMF 1 (s) 0.381 0.005 0.397 0.005 0.348 0.010 0.005 G6Pp [12xxxx]
Starch HMF 1 (d) 0.619 0.005 0.603 0.005 0.653 0.010 0.005 G6Pp [12xxxx]
Starch LVA 2 (s) 0.415 0.005 0.477 0.005 0.459 0.005 0.358 0.005 0.404 0.005 G6Pp [x234xx]
Starch LVA 2 (d1) 0.279 0.005 0.236 0.005 0.245 0.005 0.223 0.005 0.209 0.005 G6Pp [x234xx]
Starch LVA 2 (d2) 0.087 0.005 0.084 0.005 0.050 0.005 0.080 0.005 0.102 0.005 G6Pp [x234xx]
Starch LVA 2 (dd) 0.219 0.005 0.203 0.005 0.245 0.005 0.340 0.005 0.285 0.005 G6Pp [x234xx]
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD RI SD RI SD Precursor Isotopomer
Starch LVA 3 (s) 0.213 0.008 0.304 0.008 0.250 0.005 0.192 0.008 0.243 0.007 G6Pp [xx3456]
Starch LVA 3 (d1) 0.002 0.008 0.007 0.008 0.015 0.005 0.000 0.008 0.007 0.007 G6Pp [xx3456]
Starch LVA 3 (d2) 0.002 0.008 0.003 0.008 0.005 0.005 0.000 0.008 0.000 0.007 G6Pp [xx3456]
Starch LVA 3 (d3) 0.001 0.008 0.001 0.008 0.000 0.005 0.001 0.008 0.000 0.007 G6Pp [xx3456]
Starch LVA 3 (dd1) 0.020 0.008 0.014 0.008 0.063 0.005 0.000 0.008 0.013 0.007 G6Pp [xx3456]
Starch LVA 3 (dd2) 0.001 0.008 0.007 0.008 0.000 0.005 0.000 0.008 0.005 0.007 G6Pp [xx3456]
Starch LVA 3 (dd3) 0.426 0.008 0.421 0.008 0.460 0.005 0.522 0.008 0.487 0.007 G6Pp [xx3456]
Starch LVA 3 (qd) 0.335 0.008 0.244 0.008 0.204 0.005 0.284 0.008 0.246 0.007 G6Pp [xx3456]
Starch LVA 5 (s) 0.171 0.005 0.169 0.005 0.167 0.005 0.160 0.005 0.190 0.005 G6Pp [xxx456]
Starch LVA 5 (d1) 0.123 0.005 0.000 0.005 0.139 0.005 0.112 0.005 0.017 0.005 G6Pp [xxx456]
Starch LVA 5 (d2) 0.002 0.005 0.156 0.005 0.029 0.005 0.015 0.005 0.064 0.005 G6Pp [xxx456]
Starch LVA 5 (dd) 0.705 0.005 0.674 0.005 0.665 0.005 0.726 0.005 0.730 0.005 G6Pp [xxx456]
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APPENDIX II - EXTERNAL FLUXES (TEMPERATURE STUDY) 
The main inputs to the program NMR2Flux in addition to NMR labeling data include substrate 
intake, acid effluxes all the fluxes contributing towards the biomass synthesis (protein, starch, oil 
etc.). The details of the calculation of the above mentioned fluxes are explained below.  
II-1 Calculation of fluxes contributing towards biomass synthesis 
Amino acid quantification 
Each protein sample from the various temperature conditions was hydrolyzed into the 
corresponding amino acids. Amino acids in the samples were quantified by HPLC using a reverse 
phase C18 silica column, with detection at 254 nm (Protein facility in Biophysics, Biochemistry and 
Molecular Biology Department at Iowa State University). Figure II-1 shows the comparison of the 
HPLC analysis of the hydrolyzed protein for the different temperature treatments. Amino acids such 
as Thr, His and Leu were significantly different for the other temperature conditions than the MM 
temperature condition. Methionine, in extremely low quantities, also showed a significant difference. 
There was no particular trend observable in our study for amino acid composition for different 
temperature treatments.  
The proteinogenic amino acids are well distributed across the central carbon metabolism in 
soybeans. Thus, the NMR labeling data of the amino acids are important characteristic of intracellular 
fluxes. Once the biochemistry and the carbon skeleton rearrangements were identified, the 
information is used to calculate the external fluxes as explained in the following section.    
Calculation of external fluxes contributing towards protein and lipid synthesis 
The external fluxes (Table II-1) were determined from the amino acid HPLC analysis, coupled with 
the precursor-amino acid stoichiometry. To elucidate, consider flux from the precursor metabolite 
OAA towards the biosynthesis of the amino acids Asx, Ile, Lys, Met and Thr respectively. The 
biochemistry of the pathways indicate that 1 mole of Asx, Ile, Met and Thr each requires 1 mole of  
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Figure II-1: Comparison of HPLC profiles of proteinogenic amino acids for Case 1 and Case 2 (* 
indicates significant difference with respect to MM temperature condition) 
 
OAA. 1 mole of Lys, however, requires 2 moles of OAA. Similar analysis could be applied to the 
other fluxes as well. Table II-2 shows the relationship of the stoichiometry between metabolites and 
corresponding amino acids. The amount of protein present can be calculated from the biomass dry 
weight and the percentage of protein in the biomass for each temperature condition. The amino acid 
analysis provides the mol % of the amino acids. Hence, the corresponding moles of each amino acid 
synthesized to make protein for each temperature treatment can be calculated. The moles of each 
amino acid were thus calculated and summed to give the total moles per day of the precursor 
metabolite in the system. The percentage of nucleotides was assumed to be 5 % of the total biomass.  
The fatty acid composition was obtained from literature (Dey and Harborne, 1997). The amount 
of Acetyl-CoA and T3P contributing to each fatty acid is known from biochemistry. Table II-3 sums 
up the external fluxes for all the 5 temperature conditions. There was no general trend observed 
among the temperature treatments. The final values input to the program were then standardized with 
Comparison of amino acid profile
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Table II-1: External fluxes contributing towards biosynthesis of amino acids and lipids to be input to 
the program 
Precursor metabolite → Amino acids/ Lipids 
A-CoA → Lipids 
P5P → His + Nucleotides 
E4P → Phe + Tyr 
3-PG → Gly + Ser 
PEP → Phe + Tyr 
Pyr → Ala + Val + Ile + Lys + Leu 
A-CoA → Leu 
OAA → Asx + Ile + Lys + Met + Thr 
Glu → Glx + Pro + Arg  
 
respect to 20 times glycine production per day (Table II-3). The standardization was done to ensure 
the values of the input fluxes were in the range of 0-2.0. This constraint helped the program to 
converge by eliminating the occurrence of floating point overflow and underflow errors.  
II-2 Calculation of the sucrose and glutamine consumption rates  
The culture media at the end of 6 days incubation contained unused sucrose and glutamine as 
well as glucose, fructose, and other secreted metabolites. Since the sucrose intake and glutamine 
intake were not measured directly, an alternative method was used to calculate the intake rate for 
sucrose using data from the literature. The conversion factors for the glucose consumed per kg of 
product for the major biomass constituents at room temperature were obtained from literature 
(Bennett et al., 1994). These factors were considered applicable to the MM temperature treatment and 
are tabulated in Table II-4. Because the amount of protein and % of each amino acid in the protein 
were known for the MM temperature treatment, the total carbon (C) content in the protein can be 
calculated. Similarly, C content in starch and T3P and Acetyl-CoA of the lipids can also be  
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Table II-2: Molar ratios of metabolites to corresponding amino acids 
Precursor  
metabolite ⇒ 
AA ⇓ 
 
3-PGA 
 
Pyr 
 
PEP 
 
E4P 
 
A-CoA 
 
OAA 
 
2-OxoG 
 
R5P 
Ala 0 1 0 0 0 0 0 0 
Asx 0 0 0 0 0 1 0 0 
Glx 0 0 0 0 0 0 1 0 
Phe 0 0 2 1 0 0 0 0 
Gly 1 0 0 0 0 0 0 0 
His 0 0 0 0 0 0 0 1 
Ile 0 1 0 0 0 1 0 0 
Lys(50%) 0 1 0 0 0 1 0 0 
Lys(50%) 0 1 0 0 0 1 0 0 
Leu 0 2 0 0 1 0 0 0 
Met 0 0 0 0 0 1 0 0 
Pro 0 0 0 0 0 0 1 0 
Arg 0 0 0 0 0 0 1 0 
Ser 1 0 0 0 0 0 0 0 
Thr 0 0 0 0 0 1 0 0 
Val  0 2 0 0 0 0 0 0 
Tyr 0 0 2 1 0 0 0 0 
 
 
 
   
  
122 
 
Table II-3: External flux for the five temperature conditions (µmoles day-1- cotyledon-1). 
Flux HH MH MM ML LL 
Glycine  1.48 1.48 1.26 0.51 0.48 
A-CoA → lipid 48.1 51.6 32.7 12.39 11.1 
P5P → aa* 0.49 0.52 0.35 0.17 0.19 
E4P → aa 1.2 1.27 1.1 0.45 0.4 
3-PG → aa 3.26 3.42 2.75 1.06 1.01 
PEP → aa 2.39 2.54 2.29 0.89 0.81 
Pyr → aa 8.74 9.48 8.24 3.37 3.05 
A-CoA → aa 1.47 1.57 1.58 0.58 0.51 
OAA → aa 2.71 2.94 2.26 0.97 0.93 
Glu → aa 5.59 6.02 4.73 2.03 2.07 
* aa represents amino acids 
 
 
Table II-4: Conversion factors for estimating glucose consumed per kg of biomass constituent 
produced (Bennett et al., 1994) 
Biomass  
components 
Glucose consumed  
(kg glucose/kg product) 
Carbohydrates 1.211 
Proteins 1.793 
Lipids 3.03 
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calculated. Ash and moisture was assumed to be 13% of the biomass. The remainder of the biomass 
was assumed to be carbohydrates (approximately 30 % of the biomass). The composition of the 
carbohydrates was taken from literature (Mullin and Xu, 2000). Thus, a combination of C content in 
the major biomass constituents, i.e. protein, fatty acids and carbohydrates was estimated. Using the 
conversion factors in Table II-4, the amounts of glucose consumed and hence the sucrose consumed 
was estimated for the MM temperature treatment. The difference between the C content in sucrose 
consumed and C content in the biomass gave the C evolved during respiration. The method of 
calculating sucrose consumption was extrapolated to other temperature treatments and was carried out 
using two different methods. First, we assumed constant yield of biomass (defined as ratio of the 
biomass dry weight/ total amount of sucrose consumed) for all the temperature treatments. Because 
the biomass growth rate per day was known, scaling factors could be obtained for each temperature 
treatment. The amount of CO2 evolved was then calculated for the remaining temperature treatments. 
The amounts of protein, starch and carbohydrates were known for these temperature treatments and 
the C content in the biomass could be estimated. A sum of the C content in the biomass and the C 
evolved during respiration estimated the total C content in sucrose consumed for the remaining 
temperature treatments. 
The second method involved considering the temperature coefficient of respiration (Q10) equals 
2 for the soybean cotyledons. A Q10 of 2 was equivalent to considering that the respiration rate 
increased or decreased two-fold for a 10oC rise or fall in temperature. The following equation was 
used to estimate the CO2 evolution rates for the HH, MH, ML and LL temperature treatments 
respectively with respect to the MM temperature treatment.  
ln Q10 = (10/T2-T1) ln (K2/K1) 
where, T2 is the higher temperature, K2 is the reaction rate at T2; T1 is the lower temperature, K1 is the 
reaction rate at T1 and K is the respiration rates for the respective temperature. For soybean 
cotyledons, we used the growth rate of the biomass per day at the respective temperatures as a 
representation of the respiration rates. The values estimated using both methods were in the same 
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range. Table II-5 summarizes the sucrose consumption rate calculated. The final values input to the 
program were standardized with respect to 20 times glycine production per day.  
The glutamine consumption was calculated using the proteinogenic amino acid measurements. 
The glutamine fed into the system is primarily used as a nitrogen source for the biomass growth. 
Consider an amino acid, alanine, its molecular formula is given by C3H7NO2. The molar percentage 
of nitrogen in this amino acid could be calculated from the molecular and atomic weights of alanine 
(89) and nitrogen (14) as (14/89) *100, which is equal to 15.73 %. Similarly, the percentage of 
nitrogen in other amino acids could be calculated and the total amount of nitrogen in amino acids was 
estimated. The nitrogen percentages could be converted to the total amount of glutamine consumed in 
the system. The insoluble protein percentage ranged from 2-5 % of the biomass dry weight and was 
used to set upper limits for the glutamine consumption. The absolute values of glutamine intake 
decreased with decreasing temperature, which was due to the lower amount of protein in the lower 
temperature treatments (Table II-5). Thus, it was concluded that the capacity of synthesis controls the 
substrate uptake by the soybean cotyledons. 
 
Table II-5: Sucrose and glutamine consumption rates (µmoles day-1 cotyledon-1) for the five 
temperature conditions 
Consumption HH MH MM ML LL 
Sucrose (Q10) 36.4 41.6 28.3 13.4 13 
Sucrose (Constant 
Yield) 
37.5 38.2 28.3 11.8 11.7 
Glutamine 13.9 15.2 11.9 0.52 0.50 
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II-3 Additional input data assigned to the program 
 Apart from specifying the sucrose and glutamine intake limits, limits for effluxes were 
assigned to the program. Since, the pyruvate and succinate efflux were not measured, they were set 
correspondingly. The remainder of the biomass (apart from protein, starch and lipid) was assumed to 
be carbohydrates (approximately 30-35 % of the biomass). The composition of the carbohydrates was 
taken from literature (Mullin and Xu, 2000). The glucose, fructose and pentose content of the 
carbohydrate fraction are represented as glux, frux and penx respectively and are summarized for 
Case 1 and Case 2 in Table II-6. 
 
Table II-6:  Summary of efflux data for the five temperature conditions (µmoles day-1 cotyledon-1). 
Efflux HH MH MM ML LL 
Pyruvate  0-2.0 0-2.0 0-2.0 0-2.0 0-2.0 
Succinate  0-10.0 0-10.0 0-10.0 0-10.0 0-10.0 
glux 0.35-0.50 0.35-0.50 0.32-0.45 0.37-0.51 0.37-0.53 
frux 0-0.05 0-0.05 0-0.05 0-0.05 0-0.05 
penx 0.22-0.29 0.21-0.28 0.19-0.25 0.20-0.27 0.22-0.30 
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APPENDIX III – ABSOLUTE FLUXES (TEMPERATURE STUDY) 
 
 
 
 
 
 
 
Figure III-1: Absolute flux map for MH temperature condition. The thickness of the arrows is 
proportional the absolute flux values. Green and red arrows indicate that the flux is greater or lower 
than the MM (optimum) temperature condition respectively. Table III-1 at the end of this Appendix 
comprehensively lists all the absolute fluxes for the MH temperature condition. 
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Table III-1: Absolute fluxes for Case 1 are expressed in µmoles d-1 cotyledon -1. Each flux is denoted 
usually by the name of the gene encoding the enzyme catalyzing the metabolic reaction. Subscript f 
indicates forward reaction and superscripts c, p and m indicate cytosol, plastid and mitochondrion 
respectively. For reversible reactions, the net flux and reversibility is given. Net fluxes are in the 
direction of the reaction with the subscript f. Negative flux indicates that the direction of net flux is 
exactly reverse of that assumed. Reversibilities arereported in percentages; 0% and 100 % 
reversibility represent irreversible reaction and reaction at equilibrium.
Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ F6Pc hxi f c -49.60 8.39 -28.60 4.54 -10.95 3.55
9.37 20.98 51.78 26.73 3.47 5.94
G6Pp ↔ F6Pp hxi f p -18.67 14.27 -10.94 12.69 -0.34 6.09
92.43 10.63 97.04 3.16 94.23 3.35
G6Pc → P5Pc + CO2 pgl c 46.54 18.05 27.21 11.47 4.67 4.75
G6Pp → P5Pp + CO2 pgl p 47.86 18.97 32.54 14.81 14.27 6.59
P5Pc + P5Pc ↔ S7Pc + T3Pc tktA f c 7.01 2.01 1.82 0.75 0.57 0.15
81.61 29.30 90.43 17.94 88.32 22.85
S7Pc + T3Pc ↔ F6Pc + E4Pc tal f c 7.01 2.01 1.82 0.75 0.57 0.15
27.84 23.47 46.69 25.18 16.81 16.01
P5Pc + E4Pc ↔ F6Pc + T3Pc tktB f c 7.01 2.01 1.82 0.75 0.57 0.15
33.78 15.96 6.70 10.92 75.92 6.03
P5Pp + P5Pp ↔ S7Pp + T3Pp tktA f p 21.98 4.75 16.28 4.49 4.82 1.94
85.05 12.80 88.63 14.44 85.94 6.44
S7Pp + T3Pp ↔ F6Pp + E4Pp tal f p 21.98 4.75 16.28 4.49 4.82 1.94
80.83 12.11 76.13 16.07 98.22 1.80
P5Pp + E4Pp ↔ F6Pp + T3Pp tktB f p 20.71 4.75 15.17 4.49 4.38 1.94
71.49 19.33 34.04 30.70 0.86 3.68
F6Pc → T3Pc + T3Pc pfk c 4.83 7.44 3.60 4.38 3.58 3.66
F6Pp → T3Pp + T3Pp pfk p 24.02 8.46 20.51 5.22 8.86 3.50
T3Pc + T3Pc → F6Pc pfp c 0.01 0.05 0.87 0.93 0.03 0.06
T3Pp + T3Pp → F6Pp f16bp p 86.70 11.52 66.67 15.36 8.05 4.10
T3P → 3PG gap 83.65 5.66 63.87 4.99 29.32 4.82
3PG → PEP eno 81.88 5.56 62.53 4.92 28.80 4.78
PEP → Pyr pyk 74.39 4.86 55.32 4.14 23.87 3.75
Pyrp → ACAp + CO2 pdh
p 53.17 0.00 34.28 0.00 12.97 0.00
Pyrm → ACAm + CO2 pdh
m 21.35 4.58 16.70 4.05 13.83 3.64
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Reaction
MH MM ML
Absolute fluxes ( µmoles day-1 cotyledon-1)
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
Pyrc → Pyrm pyrT 21.35 4.58 16.70 4.05 13.83 3.64
G6Pc ↔ G6Pp g6pT f 32.11 16.94 24.10 11.46 15.37 5.60
63.63 29.99 50.35 26.74 82.05 28.05
P5Pc ↔ P5Pp p5pT f 17.32 18.70 15.54 11.83 -0.08 4.83
74.58 42.50 75.64 28.68 93.16 16.37
T3Pc ↔ T3Pp t3pT f 10.22 16.32 13.17 8.66 8.24 6.49
98.29 1.47 96.22 6.66 92.24 19.05
ACAm + OAAm → ICitm csaco m 19.69 4.52 15.26 4.00 13.00 3.46
ICitm → aKGm + CO2 icdh
m 18.04 4.43 13.84 3.92 12.32 3.23
aKGm → Scnm + CO2 akgdh
m 2.34 8.60 1.80 5.90 1.81 4.17
Scnm → Malm sdh f1 m 14.27 0.77 9.88 2.91 3.63 1.09
Scnm ↔ Malm sdh f2 m 30.63 4.30 19.23 3.91 17.35 3.69
75.61 2.13 89.47 3.66 89.90 5.44
Malm ↔ OAAm mdh f
m 24.28 4.56 18.94 4.03 14.66 3.55
47.93 29.83 45.21 31.83 39.93 30.13
ICitm → Goxm + Scnm icl m 1.65 0.10 1.42 0.08 0.69 0.22
ACAm + Goxm → Malm ms m 0.01 0.03 0.02 0.04 0.14 0.21
PEPc + CO2 → OAA
c pep c 6.73 0.84 6.34 0.93 4.56 1.30
Malm → Pyrm + CO2 me
m 3.50 1.27 2.70 1.24 3.04 1.24
Malp → Pyrp + CO2 me
p 6.65 0.76 1.70 0.75 3.38 1.04
Gluc → GABAc + CO2 gad
c 28.49 7.23 22.95 6.51 15.14 5.19
GABAc → GABAm gabaT 28.49 7.23 22.95 6.51 15.14 5.19
GABAm ↔ SSAm gat f
m 28.49 7.23 22.95 6.51 15.14 5.19
42.20 30.78 49.50 33.00 42.91 31.40
SSAm → Scnm ssadh m 28.49 7.23 22.95 6.51 15.14 5.19
Sucext → G6Pc + F6Pc subs1 40.51 0.92 28.66 0.31 13.41 0.56
Glnext ↔ Glnc subs2 f 17.17 0.57 14.21 0.68 5.97 0.22
68.02 2.64 83.99 2.25 72.09 2.57
Glnc → Glnp glnT 17.17 0.57 14.21 0.68 5.97 0.22
TCA cycle
GABA shunt
reversibility %
Substrate entry
reversibility %
reversibility %
reversibility %
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Glyoxylate shunt
Anaplerotic reactions
ML
Reaction
MH MM 
Absolute fluxes ( µmoles day-1 cotyledon-1)
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
aKGm → aKGc aKGT1 17.17 0.57 14.21 0.68 5.97 0.22
aKGc → aKGp aKGT2 17.17 0.57 14.21 0.68 5.97 0.22
aKGp + Glnp → Glup + Glup gogat p 294.81 163.93 265.03 131.90 106.30 52.26
Glup ↔ aKGp gdh f p 277.65 163.36 250.82 131.22 100.33 52.05
99.00 0.00 99.00 0.00 99.00 0.00
Glup ↔ Glnp as f 277.82 162.43 250.07 131.30 105.57 51.49
59.20 28.52 60.87 28.10 63.67 23.94
Malm ↔ Malc malT1 f 2.86 1.24 -2.39 1.33 -0.21 1.04
98.34 0.60 96.50 1.45 97.41 1.93
Malc → Malp malT2 9.59 2.09 3.95 2.27 4.35 2.34
Malc → OAAc mdh c 6.73 0.84 6.34 0.93 4.56 1.30
Malp → OAAP mdh p 2.94 1.33 2.26 1.52 0.97 1.30
3PG → Ser bios1 1.77 0.09 1.35 0.07 0.52 0.05
Ser ↔ Gly + C1 bios2 f 1.77 0.09 1.35 0.07 0.52 0.05
41.13 1.06 40.88 1.17 12.76 3.65
GOx → Gly bios3 1.64 -0.09 1.40 -0.07 0.55 -0.05
CO2 → resp 222.86 11.75 148.80 7.67 77.54 8.90
G6Pc → biomass bios4 11.46 1.10 5.95 0.86 4.32 0.46
G6Pp → biomass bios5 2.91 0.09 2.49 0.08 1.44 0.10
F6Pc → biomass bios6 0.10 0.10 0.10 0.08 0.03 0.04
P5Pc → biomass bios7 8.18 0.48 6.22 0.48 3.03 0.23
P5Pp → biomass bios8 0.52 0.00 0.35 0.00 0.17 0.00
E4Pp → biomass bios9 1.27 0.00 1.10 0.00 0.45 0.00
PEPp → biomass bios10 2.54 0.00 2.21 0.00 0.89 0.00
ACAp → biomass bios11 51.60 0.00 32.70 0.00 12.39 0.00
ACAp → biomass bios12 1.57 0.00 1.58 0.00 0.58 0.00
Pyr → biomass bios13 9.48 0.00 8.24 0.00 3.37 0.00
OAA → biomass bios14 2.94 0.00 2.26 0.00 0.97 0.00
Glu → biomass bios15 6.02 0.00 4.73 0.00 2.03 0.00
Pyr → pyrx 0.54 0.36 0.50 0.37 0.12 0.17
Mal → malx 0.00 0.00 0.00 0.00 0.00 0.00
Scn → scnx 1.86 1.18 6.94 1.59 0.28 0.53
Biosynthesis of Ser and Gly
reversibility %
Fluxes towards biosynthesis and effluxes into medium
reversibility %
Malate shuttle
reversibility %
reversibility %
Glutamate assimilation
MH MM ML
Reaction Absolute fluxes ( µmoles day-1 cotyledon-1)
  
130 
Table III-2: Absolute fluxes for Case 2 are expressed in µmoles d-1 cotyledon -1. Each flux is denoted 
usually by the name of the gene encoding the enzyme catalyzing the metabolic reaction. Subscript f 
indicates forward reaction and superscripts c, p and m indicate cytosol, plastid and mitochondrion 
respectively. For reversible reactions, the net flux and reversibility is given. Net fluxes are in the 
direction of the reaction with the subscript f. Negative flux indicates that the direction of net flux is 
exactly reverse of that assumed. Reversibilities arereported in percentages; 0% and 100 % 
reversibility represent irreversible reaction and reaction at equilibrium.
Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ F6Pc hxi f c -43.38 4.30 -28.60 4.54 -14.32 1.32
11.36 24.71 51.78 26.73 10.11 14.90
G6Pp ↔ F6Pp hxi f p -9.29 16.56 -10.94 12.69 -6.37 5.10
97.27 4.69 97.04 3.16 95.88 4.06
G6Pc → P5Pc + CO2 pgl c 26.84 16.01 27.21 11.47 8.41 5.13
G6Pp → P5Pp + CO2 pgl p 47.33 21.25 32.54 14.81 19.31 5.97
P5Pc + P5Pc ↔ S7Pc + T3Pc tktA f c 4.55 1.55 1.82 0.75 1.41 0.38
85.84 23.09 90.43 17.94 88.97 16.50
S7Pc + T3Pc ↔ F6Pc + E4Pc tal f c 4.55 1.55 1.82 0.75 1.41 0.38
31.53 23.08 46.69 25.18 25.74 21.86
P5Pc + E4Pc ↔ F6Pc + T3Pc tktB f c 4.55 1.55 1.82 0.75 1.41 0.38
52.77 12.30 6.70 10.92 29.08 15.20
P5Pp + P5Pp ↔ S7Pp + T3Pp tktA f p 17.55 5.69 16.28 4.49 6.92 1.82
92.84 8.39 88.63 14.44 83.18 7.06
S7Pp + T3Pp ↔ F6Pp + E4Pp tal f p 17.55 5.69 16.28 4.49 6.92 1.82
80.27 11.60 76.13 16.07 86.56 8.84
P5Pp + E4Pp ↔ F6Pp + T3Pp tktB f p 16.35 5.69 15.17 4.49 6.52 1.82
21.31 28.01 34.04 30.70 28.94 20.59
F6Pc → T3Pc + T3Pc pfk c 1.72 3.59 3.60 4.38 0.93 1.07
F6Pp → T3Pp + T3Pp pfk p 24.61 6.35 20.51 5.22 7.06 1.88
T3Pc + T3Pc → F6Pc pfp c 0.08 0.17 0.87 0.93 0.06 0.06
T3Pp + T3Pp → F6Pp f16bp p 77.45 16.80 66.67 15.36 17.88 4.85
T3P → 3PG gap 72.34 5.71 63.87 4.99 23.22 2.59
3PG → PEP eno 71.13 5.68 62.53 4.92 22.55 2.55
PEP → Pyr pyk 64.32 4.92 55.32 4.14 20.67 2.29
Pyrp → ACAp + CO2 pdh
p 49.57 0.00 34.28 0.00 11.61 0.00
Pyrm → ACAm + CO2 pdh
m 10.93 3.75 16.70 4.05 9.26 2.31
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
LL
Glycolysis and oxPPP
reversibility %
Absolute fluxes ( µmoles day-1 cotyledon-1)Reaction
HH MM 
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
Pyrc → Pyrm pyrT 10.93 3.75 16.70 4.05 9.26 2.31
G6Pc ↔ G6Pp g6pT f 40.99 16.61 24.10 11.46 14.21 5.02
57.24 35.30 50.35 26.74 73.21 31.46
P5Pc ↔ P5Pp p5pT f 4.60 16.58 15.54 11.83 1.23 5.26
94.66 8.47 75.64 28.68 94.17 8.85
T3Pc ↔ T3Pp t3pT f 9.49 9.16 13.17 8.66 7.11 2.93
97.64 3.11 96.22 6.66 95.85 8.31
ACAm + OAAm → ICitm csaco m 8.70 3.51 15.26 4.00 8.90 2.29
ICitm → aKGm + CO2 icdh
m 6.56 3.35 13.84 3.92 8.56 2.24
aKGm → Scnm + CO2 akgdh
m 6.50 9.33 1.80 5.90 1.44 3.67
Scnm → Malm sdh f1 m 13.72 1.71 9.88 2.91 4.61 0.41
Scnm ↔ Malm sdh f2 m 16.20 3.02 19.23 3.91 12.70 2.34
77.08 4.34 89.47 3.66 61.16 4.64
Malm ↔ OAAm mdh f m 13.55 3.62 18.94 4.03 10.17 2.30
39.32 29.94 45.21 31.83 62.39 33.23
ICitm → Goxm + Scnm icl m 2.14 0.16 1.42 0.08 0.35 0.05
ACAm + Goxm → Malm ms m 0.09 0.17 0.02 0.04 0.02 0.03
PEPc + CO2 → OAA
c pep c 5.63 0.94 6.34 0.93 1.75 0.32
Malm → Pyrm + CO2 me
m 1.02 0.66 2.70 1.24 1.43 0.43
Malp → Pyrp + CO2 me
p 4.64 1.40 1.70 0.75 1.94 0.25
Gluc → GABAc + CO2 gad
c 14.13 7.55 22.95 6.51 11.06 4.30
GABAc → GABAm gabaT 14.13 7.55 22.95 6.51 11.06 4.30
GABAm ↔ SSAm gat f
m 14.13 7.55 22.95 6.51 11.06 4.30
53.35 30.95 49.50 33.00 45.61 30.19
SSAm → Scnm ssadh m 14.13 7.55 22.95 6.51 11.06 4.30
Sucext → G6Pc + F6Pc subs1 36.13 0.87 28.66 0.31 12.46 0.56
Glnext ↔ Glnc subs2 f 17.52 1.48 14.21 0.68 5.67 0.12
64.61 9.60 83.99 2.25 72.89 3.07
Glnc → Glnp glnT 17.52 1.48 14.21 0.68 5.67 0.12
Absolute fluxes ( µmoles day-1 cotyledon-1)
GABA shunt
reversibility %
Substrate entry
reversibility %
Glyoxylate shunt
Anaplerotic reactions
reversibility %
TCA cycle
reversibility %
reversibility %
LL
Glycolysis and oxPPP
reversibility %
reversibility %
HH MM 
Reaction
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
aKGm → aKGc aKGT1 17.52 1.48 14.21 0.68 5.67 0.12
aKGc → aKGp aKGT2 17.52 1.48 14.21 0.68 5.67 0.12
aKGp + Glnp → Glup + Glup gogat p 293.17 168.28 265.03 131.90 104.73 48.58
Glup ↔ aKGp gdh f
p 275.65 166.80 250.82 131.22 99.06 48.46
99.00 0.00 99.00 0.00 99.00 0.00
Glup ↔ Glnp as f 260.34 166.42 250.07 131.30 100.85 48.85
47.08 32.39 60.87 28.10 54.92 29.32
Malm ↔ Malc malT1 f 1.72 1.57 -2.39 1.33 1.12 0.37
96.90 2.01 96.50 1.45 98.26 1.18
Malc → Malp malT2 7.35 2.51 3.95 2.27 2.87 0.69
Malc → OAAc mdh c -5.63 0.94 -6.34 0.93 -1.75 0.32
Malp → OAAP mdh p 2.71 1.10 2.26 1.52 0.93 0.45
3PG → Ser bios1 1.21 0.03 1.35 0.07 0.68 0.04
Ser ↔ Gly + C1 bios2 f 1.21 0.03 1.35 0.07 0.68 0.04
46.68 1.32 40.88 1.17 22.66 1.58
GOx → Gly bios3 2.05 -0.03 1.40 -0.07 0.33 -0.04
CO2 → resp 164.02 11.55 148.80 7.67 71.63 7.01
G6Pc → biomass bios4 11.68 1.08 5.95 0.86 4.15 0.41
G6Pp → biomass bios5 2.95 0.10 2.49 0.08 1.27 0.09
F6Pc → biomass bios6 0.14 0.09 0.10 0.08 0.03 0.03
P5Pc → biomass bios7 8.59 0.52 6.22 0.48 2.95 0.22
P5Pp → biomass bios8 0.49 0.00 0.35 0.00 0.19 0.00
E4Pp → biomass bios9 1.20 0.00 1.10 0.00 0.40 0.00
PEPp → biomass bios10 2.39 0.00 2.21 0.00 0.81 0.00
ACAp → biomass bios11 48.10 0.00 32.70 0.00 11.10 0.00
ACAp → biomass bios12 1.47 0.00 1.58 0.00 0.51 0.00
Pyr → biomass bios13 8.74 0.00 8.24 0.00 3.05 0.00
OAA → biomass bios14 2.71 0.00 2.26 0.00 0.93 0.00
Glu → biomass bios15 5.59 0.00 4.73 0.00 2.07 0.00
Pyr → pyrx 0.73 0.44 0.50 0.37 0.11 0.14
Mal → malx 0.00 0.00 0.00 0.00 0.00 0.00
Scn → scnx 6.57 2.31 6.94 1.59 0.15 0.20
Fluxes towards biosynthesis and effluxes into medium
reversibility %
Malate shuttle
reversibility %
Absolute fluxes ( µmoles day-1 cotyledon-1)
Biosynthesis of Ser and Gly
reversibility %
Glutamate assimilation
reversibility %
Reaction
HH MM LL
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APPENDIX IV – RELATIVE FLUXES (TEMPERATURE STUDY) 
 
 
 
 
Figure IV-1: Relative flux map for MH temperature condition. The thickness of the arrows is 
proportional the relative flux values standardized with respect to 100 moles/day of sucrose intake. 
Green and red arrows indicate that the flux is greater or lower than the MM (optimum) temperature 
condition respectively. Dashed brownish yellow arrows indicate that the flux is not statistically 
different from the MM temperature condition. Table IV-1 at the end of this Appendix IV 
comprehensively lists all the relative fluxes for the MH temperature condition. 
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Figure IV-2: Relative flux map for ML temperature condition. The thickness of the arrows is 
proportional the relative flux values standardized with respect to 100 moles/day of sucrose intake. 
Green and red arrows indicate that the flux is greater or lower than the MM (optimum) temperature 
condition respectively. Dashed brownish yellow arrows indicate that the flux is not statistically 
different from the MM temperature condition. Table IV-1 at the end of this Appendix IV 
comprehensively lists all the relative fluxes for the ML temperature condition. 
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Figure IV-3: Relative flux map for HH temperature condition. The thickness of the arrows is 
proportional the relative flux values standardized with respect to 100 moles/day of sucrose intake. 
Green and red arrows indicate that the flux is greater or lower than the MM (optimum) temperature 
condition respectively. Dashed brownish yellow arrows indicate that the flux is not statistically 
different from the MM temperature condition. Table IV-2 at the end of this Appendix IV 
comprehensively lists all the relative fluxes for the HH temperature condition. 
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Figure IV-4: Relative flux map for LL temperature condition. The thickness of the arrows is 
proportional the relative flux values standardized with respect to 100 moles/day of sucrose intake. 
Green and red arrows indicate that the flux is greater or lower than the MM (optimum) temperature 
condition respectively. Dashed brownish yellow arrows indicate that the flux is not statistically 
different from the MM temperature condition. Table IV-2 at the end of this Appendix IV 
comprehensively lists all the relative fluxes for the LL temperature condition. 
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Table IV-1: Relative fluxes for Case 1 are standardized with respect to 100 moles of sucrose intake. 
Each flux is denoted usually by the name of the gene encoding the enzyme catalyzing the metabolic 
reaction. Subscript f indicates forward reaction and superscripts c, p and m indicate cytosol, plastid and 
mitochondrion respectively. For reversible reactions, the net flux and reversibility is given. Net fluxes  
are in the direction of the reaction with the subscript f. Negative flux indicates that the direction of net 
flux is exactly reverse of that assumed. Reversibilities arereported in percentages; 0% and 100 % 
reversibility represent irreversible reaction and reaction at equilibrium.
Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ F6Pc hxi f
c
-122.33 20.00 -99.76 15.85 -81.90 26.81
9.37 20.98 51.78 26.73 3.47 5.94
G6Pp ↔ F6Pp hxi f
p
-46.07 34.95 -38.10 44.39 -2.54 45.53
92.43 10.63 97.04 3.16 94.23 3.35
G6Pc → P5Pc + CO2 pgl c 114.77 44.27 94.91 39.96 35.02 35.72
G6Pp → P5Pp + CO2 pgl p 118.13 46.81 113.49 51.69 106.34 48.65
P5Pc + P5Pc ↔ S7Pc + T3Pc tktA f c 17.31 4.92 6.34 2.62 4.29 1.08
81.61 29.30 90.43 17.94 88.32 22.85
S7Pc + T3Pc ↔ F6Pc + E4Pc tal f
c 17.31 4.92 6.34 2.62 4.29 1.08
27.84 23.47 46.69 25.18 16.81 16.01
P5Pc + E4Pc ↔ F6Pc + T3Pc tktB f c 17.31 4.92 6.34 2.62 4.29 1.08
33.78 15.96 6.70 10.92 75.92 6.03
P5Pp + P5Pp ↔ S7Pp + T3Pp tktA f p 54.21 11.37 56.76 15.62 35.99 14.52
85.05 12.80 88.63 14.44 85.94 6.44
S7Pp + T3Pp ↔ F6Pp + E4Pp tal f p 54.21 11.37 56.76 15.62 35.99 14.52
80.83 12.11 76.13 16.07 98.22 1.80
P5Pp + E4Pp ↔ F6Pp + T3Pp tktB f p 51.08 11.39 52.91 15.63 32.66 14.51
71.49 19.33 34.04 30.70 0.86 3.68
F6Pc → T3Pc + T3Pc pfk c 12.04 18.66 12.57 15.31 26.43 26.67
F6Pp → T3Pp + T3Pp pfk p 59.22 20.68 71.57 18.29 66.12 25.88
T3Pc + T3Pc → F6Pc pfp c 0.04 0.18 0.57 3.67 0.30 0.62
T3Pp + T3Pp → F6Pp f16bp p 292.88 38.87 214.35 60.88 79.60 40.48
T3P → 3PG gap 206.53 15.25 222.83 17.62 218.19 34.93
3PG → PEP eno 202.14 14.99 218.13 17.35 214.33 34.52
PEP → Pyr pyk 183.67 13.29 193.00 14.64 177.69 27.56
Pyrp → ACAp + CO2 pdh
p 131.33 3.08 119.61 1.29 96.90 4.33
Pyrm → ACAm + CO2 pdh
m 52.64 10.87 58.25 14.10 102.44 24.86
Pyrc → Pyrm pyrT 52.64 10.87 58.25 14.10 102.44 24.86
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Reaction Relative fluxes
MH MM ML
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ G6Pp g6pT f 79.26 41.87 84.08 40.03 114.58 41.32
63.63 29.99 50.35 26.74 82.05 28.05
P5Pc ↔ P5Pp p5pT f 42.63 46.23 54.17 41.23 -0.45 36.20
74.58 42.50 75.64 28.68 93.16 16.37
T3Pc ↔ T3Pp t3pT f 24.93 40.48 45.92 30.24 61.39 47.71
98.29 1.47 96.22 6.66 92.24 19.05
ACAm + OAAm → ICitm csaco m 48.54 10.74 53.23 13.93 96.32 23.63
ICitm → aKGm + CO2 icdh
m 44.46 10.50 48.27 13.64 91.22 22.04
aKGm → Scnm + CO2 akgdh
m 5.71 20.91 6.31 20.72 13.40 30.81
Scnm → Malm sdh f1
m 35.25 2.02 34.49 10.19 27.13 8.31
Scnm ↔ Malm sdh f2
m 75.58 10.15 67.07 13.62 128.82 24.65
75.61 2.13 89.47 3.66 89.90 5.44
Malm ↔ OAAm mdh f
m 59.88 10.78 66.06 14.03 108.69 23.97
47.93 29.83 45.21 31.83 39.93 30.13
ICitm → Goxm + Scnm icl m 4.08 0.24 4.96 0.29 5.10 1.59
ACAm + Goxm → Malm ms m 0.02 0.08 0.07 0.15 1.01 1.52
PEPc + CO2 → OAA
c pep c 16.60 1.96 22.13 3.24 33.83 8.98
Malm → Pyrm + CO2 me
m 8.64 3.10 9.41 4.32 22.50 8.85
Malp → Pyrp + CO2 me
p 16.42 1.94 5.92 2.63 25.21 7.61
Gluc → GABAc + CO2 gad
c 70.36 17.69 80.02 22.63 112.36 36.98
GABAc → GABAm gabaT 70.36 17.69 80.02 22.63 112.36 36.98
GABAm ↔ SSAm gat f
m 70.36 17.69 80.02 22.63 112.36 36.98
42.20 30.78 49.50 33.00 42.91 31.40
SSAm → Scnm ssadh m 70.36 17.69 80.02 22.63 112.36 36.98
Sucext → G6Pc + F6Pc subs1 100.00 0.00 100.00 0.00 100.00 0.00
Glnext ↔ Glnc subs2 f 42.41 1.81 49.59 2.36 44.56 2.43
68.02 2.64 83.99 2.25 72.09 2.57
Glnc → Glnp glnT 42.41 1.81 49.59 2.36 44.56 2.43
reversibility %
Substrate entry
reversibility %
Glutamate assimilation
Glyoxylate shunt
Anaplerotic reactions
GABA shunt
TCA cycle
reversibility %
reversibility %
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Reaction Relative fluxes
MH MM ML
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
aKGm → aKGc aKGT1 42.41 1.81 49.59 2.36 44.56 2.43
aKGc → aKGp aKGT2 42.41 1.81 49.59 2.36 44.56 2.43
aKGp + Glnp → Glup + Glup gogat p 727.15 404.72 924.39 459.51 794.44 394.51
Glup ↔ aKGp gdh f p 684.74 402.91 874.80 457.14 749.88 392.08
99.00 0.00 99.00 0.00 99.00 0.00
Glup ↔ Glnp as f 685.15 400.66 872.13 457.35 788.24 386.61
59.20 28.52 60.87 28.10 63.67 23.94
Malm ↔ Malc malT1 f 7.09 3.10 -8.33 4.66 -1.37 7.79
98.34 0.60 96.50 1.45 97.41 1.93
Malc → Malp malT2 23.68 5.06 13.80 7.90 32.47 16.77
Malc → OAAc mdh c -16.60 1.96 -22.13 3.24 -33.83 8.98
Malp → OAAP mdh p 7.26 3.12 7.88 5.27 7.26 9.17
3PG → Ser bios1 4.38 0.26 4.70 0.27 3.86 0.41
Ser ↔ Gly + C1 bios2 f 4.38 0.26 4.70 0.27 3.86 0.41
41.13 1.06 40.88 1.17 12.76 3.65
GOx → Gly bios3 4.05 -0.06 4.89 -0.16 4.10 -0.05
CO2 → resp 549.95 20.97 519.02 24.38 576.65 48.31
G6Pc → biomass bios4 28.31 2.75 20.77 3.06 32.30 4.10
G6Pp → biomass bios5 7.19 0.27 8.69 0.31 10.78 0.92
F6Pc → biomass bios6 0.24 0.24 0.35 0.28 0.24 0.29
P5Pc → biomass bios7 20.21 1.25 21.72 1.71 22.61 2.09
P5Pp → biomass bios8 1.27 0.03 1.23 0.01 1.24 0.06
E4Pp → biomass bios9 3.13 0.07 3.85 0.04 3.33 0.15
PEPp → biomass bios10 6.27 0.15 7.69 0.08 6.67 0.30
ACAp → biomass bios11 127.46 2.99 114.09 1.23 92.59 4.14
ACAp → biomass bios12 3.88 0.09 5.51 0.06 4.31 0.19
Pyr → biomass bios13 23.42 0.55 28.74 0.31 25.14 1.12
OAA → biomass bios14 7.26 0.17 7.88 0.09 7.26 0.32
Glu → biomass bios15 14.88 0.35 16.50 0.18 15.13 0.68
Pyr → pyrx 1.34 0.90 1.73 1.28 0.92 1.27
Mal → malx 0.00 0.00 0.00 0.00 0.00 0.00
Scn → scnx 4.57 2.88 24.21 5.51 2.04 3.90
Biosynthesis of Ser and Gly
reversibility %
Fluxes towards biosynthesis and effluxes into medium
Glutamate assimilation
reversibility %
Malate shuttle
reversibility %
reversibility %
Reaction Relative fluxes
MH MM ML
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Table IV-2: Relative fluxes for Case 2 are standardized with respect to 100 moles of sucrose intake. 
Each flux is denoted usually by the name of the gene encoding the enzyme catalyzing the metabolic 
reaction. Subscript f indicates forward reaction and superscripts c, p and m indicate cytosol, plastid and 
mitochondrion respectively. For reversible reactions, the net flux and reversibility is given. Net fluxes  
are in the direction of the reaction with the subscript f. Negative flux indicates that the direction of net 
flux is exactly reverse of that assumed. Reversibilities arereported in percentages; 0% and 100 % 
reversibility represent irreversible reaction and reaction at equilibrium.
Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ F6Pc hxi f c -120.05 11.29 -99.76 15.85 -114.94 9.64
11.36 24.71 51.78 26.73 10.11 14.90
G6Pp ↔ F6Pp hxi f
p
-25.43 45.75 -38.10 44.39 -50.71 40.54
97.27 4.69 97.04 3.16 95.88 4.06
G6Pc → P5Pc + CO2 pgl c 74.37 44.38 94.91 39.96 67.19 40.60
G6Pp → P5Pp + CO2 pgl p 130.60 58.02 113.49 51.69 154.83 47.64
P5Pc + P5Pc ↔ S7Pc + T3Pc tktA f c 12.59 4.27 6.34 2.62 11.30 2.99
85.84 23.09 90.43 17.94 88.97 16.50
S7Pc + T3Pc ↔ F6Pc + E4Pc tal f c 12.59 4.27 6.34 2.62 11.30 2.99
31.53 23.08 46.69 25.18 25.74 21.86
P5Pc + E4Pc ↔ F6Pc + T3Pc tktB f c 12.59 4.27 6.34 2.62 11.30 2.99
52.77 12.30 6.70 10.92 29.08 15.20
P5Pp + P5Pp ↔ S7Pp + T3Pp tktA f p 48.47 15.46 56.76 15.62 55.36 13.79
92.84 8.39 88.63 14.44 83.18 7.06
S7Pp + T3Pp ↔ F6Pp + E4Pp tal f p 48.47 15.46 56.76 15.62 55.36 13.79
80.27 11.60 76.13 16.07 86.56 8.84
P5Pp + E4Pp ↔ F6Pp + T3Pp tktB f p 45.16 15.48 52.91 15.63 52.11 13.83
21.31 28.01 34.04 30.70 28.94 20.59
F6Pc → T3Pc + T3Pc pfk c 4.74 9.90 12.57 15.31 7.40 8.60
F6Pp → T3Pp + T3Pp pfk p 68.20 17.87 71.57 18.29 56.76 15.32
T3Pc + T3Pc → F6Pc pfp c 0.26 0.56 0.57 3.67 0.63 0.65
T3Pp + T3Pp → F6Pp f16bp p 261.64 56.75 214.35 60.88 186.65 50.62
T3P → 3PG gap 200.29 16.60 222.83 17.62 186.28 22.91
3PG → PEP eno 196.94 16.48 218.13 17.35 180.83 22.49
PEP → Pyr pyk 178.07 14.32 193.00 14.64 165.82 20.46
Pyrp → ACAp + CO2 pdh
p 137.29 3.49 119.61 1.29 93.39 4.43
Pyrm → ACAm + CO2 pdh
m 30.23 10.27 58.25 14.10 74.02 17.13
Pyrc → Pyrm pyrT 30.23 10.27 58.25 14.10 74.02 17.13
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Reaction Relative fluxes
HH MM LL
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ G6Pp g6pT f 113.33 45.57 84.08 40.03 114.35 40.70
57.24 35.30 50.35 26.74 73.21 31.46
P5Pc ↔ P5Pp p5pT f 12.85 45.87 54.17 41.23 9.54 42.08
94.66 8.47 75.64 28.68 94.17 8.85
T3Pc ↔ T3Pp t3pT f 26.31 25.35 45.92 30.24 56.81 22.96
97.64 3.11 96.22 6.66 95.85 8.31
ACAm + OAAm → ICitm csaco m 24.06 9.63 53.23 13.93 71.11 16.99
ICitm → aKGm + CO2 icdh
m 18.15 9.19 48.27 13.64 68.34 16.55
aKGm → Scnm + CO2 akgdh
m 17.91 25.67 6.31 20.72 11.72 29.68
Scnm → Malm sdh f1
m 38.00 4.78 34.49 10.19 37.08 3.76
Scnm ↔ Malm sdh f2 m 44.85 8.40 67.07 13.62 101.70 16.94
77.08 4.34 89.47 3.66 61.16 4.64
Malm ↔ OAAm mdh f m 37.50 9.93 66.06 14.03 81.34 16.92
39.32 29.94 45.21 31.83 62.39 33.23
ICitm → Goxm + Scnm icl m 5.92 0.45 4.96 0.29 2.78 0.45
ACAm + Goxm → Malm ms m 0.25 0.46 0.07 0.15 0.12 0.21
PEPc + CO2 → OAA
c pep c 15.59 2.59 22.13 3.24 13.98 2.36
Malm → Pyrm + CO2 me
m 2.82 1.82 9.41 4.32 11.42 3.35
Malp → Pyrp + CO2 me
p 12.86 4.01 5.92 2.63 15.60 2.06
Gluc → GABAc + CO2 gad
c 39.18 20.95 80.02 22.63 88.36 33.56
GABAc → GABAm gabaT 39.18 20.95 80.02 22.63 88.36 33.56
GABAm ↔ SSAm gat f
m 39.18 20.95 80.02 22.63 88.36 33.56
53.35 30.95 49.50 33.00 45.61 30.19
SSAm → Scnm ssadh m 39.18 20.95 80.02 22.63 88.36 33.56
Sucext → G6Pc + F6Pc subs1 100.00 0.00 100.00 0.00 100.00 0.00
Glnext ↔ Glnc subs2 f 48.50 4.19 49.59 2.36 45.59 2.41
64.61 9.60 83.99 2.25 72.89 3.07
Glnc → Glnp glnT 48.50 4.19 49.59 2.36 45.59 2.41
reversibility %
Glutamate assimilation
Anaplerotic reactions
GABA shunt
reversibility %
Substrate entry
TCA cycle
reversibility %
reversibility %
Glyoxylate shunt
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Reaction Relative fluxes
HH MM LL
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
aKGm → aKGc aKGT1 48.50 4.19 49.59 2.36 45.59 2.41
aKGc → aKGp aKGT2 48.50 4.19 49.59 2.36 45.59 2.41
aKGp + Glnp → Glup + Glup gogat p 811.38 465.52 924.39 459.51 840.44 390.39
Glup ↔ aKGp gdh f p 762.88 461.33 874.80 457.14 794.85 387.98
99.00 0.00 99.00 0.00 99.00 0.00
Glup ↔ Glnp as f 720.53 460.24 872.13 457.35 808.66 389.91
47.08 32.39 60.87 28.10 54.92 29.32
Malm ↔ Malc malT1 f 4.78 4.38 -8.33 4.66 9.07 3.18
96.90 2.01 96.50 1.45 98.26 1.18
Malc → Malp malT2 20.38 6.98 13.80 7.90 23.04 5.53
Malc → OAAc mdh c -15.59 2.59 -22.13 3.24 -13.98 2.36
Malp → OAAP mdh p 7.51 2.96 7.88 5.27 7.45 3.47
3PG → Ser bios1 3.35 0.12 4.70 0.27 5.45 0.41
Ser ↔ Gly + C1 bios2 f 3.35 0.12 4.70 0.27 5.45 0.41
46.68 1.32 40.88 1.17 22.66 1.58
GOx → Gly bios3 5.67 0.11 4.89 -0.16 2.65 -0.03
CO2 → resp 453.73 26.51 519.02 24.38 573.67 35.60
G6Pc → biomass bios4 32.35 2.97 20.77 3.06 33.39 3.45
G6Pp → biomass bios5 8.16 0.30 8.69 0.31 10.24 0.96
F6Pc → biomass bios6 0.38 0.25 0.35 0.28 0.26 0.27
P5Pc → biomass bios7 23.77 1.43 21.72 1.71 23.74 2.12
P5Pp → biomass bios8 1.34 0.03 1.23 0.01 1.54 0.07
E4Pp → biomass bios9 3.31 0.08 3.85 0.04 3.24 0.15
PEPp → biomass bios10 6.62 0.17 7.69 0.08 6.48 0.31
ACAp → biomass bios11 133.21 3.39 114.09 1.23 89.28 4.24
ACAp → biomass bios12 4.08 0.10 5.51 0.06 4.11 0.20
Pyr → biomass bios13 24.21 0.62 28.74 0.31 24.53 1.16
OAA → biomass bios14 7.51 0.19 7.88 0.09 7.44 0.35
Glu → biomass bios15 15.48 0.39 16.50 0.18 16.62 0.79
Pyr → pyrx 2.03 1.22 1.73 1.28 0.90 1.14
Mal → malx 0.00 0.00 0.00 0.00 0.00 0.00
Scn → scnx 18.16 6.31 24.21 5.51 1.16 1.56
Fluxes towards biosynthesis and effluxes into medium
Malate shuttle
reversibility %
Biosynthesis of Ser and Gly
reversibility %
LL
Glutamate assimilation
reversibility %
reversibility %
HH MM
Reaction Relative fluxes
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APPENDIX V- CALCULATIONS ON A C mol BASIS  
 
The absolute fluxes are reported in the units: µmol day-1 cotyledon-1. 
 
For relative fluxes, we standardize absolute fluxes w.r.t. absolute sucrose intake rate. 
 
For eg: If absolute flux through pglP is 60 µmol day-1 cotyledon-1 and corresponding sucrose intake 
rate is 80 µmol day-1 cotyledon-1, then the relative flux through pglP is: 
 
Relative flux through pglP = 60 / 80 = 0.75.  
 
This automatically assumes that sucrose intake rate is 1. Similarly, relative fluxes can be reported 
based on sucrose intake rate of 100 mol, in which case the pglp flux would be 75. 
 
However, the flux ratios that are reported in this work are based on a C mol basis. Sucrose is a 12 
carbon molecule and for pglP flux, G6P gets converted to P5P and evolves one CO2. G6P is a 6 
carbon molecule, hence flux ratio of pglP relative to sucrose intake on a C mol basis is calculated as: 
 
Flux ratio of pglp relative to sucrose intake= (75*6)/(100*12) = 0.375. 
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APPENDIX VI – NADPH BALANCE FOR MH  
 
 
Table VI-1: NADPH balance in the plastid for MH temperature condition. Flux values are  
absolute with units µmoles d-1 cotyledon-1     
         
Reactions consuming NADPH   Reactions producing NADPH 
                  
Reaction Moles of Flux Total   Reaction 
Moles 
of Flux Total  
  NADPH   NADPH     
NADP
H   NADPH 
         
[Arg] -1 0.15 -0.15  oxPPP 2 47.86 95.72 
[Pro] -2 0.11 -0.22  in plastid    
[Met] -2 0.02 -0.04      
[Thr] -2 0.08 -0.16      
[Ile] -3 0.09 -0.27      
[Lys] -3 0.13 -0.39      
[Val] -1 0.12 -0.12      
[Leu] -1 0.16 -0.16      
[Phe] -1 0.08 -0.08      
[Tyr] -1 0.05 -0.05      
[Lipid] -1.11 51.6 -57.28      
mdh -1 2.94 -2.94      
GABA  -1 28.49 -28.49      
         
Total Consumed =   -90.35  Total Produced by oxPPP = 95.72 
 
 
       
Thus, ratio of Production/Consumption = 1.05      
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Table VII-1: Set 2 TP1: Relative multiplet intensities of amino acids from protein and glucosyl units from starch hydrolysates with their standard 
deviations (SDs) from 2-D [13C, 1H] HSQC spectrum. s indicates singlet, d1 and d2 indicate the first and second doublet and dd indicates the
double doublet. Bold faced carbon atom in Isotopomer indicates labeled carbon atom, normal font indicates unlabeled carbon atom and x indicates
unknown labeling state of the carbon atom. Subscripts p, c and m for precursor indicates the compartments plastid, cytosol and mitochondrion in which 
they are present. RI and SD represent relative intensities and standard deviations respectively.
Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Gly α (s) 0.454 0.005 0.485 0.005 0.499 0.005 T3P/GOx [12x]
Protein Gly α (d) 0.546 0.005 0.515 0.005 0.501 0.005 T3P/GOx [12x]
Protein Ser α (s) 0.310 0.008 0.300 0.010 0.321 0.008 Ser [123]
Protein Ser α (d1) 0.216 0.008 0.245 0.010 0.186 0.008 Ser [123]
Protein Ser α (d2) 0.124 0.008 0.121 0.010 0.126 0.008 Ser [123]
Protein Ser α (dd) 0.349 0.008 0.334 0.010 0.367 0.008 Ser [123]
Protein Ser β (s) 0.638 0.012 0.571 0.017 0.485 0.012 Ser [x23]
Protein Ser β (d) 0.362 0.012 0.429 0.017 0.515 0.012 Ser [x23]
Protein Ala α (s) 0.231 0.010 0.241 0.010 0.265 0.010 Pyr [123]
Protein Ala α (d1) 0.039 0.010 0.040 0.010 0.039 0.010 Pyr [123]
Protein Ala α (d2) 0.146 0.010 0.138 0.010 0.174 0.010 Pyr [123]
Protein Ala α (dd) 0.584 0.010 0.581 0.010 0.522 0.010 Pyr [123]
Protein Ala β (s) 0.280 0.003 0.278 0.003 0.284 0.003 Pyr [x23]
Protein Ala β (d) 0.720 0.003 0.722 0.003 0.716 0.003 Pyr [x23]
Protein Ile γ2 (s) 0.272 0.003 0.283 0.003 0.283 0.003 Pyrp [x23]
Protein Ile γ2 (d) 0.729 0.003 0.717 0.003 0.717 0.003 Pyrp [x23]
Protein Leu δ1 (s) Pyrp [x23]
Protein Leu δ1 (d) Pyrp [x23]
Protein Val α (s) 0.373 0.015 0.383 0.015 0.430 0.015 Pyrp [12x]·[x2x]
Protein Val α (d1) 0.505 0.015 0.503 0.015 0.478 0.015 Pyrp [12x]·[x2x]
Protein Val α (d2) 0.087 0.015 0.055 0.015 0.052 0.015 Pyrp [12x]·[x2x]
Protein Val α (dd) 0.035 0.015 0.060 0.015 0.040 0.015 Pyrp [12x]·[x2x]
Protein Val γ1 (s) 0.304 0.010 0.288 0.003 0.304 0.006 Pyrp [x23]
Protein Val γ1 (d) 0.697 0.010 0.712 0.003 0.696 0.006 Pyrp [x23]
Protein Val γ2 (s) 0.900 0.003 0.891 0.003 0.899 0.003 Pyrp [x2x]·[xx3]
High PI Set 2 TP1 BC3-128 Set 2 TP1 Evans Set 2 TP1
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Val γ2 (d) 0.101 0.003 0.109 0.003 0.101 0.003 Pyrp [x2x]·[xx3]
Protein Leu δ2 (s) 0.892 0.003 0.900 0.008 0.893 0.008 Pyrp [x2x]·[xx3]
Protein Leu δ2 (d) 0.108 0.003 0.100 0.008 0.107 0.008 Pyrp [x2x]·[xx3]
Protein Phe α (s) 0.219 0.010 0.252 0.010 PEPp [123]
Protein Phe α (d1) 0.025 0.010 0.014 0.010 PEPp [123]
Protein Phe α (d2) 0.128 0.010 0.167 0.010 PEPp [123]
Protein Phe α (dd) 0.629 0.010 0.567 0.010 PEPp [123]
Protein Phe β (s) 0.248 0.015 0.255 0.015 PEPp [x23]·[x2x]
Protein Phe β (d1) 0.687 0.015 0.676 0.015 PEPp [x23]·[x2x]
Protein Phe β (d2) 0.017 0.015 0.003 0.015 PEPp [x23]·[x2x]
Protein Phe β (dd) 0.048 0.015 0.066 0.015 PEPp [x23]·[x2x]
Protein Tyr α (s) 0.216 0.011 0.224 0.011 0.262 0.011 PEPp [123]
Protein Tyr α (d1) 0.019 0.011 0.010 0.011 0.020 0.011 PEPp [123]
Protein Tyr α (d2) 0.158 0.011 0.161 0.011 0.203 0.011 PEPp [123]
Protein Tyr α (dd) 0.607 0.011 0.605 0.011 0.516 0.011 PEPp [123]
Protein Tyr β (s) 0.217 0.012 0.224 0.012 0.198 0.012 PEPp [x23]·[x2x]
Protein Tyr β (d) 0.715 0.012 0.682 0.012 0.678 0.012 PEPp [x23]·[x2x] + [x23]·[x2x]
Protein Tyr β (t) 0.069 0.012 0.094 0.012 0.124 0.012 PEPp [x23]·[x2x]
Protein Leu α (s) 0.277 0.010 0.250 0.010 0.296 0.010 ACoA p /Pyrp [1 2 ] ·[x2x]
Protein Leu α (d1) 0.599 0.010 0.636 0.010 0.596 0.010 ACoA p /Pyrp [ 12 ] ·[x2x]
Protein Leu α (d2) 0.074 0.010 0.050 0.010 0.040 0.010 ACoA p /Pyrp [1 2 ] ·[x2x]
Protein Leu α (dd) 0.051 0.010 0.063 0.010 0.068 0.010 ACoA p /Pyrp [ 12 ] ·[x2x]
Protein Leu b (s) 0.794 0.007 0.781 0.007 0.810 0.007 ACoA p /Pyrp [x2] ·[x2x].[x2x]
Protein Leu b (d) 0.164 0.007 0.216 0.007 0.149 0.007 ACoA p /Pyrp [x 2 ] ·[x2x].[x2x]+[x2]·[x2x].[x2x]
Protein Leu b (t) 0.042 0.007 0.004 0.007 0.041 0.007 ACoA p /Pyrp [x 2 ] ·[x2x].[x2x]
Protein His β (s) 0.327 0.008 0.311 0.008 0.380 0.008 P5Pp [x234x]
Protein His β (d1) 0.011 0.015 0.002 0.015 0.028 0.015 P5Pp [x234x]
Protein His β (d2) 0.547 0.015 0.539 0.015 0.504 0.015 P5Pp [x234x]
Protein His β (dd) 0.115 0.008 0.148 0.008 0.088 0.008 P5Pp [x234x]
Protein His δ2 (s) 0.634 0.022 0.666 0.022 0.622 0.007 P5Pp [12xxx]
High PI Set 2 TP1 BC3-128 Set 2 TP1 Evans Set 2 TP1
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein His δ2 (d) 0.367 0.022 0.334 0.022 0.378 0.007 P5Pp [12xxx]
Protein Tyr δ1 (s) 0.238 0.007 0.222 0.007 0.262 0.007 PEP p /E4Pp [x2 3 ] ·[1xxx]
Protein Tyr δ2 (s) PEP p /E4Pp [x2x] ·[43xx]
Protein Tyr δ1 (d) 0.689 0.007 0.707 0.007 0.669 0.007 PEP p /E4Pp [x 23 ] ·[1xxx] + [x2 3 ] ·[1xxx]
Protein Tyr δ2 (d) PEP p /E4Pp [x 2 x] ·[43xx] + [x2x] ·[43xx]
Protein Tyr δ1 (t) 0.073 0.007 0.071 0.007 0.069 0.007 PEP p /E4Pp [x 23 ] ·[1xxx]
Protein Tyr δ2 (t) PEP p /E4Pp [x 2 x] ·[43xx]
Protein Tyr ε1 (s) 0.510 0.007 0.498 0.007 0.539 0.007 PEP p /E4Pp [xx3] ·[12xx]
Protein Tyr ε2 (s) E4Pp [x234]
Protein Tyr ε1 (d) 0.217 0.007 0.219 0.007 0.205 0.007 PEP p /E4Pp [xx 3 ] ·[12xx] + [xx3] ·[12xx]
Protein Tyr ε2 (d) E4Pp [x234] + [x234]
Protein Tyr ε1 (t) 0.273 0.007 0.283 0.007 0.256 0.007 PEP p /E4Pp [xx 3 ] ·[12xx]
Protein Tyr ε2 (t) E4Pp [x234]
Protein Arg β (s) 0.833 0.040 0.806 0.040 0.840 0.040 Glup [x234x]
Protein Arg β (d) 0.167 0.040 0.194 0.040 0.160 0.040 Glup [x234x] + [x234x]
Protein Arg β (t) 0.000 0.040 0.000 0.040 0.000 0.040 Glup [x234x]
Protein Arg δ (s) 0.708 0.010 0.650 0.010 0.666 0.010 Glup [xxx45]
Protein Arg δ (d) 0.293 0.010 0.351 0.010 0.334 0.010 Glup [xxx45]
Protein Glu β (s) 0.830 0.025 0.829 0.025 0.836 0.025 Glu [x234x]
Protein Glu β (d) 0.163 0.025 0.171 0.025 0.152 0.025 Glu [x234x] + [x234x]
Protein Glu β (t) 0.007 0.025 0.000 0.025 0.012 0.025 Glu [x234x]
Protein Glu γ (s) 0.679 0.010 0.600 0.010 0.673 0.010 Glu [xx345]
Protein Glu γ (d1) 0.027 0.010 0.009 0.010 0.026 0.010 Glu [xx345]
Protein Glu γ (d2) 0.282 0.010 0.364 0.010 0.301 0.010 Glu [xx345]
Protein Glu γ (dd) 0.012 0.010 0.027 0.010 0.000 0.010 Glu [xx345]
Protein Pro γ (s) 0.672 0.013 0.609 0.013 0.641 0.013 Glup [xx345]
Protein Pro γ (d) 0.329 0.013 0.391 0.013 0.326 0.013 Glup [xx345] + [xx345]
Protein Pro γ (t) 0.000 0.013 0.000 0.013 0.033 0.013 Glup [xx345]
Protein Pro δ (s) 0.681 0.014 0.613 0.014 0.660 0.014 Glup [xxx45]
Protein Pro δ (d) 0.319 0.014 0.387 0.014 0.340 0.014 Glup [xxx45]
High PI Set 2 TP1 BC3-128 Set 2 TP1 Evans Set 2 TP1
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Asp α (s) 0.517 0.009 0.510 0.010 0.528 0.009 OAA [123x]
Protein Asp α (d1) 0.157 0.009 0.132 0.010 0.129 0.009 OAA [123x]
Protein Asp α (d2) 0.192 0.009 0.204 0.010 0.196 0.009 OAA [123x]
Protein Asp α (dd) 0.134 0.009 0.154 0.010 0.148 0.009 OAA [123x]
Protein Asp β (s) 0.508 0.009 0.493 0.010 0.520 0.009 OAA [x234]
Protein Asp β (d1) 0.268 0.009 0.250 0.010 0.245 0.009 OAA [x234]
Protein Asp β (d2) 0.097 0.009 0.118 0.010 0.097 0.009 OAA [x234]
Protein Asp β (dd) 0.127 0.009 0.138 0.010 0.138 0.009 OAA [x234]
Protein Ile α (s) 0.626 0.012 0.651 0.012 0.631 0.012 OAA p /Pyrp [1 2 xx] ·[x2x]
Protein Ile α (d1) 0.287 0.012 0.280 0.012 0.239 0.012 OAA p /Pyrp [ 12 xx] ·[x2x]
Protein Ile α (d2) 0.053 0.012 0.068 0.012 0.083 0.012 OAA p /Pyrp [1 2 xx] ·[x2x]
Protein Ile α (dd) 0.035 0.012 0.000 0.012 0.047 0.012 OAA p /Pyrp [ 12 xx] ·[x2x]
Protein Ile γ1(s) 0.710 0.017 0.662 0.022 0.693 0.022 Pyrp/OAA p [x2x]·[xx 3 4]
Protein Ile γ1(d) 0.290 0.017 0.338 0.022 0.307 0.022 Pyrp/OAA p [x2x]·[xx 3 4]  + [x2x]·[xx 34 ]
Protein Ile γ1(t) 0.000 0.017 0.000 0.022 0.000 0.022 Pyrp/OAA p [x2x]·[xx 34 ]
Protein Ile δ (s) 0.749 0.010 0.736 0.012 0.783 0.012 OAAp [xx34]
Protein Ile δ (d) 0.252 0.010 0.264 0.012 0.218 0.012 OAAp [xx34]
Protein Met γ (s) 0.773 0.025 0.725 0.020 0.773 0.020 OAAp [xx34]
Protein Met γ (d) 0.228 0.025 0.275 0.020 0.227 0.020 OAAp [xx34]
Protein Thr α (s) 0.482 0.013 0.433 0.010 0.494 0.010 OAAp [123x]
Protein Thr α (d1) 0.141 0.013 0.137 0.010 0.129 0.010 OAAp [123x]
Protein Thr α (d2) 0.212 0.013 0.241 0.010 0.212 0.010 OAAp [123x]
Protein Thr α (dd) 0.165 0.013 0.189 0.010 0.165 0.010 OAAp [123x]
Protein Thr γ2 (s) 0.740 0.004 0.715 0.004 0.736 0.004 OAAp [xx34]
Protein Thr γ2 (d) 0.260 0.004 0.285 0.004 0.264 0.004 OAAp [xx34]
Protein Lys γ (s) 0.686 0.017 0.644 0.017 0.688 0.017 OAA p /Pyrp [xx3 4 ] ·[xx3]
Protein Lys γ (d) 0.331 0.017 0.340 0.017 0.310 0.017 OAA p /Pyrp [xx 34 ] ·[xx3] + [xx3 4 ]·[xx 3 ]
Protein Lys γ (t) 0.000 0.017 0.017 0.017 0.000 0.017 OAA p /Pyrp [xx 34 ] ·[xx3]
Protein Lys β (s) 0.361 0.011 0.289 0.011 0.356 0.011 OAA p /Pyrp ½{[x2 3 4]  + [x23]·[xxx4] }
Protein Lys β (d) 0.584 0.011 0.611 0.011 0.598 0.011 OAA p /Pyrp ½{[x 23 4]  + [x2 34 ] +
OAA p /Pyrp  [x23]·[xxx4]  + [x23]·[xxx 4 ] }
High PI Set 2 TP1 BC3-128 Set 2 TP1 Evans Set 2 TP1
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Lys β (t) 0.055 0.011 0.100 0.011 0.047 0.011 OAA p /Pyrp ½{[x 234 ]  + [x23]·[xxx 4 ] }
Protein Lys δ (s) 0.302 0.012 0.308 0.012 0.340 0.012 OAA p /Pyrp ½{[x2 3 4]  + [x23]·[xxx4] }
Protein Lys δ (d) 0.599 0.012 0.588 0.012 0.567 0.012 OAA p /Pyrp ½{[x 23 4]  + [x2 34 ]  +
 [x23]·[xxx4] + [x23]·[xxx 4 ] }
Protein Lys δ (t) 0.098 0.012 0.104 0.012 0.093 0.012 OAA p /Pyrp ½{[x 234 ]  + [x23]·[xxx 4 ] }
Protein Lys ε (s) 0.394 0.005 0.381 0.005 0.406 0.005 OAA p /Pyrp ½{[x23] + [x 2 3x] }
Protein Lys ε (d) 0.606 0.005 0.619 0.005 0.594 0.005 OAA p /Pyrp ½{[x23] + [x 23 x] }
Protein HMF 1 (s) 0.136 0.030 0.227 0.030 G6Pc/F6Pc [12xxxx]
Protein HMF 1 (d) 0.864 0.030 0.774 0.030 G6Pc/F6Pc [12xxxx]
Protein LVA 3 (s) 0.221 0.006 0.177 0.007 0.291 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 3 (d1) 0.028 0.006 0.009 0.007 0.048 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 3 (d2) 0.040 0.006 0.001 0.007 0.032 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 3 (dd) 0.710 0.006 0.813 0.007 0.630 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 6 (s) 0.135 0.006 0.107 0.007 0.156 0.007 G6Pc/F6Pc [xxx456]
Protein LVA 6 (d1) 0.007 0.006 0.000 0.007 0.028 0.007 G6Pc/F6Pc [xxx456]
Protein LVA 6 (d2) 0.028 0.006 0.034 0.007 0.059 0.007 G6Pc/F6Pc [xxx456]
Protein LVA 6 (dd) 0.830 0.006 0.859 0.007 0.758 0.007 G6Pc/F6Pc [xxx456]
Starch HMF 1 (s) 0.405 0.010 0.506 0.015 0.377 0.015 G6Pp [12xxxx]
Starch HMF 1 (d) 0.595 0.010 0.494 0.015 0.623 0.015 G6Pp [12xxxx]
Starch LVA 3 (s) 0.513 0.006 0.571 0.007 0.503 0.007 G6Pp [x234xx]
Starch LVA 3 (d1) 0.164 0.006 0.145 0.007 0.231 0.007 G6Pp [x234xx]
Starch LVA 3 (d2) 0.057 0.006 0.059 0.007 0.072 0.007 G6Pp [x234xx]
Starch LVA 3 (dd) 0.266 0.006 0.225 0.007 0.194 0.007 G6Pp [x234xx]
Starch LVA 6 (s) 0.193 0.006 0.231 0.007 0.243 0.007 G6Pp [xxx456]
Starch LVA 6 (d1) 0.005 0.006 0.000 0.007 0.002 0.007 G6Pp [xxx456]
Starch LVA 6 (d2) 0.089 0.006 0.129 0.007 0.128 0.007 G6Pp [xxx456]
Starch LVA 6 (dd) 0.714 0.006 0.640 0.007 0.627 0.007 G6Pp [xxx456]
High PI Set 2 TP1 BC3-128 Set 2 TP1 Evans Set 2 TP1
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Table VII-2: Set 3 TP1: Relative multiplet intensities of amino acids from protein and glucosyl units from starch hydrolysates with their standard 
deviations (SDs) from 2-D [13C, 1H] HSQC spectrum. s indicates singlet, d1 and d2 indicate the first and second doublet and dd indicates the
double doublet. Bold faced carbon atom in Isotopomer indicates labeled carbon atom, normal font indicates unlabeled carbon atom and x indicates
unknown labeling state of the carbon atom. Subscripts p, c and m for precursor indicates the compartments plastid, cytosol and mitochondrion in which 
they are present. RI and SD represent relative intensities and standard deviations respectively.
Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Gly α (s) 0.499 0.005 0.479 0.005 0.469 0.005 T3P/GOx [12x]
Protein Gly α (d) 0.501 0.005 0.521 0.005 0.531 0.005 T3P/GOx [12x]
Protein Ser α (s) 0.307 0.010 0.314 0.010 0.315 0.010 Ser [123]
Protein Ser α (d1) 0.234 0.010 0.207 0.010 0.237 0.010 Ser [123]
Protein Ser α (d2) 0.120 0.010 0.131 0.010 0.115 0.010 Ser [123]
Protein Ser α (dd) 0.339 0.010 0.348 0.010 0.332 0.010 Ser [123]
Protein Ser β (s) 0.583 0.017 0.554 0.017 0.575 0.015 Ser [x23]
Protein Ser β (d) 0.417 0.017 0.446 0.017 0.425 0.015 Ser [x23]
Protein Ala α (s) 0.238 0.010 0.242 0.010 0.220 0.011 Pyr [123]
Protein Ala α (d1) 0.035 0.010 0.051 0.010 0.039 0.011 Pyr [123]
Protein Ala α (d2) 0.178 0.010 0.175 0.010 0.172 0.011 Pyr [123]
Protein Ala α (dd) 0.550 0.010 0.531 0.010 0.562 0.011 Pyr [123]
Protein Ala β (s) 0.309 0.010 0.287 0.003 0.289 0.004 Pyr [x23]
Protein Ala β (d) 0.691 0.010 0.713 0.003 0.711 0.004 Pyr [x23]
Protein Ile γ2 (s) 0.270 0.005 0.327 0.010 0.288 0.004 Pyrp [x23]
Protein Ile γ2 (d) 0.730 0.005 0.673 0.010 0.712 0.004 Pyrp [x23]
Protein Leu δ1 (s) Pyrp [x23]
Protein Leu δ1 (d) Pyrp [x23]
Protein Val α (s) 0.374 0.015 0.403 0.015 0.381 0.015 Pyrp [12x]·[x2x]
Protein Val α (d1) 0.463 0.015 0.464 0.015 0.494 0.015 Pyrp [12x]·[x2x]
Protein Val α (d2) 0.086 0.015 0.073 0.015 0.057 0.015 Pyrp [12x]·[x2x]
Protein Val α (dd) 0.077 0.015 0.061 0.015 0.068 0.015 Pyrp [12x]·[x2x]
Protein Val γ1 (s) 0.290 0.005 0.336 0.010 0.305 0.004 Pyrp [x23]
Protein Val γ1 (d) 0.710 0.005 0.664 0.010 0.695 0.004 Pyrp [x23]
Protein Val γ2 (s) 0.883 0.003 0.888 0.003 0.884 0.004 Pyrp [x2x]·[xx3]
Protein Val γ2 (d) 0.117 0.003 0.112 0.003 0.116 0.004 Pyrp [x2x]·[xx3]
High PI Set 3 TP1 BC3-128 Set 3 TP1 Evans Set 3 TP1
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Leu δ2 (s) 0.897 0.003 0.898 0.003 0.896 0.005 Pyrp [x2x]·[xx3]
Protein Leu δ2 (d) 0.103 0.003 0.102 0.003 0.104 0.005 Pyrp [x2x]·[xx3]
Protein Phe α (s) 0.224 0.010 0.250 0.010 0.220 0.011 PEPp [123]
Protein Phe α (d1) 0.027 0.010 0.028 0.010 0.020 0.011 PEPp [123]
Protein Phe α (d2) 0.166 0.010 0.170 0.010 0.169 0.011 PEPp [123]
Protein Phe α (dd) 0.583 0.010 0.552 0.010 0.590 0.011 PEPp [123]
Protein Phe β (s) 0.204 0.015 0.218 0.015 PEPp [x23]·[x2x]
Protein Phe β (d1) 0.651 0.015 0.609 0.015 PEPp [x23]·[x2x]
Protein Phe β (d2) 0.051 0.015 0.084 0.015 PEPp [x23]·[x2x]
Protein Phe β (dd) 0.095 0.015 0.090 0.015 PEPp [x23]·[x2x]
Protein Tyr α (s) 0.208 0.022 0.240 0.014 0.200 0.020 PEPp [123]
Protein Tyr α (d1) 0.017 0.022 0.022 0.014 0.021 0.020 PEPp [123]
Protein Tyr α (d2) 0.208 0.022 0.162 0.014 0.189 0.020 PEPp [123]
Protein Tyr α (dd) 0.568 0.022 0.576 0.014 0.590 0.020 PEPp [123]
Protein Tyr β (s) 0.204 0.015 0.229 0.015 0.204 0.015 PEPp [x23]·[x2x]
Protein Tyr β (d) 0.686 0.015 0.667 0.015 0.690 0.015 PEPp [x23]·[x2x] + [x23]·[x2x]
Protein Tyr β (t) 0.111 0.015 0.104 0.015 0.106 0.015 PEPp [x23]·[x2x]
Protein Leu α (s) 0.242 0.010 0.292 0.010 0.249 0.010 ACoA p /Pyrp [1 2 ] ·[x2x]
Protein Leu α (d1) 0.573 0.015 0.555 0.010 0.587 0.010 ACoA p /Pyrp [ 12 ] ·[x2x]
Protein Leu α (d2) 0.079 0.015 0.070 0.010 0.061 0.010 ACoA p /Pyrp [1 2 ] ·[x2x]
Protein Leu α (dd) 0.107 0.010 0.083 0.010 0.102 0.010 ACoA p /Pyrp [ 12 ] ·[x2x]
Protein Leu b (s) 0.785 0.007 0.794 0.007 0.761 0.007 ACoA p /Pyrp [x2] ·[x2x].[x2x]
Protein Leu b (d) 0.172 0.007 0.146 0.007 0.165 0.007 ACoA p /Pyrp [x 2 ] ·[x2x].[x2x]+[x2]·[x2x].[x2x]
Protein Leu b (t) 0.042 0.007 0.060 0.007 0.074 0.007 ACoA p /Pyrp [x 2 ] ·[x2x].[x2x]
Protein His β (s) 0.322 0.008 0.349 0.008 0.335 0.010 P5Pp [x234x]
Protein His β (d1) 0.035 0.008 0.039 0.015 0.031 0.010 P5Pp [x234x]
Protein His β (d2) 0.510 0.008 0.496 0.015 0.511 0.010 P5Pp [x234x]
Protein His β (dd) 0.133 0.008 0.116 0.008 0.124 0.010 P5Pp [x234x]
Protein His δ2 (s) 0.678 0.011 0.608 0.017 0.642 0.015 P5Pp [12xxx]
Protein His δ2 (d) 0.322 0.011 0.392 0.017 0.358 0.015 P5Pp [12xxx]
High PI Set 3 TP1 BC3-128 Set 3 TP1 Evans Set 3 TP1
  
152
 
 
Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Tyr δ1 (s) 0.224 0.007 0.304 0.007 0.237 0.007 PEP p /E4Pp [x2 3 ] ·[1xxx]
Protein Tyr δ2 (s) PEP p /E4Pp [x2x] ·[43xx]
Protein Tyr δ1 (d) 0.690 0.007 0.623 0.007 0.697 0.007 PEP p /E4Pp [x 23 ] ·[1xxx] + [x2 3 ] ·[1xxx]
Protein Tyr δ2 (d) PEP p /E4Pp [x 2 x] ·[43xx] + [x2x] ·[43xx]
Protein Tyr δ1 (t) 0.086 0.007 0.073 0.007 0.066 0.007 PEP p /E4Pp [x 23 ] ·[1xxx]
Protein Tyr δ2 (t) PEP p /E4Pp [x 2 x] ·[43xx]
Protein Tyr ε1 (s) 0.534 0.007 0.513 0.007 0.526 0.007 PEP p /E4Pp [xx3] ·[12xx]
Protein Tyr ε2 (s) E4Pp [x234]
Protein Tyr ε1 (d) 0.195 0.007 0.199 0.007 0.206 0.007 PEP p /E4Pp [xx 3 ] ·[12xx] + [xx3] ·[12xx]
Protein Tyr ε2 (d) E4Pp [x234] + [x234]
Protein Tyr ε1 (t) 0.271 0.007 0.287 0.007 0.268 0.007 PEP p /E4Pp [xx 3 ] ·[12xx]
Protein Tyr ε2 (t) E4Pp [x234]
Protein Arg β (s) 0.848 0.030 0.820 0.030 0.804 0.040 Glup [x234x]
Protein Arg β (d) 0.152 0.030 0.180 0.030 0.196 0.040 Glup [x234x] + [x234x]
Protein Arg β (t) 0.000 0.040 0.000 0.030 0.000 0.040 Glup [x234x]
Protein Arg δ (s) 0.696 0.010 0.670 0.010 0.641 0.010 Glup [xxx45]
Protein Arg δ (d) 0.304 0.010 0.330 0.010 0.359 0.010 Glup [xxx45]
Protein Glu β (s) 0.839 0.025 0.854 0.025 0.870 0.025 Glu [x234x]
Protein Glu β (d) 0.161 0.025 0.146 0.025 0.130 0.025 Glu [x234x] + [x234x]
Protein Glu β (t) 0.000 0.025 0.000 0.025 0.000 0.025 Glu [x234x]
Protein Pro γ (s) 0.669 0.013 0.641 0.013 0.620 0.013 Glup [xx345]
Protein Pro γ (d) 0.332 0.013 0.359 0.013 0.380 0.013 Glup [xx345] + [xx345]
Protein Pro γ (t) 0.000 0.013 0.000 0.013 0.000 0.013 Glup [xx345]
Protein Pro δ (s) 0.678 0.014 0.650 0.014 0.603 0.014 Glup [xxx45]
Protein Pro δ (d) 0.322 0.014 0.350 0.014 0.397 0.014 Glup [xxx45]
Protein Asp α (s) 0.531 0.010 0.499 0.010 0.458 0.011 OAA [123x]
Protein Asp α (d1) 0.133 0.010 0.126 0.010 0.222 0.011 OAA [123x]
Protein Asp α (d2) 0.198 0.010 0.219 0.010 0.137 0.011 OAA [123x]
Protein Asp α (dd) 0.138 0.010 0.157 0.010 0.184 0.011 OAA [123x]
Protein Asp β (s) 0.510 0.010 0.493 0.010 0.441 0.011 OAA [x234]
Protein Asp β (d1) 0.245 0.010 0.266 0.010 0.122 0.011 OAA [x234]
High PI Set 3 TP1 BC3-128 Set 3 TP1 Evans Set 3 TP1
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Asp β (d2) 0.110 0.010 0.107 0.010 0.277 0.011 OAA [x234]
Protein Asp β (dd) 0.136 0.010 0.134 0.010 0.160 0.011 OAA [x234]
Protein Ile α (s) 0.623 0.014 0.603 0.012 0.567 0.014 OAA p /Pyrp [1 2 xx] ·[x2x]
Protein Ile α (d1) 0.262 0.014 0.250 0.012 0.300 0.014 OAA p /Pyrp [ 12 xx] ·[x2x]
Protein Ile α (d2) 0.049 0.014 0.083 0.012 0.049 0.014 OAA p /Pyrp [1 2 xx] ·[x2x]
Protein Ile α (dd) 0.066 0.012 0.064 0.012 0.085 0.014 OAA p /Pyrp [ 12 xx] ·[x2x]
Protein Ile γ1(s) 0.667 0.017 0.677 0.022 0.695 0.022 Pyrp/OAA p [x2x]·[xx 3 4]
Protein Ile γ1(d) 0.333 0.017 0.323 0.022 0.305 0.022 Pyrp/OAA p [x2x]·[xx 3 4]  + [x2x]·[xx 34 ]
Protein Ile γ1(t) 0.000 0.017 0.000 0.022 0.000 0.022 Pyrp/OAA p [x2x]·[xx 34 ]
Protein Ile δ (s) 0.750 0.015 0.732 0.010 0.764 0.012 OAAp [xx34]
Protein Ile δ (d) 0.250 0.015 0.268 0.010 0.237 0.012 OAAp [xx34]
Protein Met γ (s) 0.750 0.020 0.759 0.030 OAAp [xx34]
Protein Met γ (d) 0.250 0.020 0.241 0.030 OAAp [xx34]
Protein Thr α (s) 0.467 0.010 0.454 0.010 0.393 0.015 OAAp [123x]
Protein Thr α (d1) 0.141 0.010 0.136 0.010 0.111 0.015 OAAp [123x]
Protein Thr α (d2) 0.180 0.010 0.202 0.010 0.199 0.015 OAAp [123x]
Protein Thr α (dd) 0.213 0.010 0.208 0.010 0.296 0.015 OAAp [123x]
Protein Thr γ2 (s) 0.721 0.003 0.732 0.003 0.719 0.004 OAAp [xx34]
Protein Thr γ2 (d) 0.279 0.003 0.268 0.003 0.281 0.004 OAAp [xx34]
Protein Lys γ (s) 0.635 0.017 0.643 0.017 0.638 0.017 OAA p /Pyrp [xx3 4 ] ·[xx3]
Protein Lys γ (d) 0.299 0.017 0.293 0.017 0.268 0.017 OAA p /Pyrp [xx 34 ] ·[xx3] + [xx3 4 ]·[xx 3 ]
Protein Lys γ (t) 0.066 0.017 0.064 0.017 0.094 0.017 OAA p /Pyrp [xx 34 ] ·[xx3]
Protein Lys β (s) 0.314 0.011 0.356 0.011 0.314 0.011 OAA p /Pyrp ½{[x2 3 4]  + [x23]·[xxx4] }
Protein Lys β (d) 0.616 0.011 0.567 0.011 0.616 0.011 OAA p /Pyrp ½{[x 23 4]  + [x2 34 ] +
OAA p /Pyrp  [x23]·[xxx4]  + [x23]·[xxx 4 ] }
Protein Lys β (t) 0.070 0.011 0.076 0.011 0.070 0.011 OAA p /Pyrp ½{[x 234 ]  + [x23]·[xxx 4 ] }
Protein Lys δ (s) 0.347 0.012 0.340 0.012 0.295 0.012 OAA p /Pyrp ½{[x2 3 4]  + [x23]·[xxx4] }
Protein Lys δ (d) 0.653 0.012 0.567 0.012 0.612 0.012 OAA p /Pyrp ½{[x 23 4]  + [x2 34 ]  +
 [x23]·[xxx4] + [x23]·[xxx 4 ] }
Protein Lys δ (t) 0.000 0.012 0.093 0.012 0.093 0.012 OAA p /Pyrp ½{[x 234 ]  + [x23]·[xxx 4 ] }
Protein Lys ε (s) 0.379 0.005 0.395 0.005 0.389 0.005 OAA p /Pyrp ½{[x23] + [x 2 3x] }
High PI Set 3 TP1 BC3-128 Set 3 TP1 Evans Set 3 TP1
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Lys ε (d) 0.622 0.005 0.605 0.005 0.611 0.005 OAA p /Pyrp ½{[x23] + [x 23 x] }
Protein HMF 1 (s) 0.176 0.030 0.202 0.030 0.166 0.030 G6Pc/F6Pc [12xxxx]
Protein HMF 1 (d) 0.824 0.030 0.798 0.030 0.834 0.030 G6Pc/F6Pc [12xxxx]
Protein LVA 3 (s) 0.240 0.007 0.213 0.007 0.178 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 3 (d1) 0.025 0.007 0.008 0.007 0.037 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 3 (d2) 0.024 0.007 0.003 0.007 0.000 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 3 (dd) 0.711 0.007 0.775 0.007 0.785 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 6 (s) 0.129 0.007 0.090 0.007 0.093 0.007 G6Pc/F6Pc [xxx456]
Protein LVA 6 (d1) 0.001 0.007 0.000 0.007 0.000 0.007 G6Pc/F6Pc [xxx456]
Protein LVA 6 (d2) 0.059 0.007 0.076 0.007 0.041 0.007 G6Pc/F6Pc [xxx456]
Protein LVA 6 (dd) 0.811 0.007 0.834 0.007 0.866 0.007 G6Pc/F6Pc [xxx456]
Starch HMF 1 (s) 0.386 0.020 0.399 0.020 0.409 0.027 G6Pp [12xxxx]
Starch HMF 1 (d) 0.614 0.020 0.601 0.020 0.591 0.027 G6Pp [12xxxx]
Starch LVA 3 (s) 0.390 0.008 0.483 0.007 0.399 0.007 G6Pp [x234xx]
Starch LVA 3 (d1) 0.190 0.008 0.217 0.007 0.220 0.007 G6Pp [x234xx]
Starch LVA 3 (d2) 0.032 0.008 0.043 0.007 0.053 0.007 G6Pp [x234xx]
Starch LVA 3 (dd) 0.388 0.008 0.257 0.007 0.327 0.007 G6Pp [x234xx]
Starch LVA 6 (s) 0.254 0.010 0.242 0.007 0.249 0.010 G6Pp [xxx456]
Starch LVA 6 (d1) 0.001 0.010 0.003 0.007 0.000 0.010 G6Pp [xxx456]
Starch LVA 6 (d2) 0.084 0.010 0.170 0.007 0.120 0.010 G6Pp [xxx456]
Starch LVA 6 (dd) 0.661 0.010 0.585 0.007 0.631 0.010 G6Pp [xxx456]
High PI Set 3 TP1 BC3-128 Set 3 TP1 Evans Set 3 TP1
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Table VII-3: Set 2 TP2: Relative multiplet intensities of amino acids from protein and glucosyl units from starch hydrolysates with their standard 
deviations (SDs) from 2-D [13C, 1H] HSQC spectrum. s indicates singlet, d1 and d2 indicate the first and second doublet and dd indicates the
double doublet. Bold faced carbon atom in Isotopomer indicates labeled carbon atom, normal font indicates unlabeled carbon atom and x indicates
unknown labeling state of the carbon atom. Subscripts p, c and m for precursor indicates the compartments plastid, cytosol and mitochondrion in which 
they are present. RI and SD represent relative intensities and standard deviations respectively.
Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Gly α (s) 0.575 0.005 0.561 0.005 0.539 0.005 T3P/GOx [12x]
Protein Gly α (d) 0.426 0.005 0.439 0.005 0.461 0.005 T3P/GOx [12x]
Protein Ser α (s) 0.379 0.008 0.351 0.008 0.318 0.008 Ser [123]
Protein Ser α (d1) 0.224 0.008 0.209 0.008 0.196 0.008 Ser [123]
Protein Ser α (d2) 0.126 0.008 0.138 0.008 0.168 0.008 Ser [123]
Protein Ser α (dd) 0.272 0.008 0.303 0.008 0.318 0.008 Ser [123]
Protein Ser β (s) 0.629 0.015 0.633 0.015 0.597 0.015 Ser [x23]
Protein Ser β (d) 0.372 0.015 0.367 0.015 0.403 0.015 Ser [x23]
Protein Ala α (s) 0.306 0.008 0.320 0.008 0.307 0.008 Pyr [123]
Protein Ala α (d1) 0.031 0.008 0.032 0.008 0.027 0.008 Pyr [123]
Protein Ala α (d2) 0.170 0.008 0.200 0.008 0.198 0.008 Pyr [123]
Protein Ala α (dd) 0.494 0.008 0.448 0.008 0.469 0.008 Pyr [123]
Protein Ala β (s) 0.366 0.005 0.328 0.005 0.349 0.003 Pyr [x23]
Protein Ala β (d) 0.634 0.005 0.672 0.005 0.651 0.003 Pyr [x23]
Protein Ile γ2 (s) 0.361 0.003 0.352 0.003 0.292 0.005 Pyrp [x23]
Protein Ile γ2 (d) 0.639 0.003 0.648 0.003 0.708 0.005 Pyrp [x23]
Protein Leu δ1 (s) Pyrp [x23]
Protein Leu δ1 (d) Pyrp [x23]
Protein Val α (s) 0.455 0.010 0.465 0.010 0.422 0.010 Pyrp [12x]·[x2x]
Protein Val α (d1) 0.431 0.010 0.427 0.010 0.485 0.010 Pyrp [12x]·[x2x]
Protein Val α (d2) 0.068 0.010 0.073 0.010 0.056 0.010 Pyrp [12x]·[x2x]
Protein Val α (dd) 0.047 0.010 0.035 0.010 0.036 0.010 Pyrp [12x]·[x2x]
Protein Val γ1 (s) 0.398 0.003 0.356 0.003 0.317 0.003 Pyrp [x23]
Protein Val γ1 (d) 0.602 0.003 0.644 0.003 0.683 0.003 Pyrp [x23]
Protein Val γ2 (s) 0.917 0.003 0.912 0.003 0.903 0.003 Pyrp [x2x]·[xx3]
Protein Val γ2 (d) 0.083 0.003 0.088 0.003 0.097 0.003 Pyrp [x2x]·[xx3]
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Leu δ2 (s) 0.914 0.003 0.914 0.003 0.909 0.003 Pyrp [x2x]·[xx3]
Protein Leu δ2 (d) 0.086 0.003 0.086 0.003 0.091 0.003 Pyrp [x2x]·[xx3]
Protein Phe α (s) 0.349 0.008 0.308 0.008 0.276 0.008 PEPp [123]
Protein Phe α (d1) 0.048 0.008 0.019 0.008 0.008 0.008 PEPp [123]
Protein Phe α (d2) 0.121 0.008 0.166 0.008 0.158 0.008 PEPp [123]
Protein Phe α (dd) 0.482 0.008 0.507 0.008 0.558 0.008 PEPp [123]
Protein Phe β (s) 0.309 0.011 0.281 0.011 0.271 0.011 PEPp [x23]·[x2x]
Protein Phe β (d1) 0.609 0.011 0.626 0.011 0.660 0.015 PEPp [x23]·[x2x]
Protein Phe β (d2) 0.005 0.011 0.018 0.011 0.003 0.015 PEPp [x23]·[x2x]
Protein Phe β (dd) 0.077 0.011 0.075 0.011 0.066 0.011 PEPp [x23]·[x2x]
Protein Tyr α (s) 0.308 0.008 0.294 0.008 0.278 0.008 PEPp [123]
Protein Tyr α (d1) 0.021 0.008 0.024 0.008 0.009 0.008 PEPp [123]
Protein Tyr α (d2) 0.154 0.008 0.203 0.008 0.189 0.008 PEPp [123]
Protein Tyr α (dd) 0.517 0.008 0.479 0.008 0.525 0.008 PEPp [123]
Protein Tyr β (s) 0.311 0.012 0.245 0.012 0.221 0.012 PEPp [x23]·[x2x]
Protein Tyr β (d) 0.591 0.012 0.613 0.012 0.644 0.012 PEPp [x23]·[x2x] + [x23]·[x2x]
Protein Tyr β (t) 0.098 0.012 0.142 0.012 0.136 0.012 PEPp [x23]·[x2x]
Protein Leu α (s) 0.352 0.010 0.343 0.010 0.293 0.012 ACoA p /Pyrp [1 2 ] ·[x2x]
Protein Leu α (d1) 0.561 0.010 0.554 0.010 0.535 0.012 ACoA p /Pyrp [ 12 ] ·[x2x]
Protein Leu α (d2) 0.029 0.010 0.044 0.010 0.076 0.012 ACoA p /Pyrp [1 2 ] ·[x2x]
Protein Leu α (dd) 0.058 0.010 0.058 0.010 0.096 0.012 ACoA p /Pyrp [ 12 ] ·[x2x]
Protein Leu b (s) 0.813 0.007 0.815 0.007 0.793 0.007 ACoA p /Pyrp [x2] ·[x2x].[x2x]
Protein Leu b (d) 0.153 0.007 0.150 0.007 0.168 0.007 ACoA p /Pyrp [x 2 ] ·[x2x].[x2x]+[x2]·[x2x].[x2x]
Protein Leu b (t) 0.034 0.007 0.035 0.007 0.039 0.007 ACoA p /Pyrp [x 2 ] ·[x2x].[x2x]
Protein His β (s) 0.354 0.010 0.391 0.080 0.364 0.008 P5Pp [x234x]
Protein His β (d1) 0.032 0.013 0.016 0.012 0.016 0.012 P5Pp [x234x]
Protein His β (d2) 0.439 0.013 0.525 0.012 0.521 0.012 P5Pp [x234x]
Protein His β (dd) 0.175 0.010 0.068 0.080 0.099 0.008 P5Pp [x234x]
Protein His δ2 (s) 0.700 0.025 0.595 0.015 0.702 0.015 P5Pp [12xxx]
Protein His δ2 (d) 0.300 0.025 0.405 0.015 0.298 0.015 P5Pp [12xxx]
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Tyr δ1 (s) 0.266 0.007 0.267 0.007 0.277 0.007 PEP p /E4Pp [x2 3 ] ·[1xxx]
Protein Tyr δ2 (s) PEP p /E4Pp [x2x] ·[43xx]
Protein Tyr δ1 (d) 0.658 0.007 0.670 0.007 0.667 0.007 PEP p /E4Pp [x 23 ] ·[1xxx] + [x2 3 ] ·[1xxx]
Protein Tyr δ2 (d) PEP p /E4Pp [x 2 x] ·[43xx] + [x2x] ·[43xx]
Protein Tyr δ1 (t) 0.076 0.007 0.062 0.007 0.057 0.007 PEP p /E4Pp [x 23 ] ·[1xxx]
Protein Tyr δ2 (t) PEP p /E4Pp [x 2 x] ·[43xx]
Protein Tyr ε1 (s) 0.584 0.007 0.579 0.007 0.550 0.007 PEP p /E4Pp [xx3] ·[12xx]
Protein Tyr ε2 (s) E4Pp [x234]
Protein Tyr ε1 (d) 0.170 0.007 0.189 0.007 0.198 0.007 PEP p /E4Pp [xx 3 ] ·[12xx] + [xx3] ·[12xx]
Protein Tyr ε2 (d) E4Pp [x234] + [x234]
Protein Tyr ε1 (t) 0.247 0.007 0.232 0.007 0.252 0.007 PEP p /E4Pp [xx 3 ] ·[12xx]
Protein Tyr ε2 (t) E4Pp [x234]
Protein Arg β (s) 0.827 0.048 0.832 0.040 Glup [x234x]
Protein Arg β (d) 0.173 0.048 0.168 0.040 Glup [x234x] + [x234x]
Protein Arg β (t) 0.000 0.048 0.000 0.040 Glup [x234x]
Protein Arg δ (s) 0.764 0.010 0.743 0.010 0.693 0.010 Glup [xxx45]
Protein Arg δ (d) 0.236 0.010 0.257 0.010 0.307 0.010 Glup [xxx45]
Protein Glu β (s) 0.777 0.025 0.873 0.025 0.837 0.025 Glu [x234x]
Protein Glu β (d) 0.140 0.025 0.113 0.025 0.148 0.025 Glu [x234x] + [x234x]
Protein Glu β (t) 0.083 0.025 0.014 0.025 0.016 0.025 Glu [x234x]
Protein Glu γ (s) 0.708 0.010 0.748 0.010 0.707 0.010 Glu [xx345]
Protein Glu γ (d1) 0.027 0.010 0.016 0.010 0.012 0.010 Glu [xx345]
Protein Glu γ (d2) 0.243 0.010 0.218 0.010 0.279 0.010 Glu [xx345]
Protein Glu γ (dd) 0.023 0.010 0.018 0.010 0.002 0.010 Glu [xx345]
Protein Pro γ (s) 0.725 0.018 0.696 0.018 0.679 0.018 Glup [xx345]
Protein Pro γ (d) 0.276 0.018 0.271 0.018 0.321 0.018 Glup [xx345] + [xx345]
Protein Pro γ (t) 0.000 0.018 0.033 0.018 0.000 0.018 Glup [xx345]
Protein Pro δ (s) 0.723 0.015 0.723 0.015 0.675 0.017 Glup [xxx45]
Protein Pro δ (d) 0.277 0.015 0.277 0.015 0.325 0.017 Glup [xxx45]
Protein Asp α (s) 0.641 0.006 0.514 0.006 0.504 0.010 OAA [123x]
Protein Asp α (d1) 0.122 0.006 0.108 0.006 0.109 0.010 OAA [123x]
High PI Set 2 TP2 BC3-128 Set 2 TP2 Evans Set 2 TP2
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Asp α (d2) 0.154 0.006 0.205 0.006 0.239 0.010 OAA [123x]
Protein Asp α (dd) 0.083 0.006 0.173 0.006 0.148 0.010 OAA [123x]
Protein Asp β (s) 0.626 0.006 0.551 0.006 0.503 0.010 OAA [x234]
Protein Asp β (d1) 0.185 0.006 0.287 0.006 0.219 0.010 OAA [x234]
Protein Asp β (d2) 0.097 0.006 0.066 0.006 0.108 0.010 OAA [x234]
Protein Asp β (dd) 0.091 0.006 0.096 0.006 0.171 0.010 OAA [x234]
Protein Ile α (s) 0.687 0.014 0.601 0.014 0.673 0.020 OAA p /Pyrp [1 2 xx] ·[x2x]
Protein Ile α (d1) 0.209 0.014 0.272 0.014 0.201 0.020 OAA p /Pyrp [ 12 xx] ·[x2x]
Protein Ile α (d2) 0.049 0.014 0.047 0.014 0.106 0.020 OAA p /Pyrp [1 2 xx] ·[x2x]
Protein Ile α (dd) 0.055 0.014 0.080 0.014 0.021 0.020 OAA p /Pyrp [ 12 xx] ·[x2x]
Protein Ile γ1(s) 0.722 0.020 0.739 0.030 0.707 0.030 Pyrp/OAA p [x2x]·[xx 3 4]
Protein Ile γ1(d) 0.278 0.020 0.261 0.030 0.293 0.030 Pyrp/OAA p [x2x]·[xx 3 4]  + [x2x]·[xx 34 ]
Protein Ile γ1(t) 0.000 0.020 0.000 0.030 0.000 0.030 Pyrp/OAA p [x2x]·[xx 34 ]
Protein Ile δ (s) 0.805 0.012 0.792 0.012 0.778 0.018 OAAp [xx34]
Protein Ile δ (d) 0.195 0.012 0.209 0.012 0.223 0.018 OAAp [xx34]
Protein Met γ (s) 0.785 0.012 OAAp [xx34]
Protein Met γ (d) 0.215 0.012 OAAp [xx34]
Protein Thr α (s) 0.593 0.010 0.535 0.010 0.464 0.006 OAAp [123x]
Protein Thr α (d1) 0.136 0.010 0.083 0.010 0.132 0.006 OAAp [123x]
Protein Thr α (d2) 0.124 0.010 0.232 0.010 0.224 0.006 OAAp [123x]
Protein Thr α (dd) 0.148 0.010 0.151 0.010 0.180 0.006 OAAp [123x]
Protein Thr γ2 (s) 0.771 0.003 0.773 0.003 0.744 0.003 OAAp [xx34]
Protein Thr γ2 (d) 0.229 0.003 0.227 0.003 0.257 0.003 OAAp [xx34]
Protein Lys γ (s) 0.726 0.017 0.714 0.017 0.697 0.017 OAA p /Pyrp [xx3 4 ] ·[xx3]
Protein Lys γ (d) 0.274 0.017 0.286 0.017 0.302 0.017 OAA p /Pyrp [xx 34 ] ·[xx3] + [xx3 4 ]·[xx 3 ]
Protein Lys γ (t) 0.000 0.017 0.000 0.017 0.001 0.017 OAA p /Pyrp [xx 34 ] ·[xx3]
Protein Lys β (s) 0.438 0.013 0.392 0.013 0.364 0.013 OAA p /Pyrp ½{[x2 3 4]  + [x23]·[xxx4] }
Protein Lys β (d) 0.543 0.013 0.525 0.013 0.561 0.013 OAA p /Pyrp ½{[x 23 4]  + [x2 34 ] +
OAA p /Pyrp  [x23]·[xxx4]  + [x23]·[xxx 4 ] }
Protein Lys β (t) 0.019 0.013 0.083 0.013 0.076 0.013 OAA p /Pyrp ½{[x 234 ]  + [x23]·[xxx 4 ] }
Protein Lys δ (s) 0.471 0.010 0.392 0.010 0.697 0.017 OAA p /Pyrp ½{[x2 3 4]  + [x23]·[xxx4] }
High PI Set 2 TP2 BC3-128 Set 2 TP2 Evans Set 2 TP2
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Hydroly- Cross peak
sate (multiplet) RI SD RI SD RI SD Precursor Isotopomer
Protein Lys δ (d) 0.530 0.010 0.521 0.010 0.302 0.017 OAA p /Pyrp ½{[x 23 4]  + [x2 34 ]  +
 [x23]·[xxx4] + [x23]·[xxx 4 ] }
Protein Lys δ (t) 0.000 0.010 0.087 0.010 0.001 0.017 OAA p /Pyrp ½{[x 234 ]  + [x23]·[xxx 4 ] }
Protein Lys ε (s) 0.494 0.005 0.427 0.005 0.341 0.011 OAA p /Pyrp ½{[x23] + [x 2 3x] }
Protein Lys ε (d) 0.506 0.005 0.573 0.005 0.557 0.011 OAA p /Pyrp ½{[x23] + [x 23 x] }
Protein HMF 1 (s) 0.439 0.015 0.155 0.015 0.203 0.020 G6Pc/F6Pc [12xxxx]
Protein HMF 1 (d) 0.561 0.015 0.846 0.015 0.797 0.020 G6Pc/F6Pc [12xxxx]
Protein LVA 3 (s) 0.279 0.008 0.173 0.008 0.218 0.008 G6Pc/F6Pc [x234xx]
Protein LVA 3 (d1) 0.062 0.008 0.004 0.008 0.002 0.008 G6Pc/F6Pc [x234xx]
Protein LVA 3 (d2) 0.065 0.008 0.012 0.008 0.013 0.008 G6Pc/F6Pc [x234xx]
Protein LVA 3 (dd) 0.594 0.008 0.811 0.008 0.767 0.008 G6Pc/F6Pc [x234xx]
Protein LVA 6 (s) 0.127 0.008 0.144 0.008 0.119 0.008 G6Pc/F6Pc [xxx456]
Protein LVA 6 (d1) 0.001 0.008 0.001 0.008 0.006 0.008 G6Pc/F6Pc [xxx456]
Protein LVA 6 (d2) 0.066 0.008 0.031 0.008 0.036 0.008 G6Pc/F6Pc [xxx456]
Protein LVA 6 (dd) 0.806 0.008 0.824 0.008 0.839 0.008 G6Pc/F6Pc [xxx456]
Starch HMF 1 (s) 0.420 0.015 0.409 0.020 G6Pp [12xxxx]
Starch HMF 1 (d) 0.580 0.015 0.591 0.020 G6Pp [12xxxx]
Starch LVA 3 (s) 0.601 0.008 0.583 0.008 0.497 0.008 G6Pp [x234xx]
Starch LVA 3 (d1) 0.141 0.008 0.127 0.008 0.211 0.008 G6Pp [x234xx]
Starch LVA 3 (d2) 0.069 0.008 0.027 0.008 0.088 0.008 G6Pp [x234xx]
Starch LVA 3 (dd) 0.189 0.008 0.263 0.008 0.204 0.008 G6Pp [x234xx]
Starch LVA 6 (s) 0.393 0.008 0.235 0.008 0.232 0.008 G6Pp [xxx456]
Starch LVA 6 (d1) 0.002 0.008 0.006 0.008 0.025 0.008 G6Pp [xxx456]
Starch LVA 6 (d2) 0.173 0.008 0.153 0.008 0.113 0.008 G6Pp [xxx456]
Starch LVA 6 (dd) 0.432 0.008 0.606 0.008 0.631 0.008 G6Pp [xxx456]
High PI Set 2 TP2 BC3-128 Set 2 TP2 Evans Set 2 TP2
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APPENDIX VIII-EXTERNAL FLUX DATA (GENOTYPE STUDY) 
 
 
Table VIII-1: Input data for external fluxes for Set 2 TP1 (standardized w.r.t. 20 times 
glycine production in µmol day-1 cotyledon-1) 
     
Flux High PI BC3-128 Evans  
A-CoA → lipid 1.22-1.32 1.65-1.85 1.26-1.36  
P5P → aa* 0.012-0.017 0.019-0.02 0.017-0.018  
E4P → aa 0.042-0.052 0.04-0.05 0.048-0.058  
3-PG → aa 0.09-0.1 0.085-0.1 0.09-0.101  
PEP → aa 0.09-0.1 0.084-0.093 0.1-0.11  
Pyr → aa 0.295-0.305 0.308-0.32 0.343-0.353  
A-CoA → aa 0.052-0.062 0.052-0.062 0.06-0.07  
OAA → aa 0.16-0.185 0.15-0.18 0.16-0.185  
Glu → aa 0.212-0.222 0.23-0.24 0.239-0.249  
G6P → starch 0.13-0.2 0.21-0.24 0.19-0.29  
Pyruvate efflux range 0-0.1 0-0.15 0-0.3  
Succinate efflux 
range 0-1.2 0-1.8 0-2.5  
P5P to Psac# 0.14-0.22 0.2-0.29 0.14-0.28  
G6P to Psac 0.32-0.42 0.44-0.57 0.34-0.45 
 
Sucrose uptake 1.65-2.05 3-3.4 3.8-4.6  
 
Glutamine uptake 0.6-0.8 0.95-1.1 1.3-1.7 
 
     
Glycine production φ 1.36 1.2 0.98  
         
* aa represents amino acids 
   
# Psac represents cell wall polysaccharides    
φ Units are µmol day-1 cotyledon-1    
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Table VIII-2: Input data for external fluxes for Set 3 TP1 (standardized w.r.t. 20 times 
glycine production in µmol day-1 cotyledon-1) 
     
Flux High PI BC3-128 Evans  
A-CoA → lipid 0.85-1.05 0.7-0.9 1.05-1.25  
P5P → aa* 0.014-0.017 0.0187-0.02 0.0165-0.018  
E4P → aa 0.04-0.05 0.038-0.048 0.042-0.052  
3-PG → aa 0.095-0.105 0.087-0.097 0.095-0.11  
PEP → aa 0.082-0.092 0.082-0.093 0.085-0.105  
Pyr → aa 0.3-0.315 0.308-0.32 0.29-0.305  
A-CoA → aa 0.053-0.063 0.052-0.062 0.05-0.062  
OAA → aa 0.16-0.18 0.15-0.17 0.18-0.22  
Glu → aa 0.221-0.231 0.23-0.242 0.208-0.22  
G6P → starch 0.175-0.19 0.23-0.25 0.13-0.15  
Pyruvate efflux range 0-0.06 0-0.08 0-0.05  
Succinate efflux 
range 0-1.5 0-1.0 0-1.2  
P5P to Psac# 0.2-0.27 0.24-0.32 0.188-0.28  
G6P to Psac 0.36-0.5 0.43-0.59 0.405-0.53  
Sucrose uptake 2-2.5 3.25-3.95 1.75-2.1  
Glutamine uptake 0.63-0.83 0.96-1.16 0.5-0.9  
     
Glycine production φ 1.34 1.03 1.49  
         
* aa represents amino acids 
   
# Psac represents cell wall polysaccharides    
φ Units are µmol day-1 cotyledon-1    
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Table VII-3: Input data for external fluxes for Set 2 TP2 (standardized w.r.t. 20 times 
glycine production in µmol day-1 cotyledon-1) 
     
Flux High PI BC3-128 Evans  
A-CoA → lipid 1.4-1.6 0.9-1.1 1.3-1.45  
P5P → aa* 0.015-0.022 0.015-0.019 0.015-0.02  
E4P → aa 0.035-0.05 0.04-0.05 0.04-0.07  
3-PG → aa 0.08-0.13 0.08-0.14 0.08-0.13  
PEP → aa 0.08-0.12 0.08-0.11 0.08-0.13  
Pyr → aa 0.27-0.31 0.21-0.33 0.32-0.37  
A-CoA → aa 0.04-0.07 0.05-0.075 0.04-0.09  
OAA → aa 0.16-0.2 0.19-0.26 0.16-0.24  
Glu → aa 0.22-0.28 0.19-0.23 0.15-0.21  
G6P → starch 0.02-0.08 0.13-0.15 0.2-0.26  
Pyruvate efflux range 0-0.15 0-0.15 0-0.15  
Succinate efflux 
range 0-1.3 0-1.3 0-1.2  
P5P to Psac# 0.24-0.32 0.15-0.2 0.14-0.18  
G6P to Psac 0.38-0.54 0.39-0.44 0.29-0.39  
Sucrose uptake 1.45-1.8 1.95-2.45 1.2-2.1  
Glutamine uptake 0.7-0.9 0.6-0.8 0.88-1.08  
     
Glycine production φ 1.43 2.07 1.85  
         
* aa represents amino acids 
   
# Psac represents cell wall polysaccharides    
φ Units are µmol day-1 cotyledon-1    
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APPENDIX IX- COMPARISON OF SIMULATED AND 
EXPERIMENTAL NMR INTENSITIES 
 
Figure IX-1: Comparison of simulated and experimental intensities for High PI (Set 2 TP1). 
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Figure IX-2: Comparison of simulated and experimental intensities for Evans (Set 2 TP1). 
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Figure IX-3: Comparison of simulated and experimental intensities for BC3-128 (Set 3 TP1). 
 
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
0 0.2 0.4 0.6 0.8 1
Ix (experimental intensity)
I
 (
s
im
u
la
te
d
 i
n
te
n
s
it
y
)
"90%" lines correspond to σ  = ± 0.0434
  
166 
 
 
 
Figure IX-4: Comparison of simulated and experimental intensities for BC3-128 (Set 2 TP2) 
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Figure IX-5: Comparison of simulated and experimental intensities for Evans (Set 2 TP2) 
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Figure IX-6: Comparison of simulated and experimental intensities for High PI (Set 2 TP2) 
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Figure IX-7: LVA 5 peak from the starch hydrolysate for High PI (Set 2 TP2). The wide 
central peak is a combination of singlet and double doublet 
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APPENDIX X- RELATIVE FLUXES (WITH AND WITHOUT Leu δ1 
PEAK ) 
 
 
Table X-1: BC3-128 (Set 2 TP1) with and without Leucine δ1- Relative fluxes are expressed in terms of 
100 mol of sucrose intake. Each flux is represented usually by the name of the gene encoding the enzyme
catalyzing the metabolic reaction. Subscripts f indicates forward reaction and superscripts c, p and m
indicate cytosol, plastid and mitochondrion. For reversible reactions, the net flux and reversibility is given.
Net fluxes are in the direction of the reaction with the subscript f. Negative flux indicates that the direction
of net flux is exactly reverse of that assumed. Reversibilities are reported in percentages; 0 and 0.99
reversibility represent irreversible reaction and reaction at equilibrium.
Reaction
Name
Net Flux S.D. Net Flux S.D.
G6Pc ↔ F6Pc hxi f c -94.98 10.70 -97.80 10.46
0.69 0.27 0.65 0.29
G6Pp ↔ F6Pp hxi f
p
-93.67 37.26 -95.39 35.98
0.64 0.23 0.62 0.24
G6Pc → P5Pc + CO2 pgl c 143.05 21.96 144.56 20.84
G6Pp → P5Pp + CO2 pgl p 123.93 36.89 126.53 37.39
P5Pc + P5Pc ↔ S7Pc + T3Pc tktA f c 2.25 2.25 3.14 2.99
0.79 0.28 0.75 0.32
S7Pc + T3Pc ↔ F6Pc + E4Pc tal f
c
2.25 2.25 3.14 2.99
0.35 0.24 0.33 0.25
P5Pc + E4Pc ↔ F6Pc + T3Pc tktB f
c
2.25 2.25 3.14 2.99
0.12 0.22 0.11 0.22
P5Pp + P5Pp ↔ S7Pp + T3Pp tktA f
p
84.59 13.00 85.05 12.52
0.93 0.06 0.91 0.10
S7Pp + T3Pp ↔ F6Pp + E4Pp tal f p 84.59 13.00 85.05 12.52
0.79 0.07 0.78 0.09
P5Pp + E4Pp ↔ F6Pp + T3Pp tktB f p 83.21 13.00 83.70 12.50
0.46 0.25 0.57 0.23
F6Pc → T3Pc + T3Pc pfk c 9.41 9.28 8.37 8.61
F6Pp → T3Pp + T3Pp pfk p 74.13 13.51 73.36 13.12
T3Pc + T3Pc → F6Pc pfp c 5.14 6.80 3.72 5.73
T3Pp + T3Pp → F6Pp f16bp p 16.58 2.50 16.24 2.50
T3P → 3PG gap 249.84 14.42 247.65 13.50
3PG → PEP eno 247.14 14.28 244.97 13.37
PEP → Pyr pyk 218.26 12.85 217.17 12.31
Pyrp → ACAp + CO2 pdh
p
54.80 2.93 54.59 2.78
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Reaction Relative fluxes 
with leud1 without leud1
  
171 
 
Reaction
Name
Net Flux S.D. Net Flux S.D.
Pyrm → ACAm + CO2 pdh
m
178.07 14.57 175.99 13.60
Pyrc → Pyrm pyrT 178.07 14.57 175.99 13.60
G6Pc ↔ G6Pp g6pT f 37.16 20.53 38.07 20.74
0.52 0.19 0.51 0.23
P5Pc ↔ P5Pp p5pT f 129.04 21.79 127.85 21.43
0.67 0.28 0.72 0.28
T3Pc ↔ T3Pp t3pT f 175.34 19.51 172.56 19.14
0.69 0.30 0.81 0.25
ACAm + OAAm → ICitm csaco m 174.56 14.52 172.56 13.61
ICitm → aKGm + CO2 icdh
m
171.13 14.23 169.19 13.20
aKGm → Scnm + CO2 akgdh
m
5.80 16.31 18.48 35.81
Scnm → Malm sdh f1 m 28.64 2.79 28.83 2.62
Scnm ↔ Malm sdh f2 m 179.80 20.21 177.88 19.34
0.72 0.03 0.72 0.03
Malm ↔ OAAm mdh f m 180.50 14.55 178.42 13.58
0.56 0.32 0.49 0.33
ICitm → Goxm + Scnm icl m 3.43 0.29 3.37 0.41
ACAm + Goxm → Malm ms m 0.08 0.18 0.05 0.17
PEPc + CO2 → OAA
c ppc c 28.90 2.22 27.79 2.03
Malm → Pyrm + CO2 me
m
14.92 10.62 15.82 10.45
Malp → Pyrp + CO2 me
p
10.91 1.67 8.99 1.87
Gluc → GABAc + CO2 gad
c
192.70 22.90 178.46 37.29
GABAc → GABAm gabaT 192.70 22.90 178.46 37.29
GABAm ↔ SSAm gat f
m
192.70 22.90 178.46 37.29
0.49 0.32 0.57 0.31
SSAm → Scnm ssadh m 192.70 22.90 178.46 37.29
Sucext → G6Pc + F6Pc subs1 100.00 0.00 100.00 0.00
Glnext ↔ Glnc subs2 f 31.19 1.66 31.64 1.79
0.99 0.00 0.99 0.00
Glnc → Glnp glnT 31.19 1.66 31.64 1.79
aKGm → aKGc aKGT1 31.19 1.66 31.64 1.79
reversibility %
Glutamate assimilation
Anaplerotic reactions
GABA shunt
reversibility %
Substrate entry
TCA cycle
reversibility %
reversibility %
Glyoxylate shunt
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Reaction Relative fluxes 
High PI Set 2 TP1 BC3-128 Set 2 TP1
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Reaction
Name
Net Flux S.D. Net Flux S.D.
aKGm → aKGc aKGT1 31.19 1.66 31.64 1.79
aKGc → aKGp aKGT2 31.19 1.66 31.64 1.79
aKGp + Glnp → Glup + Glup gogat p 1114.77 251.62 1102.97 293.41
Glup ↔ aKGp gdh f p 1083.58 249.96 1071.33 291.62
0.89 0.20 0.90 0.21
Glup ↔ Glnp as f 1221.15 249.19 1193.77 288.92
0.85 0.10 0.85 0.10
Malm ↔ Malc malT1 f -15.54 2.89 -16.30 2.99
0.99 0.00 0.99 0.00
Malc → Malp malT2 15.87 2.07 13.97 2.29
Malc → OAAc mdh c 28.90 2.22 27.79 2.03
Malp → OAAP mdh p 4.96 0.40 4.98 0.43
3PG → Ser bios1 2.70 0.14 2.67 0.13
Ser ↔ Gly + C1 bios2 f 2.70 0.14 2.67 0.13
0.55 0.01 0.55 0.01
GOx → Gly bios3 3.35 0.30 3.32 0.39
CO2 → resp 869.83 36.70 868.19 39.07
G6Pc → biomass bios4 14.77 1.24 15.17 1.32
G6Pp → biomass bios5 6.90 0.40 6.92 0.46
F6Pc → biomass bios6 0.11 0.12 0.11 0.13
P5Pc → biomass bios7 7.27 0.99 7.28 0.83
P5Pp → biomass bios8 0.58 0.03 0.58 0.03
E4Pp → biomass bios9 1.38 0.14 1.35 0.15
PEPp → biomass bios10 2.70 0.14 2.68 0.14
ACAp → biomass bios11 1.70 0.14 1.70 0.14
ACAp → biomass bios12 53.09 2.86 52.89 2.71
Pyr → biomass bios13 9.55 0.38 9.59 0.36
OAA → biomass bios14 4.96 0.40 4.98 0.43
Glu → biomass bios15 7.25 0.32 7.26 0.34
Pyr → pyrx 1.67 1.37 1.82 1.37
Mal → malx 0.00 0.00 0.00 0.00
Scn → scnx 22.13 11.77 22.44 11.79
Biosynthesis of Ser and Gly
reversibility %
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
reversibility %
reversibility %
Malate shuttle
reversibility %
High PI Set 2 TP1 BC3-128 Set 2 TP1
Glutamate assimilation
Reaction Relative fluxes 
  
173 
APPENDIX XI- ABSOLUTE FLUXES (GENOTYPE STUDY) 
Table XI-1: Set 2 TP1- Absolute fluxes are expressed in terms of µmoles d-1 cotyledon-1. Each flux is 
represented usually by the name of the gene encoding the enzyme catalyzing the metabolic reaction
Subscripts f indicates forward reaction and superscripts c, p and m indicate cytosol, plastid and mitochondrion.
For reversible reactions, the net flux and reversibility is given. Net fluxes are in the direction of the reaction
with the subscript f. Negative flux indicates that the direction of net flux is exactly reverse of that assumed.
assumed. Reversibilities are reported in percentages; 0 and 0.99 reversibility represent irreversible reaction 
and reaction at equilibrium.
Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ F6Pc hxi f c -53.78 7.53 -76.47 8.08 -84.30 20.67
0.62 0.26 0.65 0.29 0.29 0.26
G6Pp ↔ F6Pp hxi f p -47.97 24.29 -74.42 27.84 -30.23 28.13
0.74 0.21 0.62 0.24 0.89 0.10
G6Pc → P5Pc + CO2 pgl c 57.26 20.57 113.05 16.45 95.17 15.21
G6Pp → P5Pp + CO2 pgl p 85.44 25.77 98.82 28.96 89.74 19.90
P5Pc + P5Pc ↔ S7Pc + T3Pc tktA f c 3.61 2.21 2.45 2.32 16.24 5.46
0.78 0.29 0.75 0.32 0.98 0.01
S7Pc + T3Pc ↔ F6Pc + E4Pc tal f c 3.61 2.21 2.45 2.32 16.24 5.46
0.34 0.22 0.33 0.25 0.37 0.24
P5Pc + E4Pc ↔ F6Pc + T3Pc tktB f c 3.61 2.21 2.45 2.32 16.24 5.46
0.28 0.20 0.11 0.22 0.06 0.09
P5Pp + P5Pp ↔ S7Pp + T3Pp tktA f p 42.78 8.28 66.48 9.60 44.37 9.03
0.95 0.09 0.91 0.10 0.94 0.05
S7Pp + T3Pp ↔ F6Pp + E4Pp tal f p 42.78 8.28 66.48 9.60 44.37 9.03
0.75 0.11 0.78 0.09 0.82 0.07
P5Pp + E4Pp ↔ F6Pp + T3Pp tktB f p 41.51 8.29 65.42 9.60 43.38 9.04
0.51 0.22 0.57 0.23 0.40 0.21
F6Pc → T3Pc + T3Pc pfk c 7.86 6.76 6.59 6.82 30.45 16.20
F6Pp → T3Pp + T3Pp pfk p 36.32 9.99 57.48 10.94 57.53 16.54
T3Pc + T3Pc → F6Pc pfp c 3.80 4.56 2.92 4.49 3.65 2.79
T3Pp + T3Pp → F6Pp f16bp p 17.33 2.52 12.68 1.85 15.72 1.04
T3P → 3PG gap 130.99 13.01 193.93 14.71 233.71 18.49
3PG → PEP eno 128.50 12.94 191.84 14.64 231.84 18.43
PEP → Pyr pyk 115.39 11.37 170.07 13.25 207.55 16.63
Pyrp → ACAp + CO2 pdh
p
35.39 0.82 42.66 1.41 26.77 0.62
Pyrm → ACAm + CO2 pdh
m
92.69 14.21 137.83 13.01 183.26 18.73
Pyrc → Pyrm pyrT 92.69 14.21 137.83 13.01 183.26 18.73
Reaction
reversibility %
reversibility %
Absolute fluxes ( µmoles day-1 cotyledon-1)
High PI Set 2 TP1 BC3-128 Set 2 TP1 Evans Set 2 TP1
reversibility %
reversibility %
reversibility %
reversibility %
Glycolysis and oxPPP
reversibility %
reversibility %
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ G6Pp g6pT f 41.55 20.17 29.81 16.42 63.86 23.12
0.55 0.22 0.51 0.23 0.20 0.22
P5Pc ↔ P5Pp p5pT f 42.00 21.65 100.01 17.01 42.72 21.31
0.74 0.27 0.72 0.28 0.00 0.03
T3Pc ↔ T3Pp t3pT f 75.61 15.97 135.15 16.85 129.06 31.36
0.94 0.14 0.81 0.25 0.97 0.02
ACAm + OAAm → ICitm csaco m 90.24 14.13 135.15 12.98 181.35 18.71
ICitm → aKGm + CO2 icdh
m
87.80 13.89 132.52 12.68 179.47 18.50
aKGm → Scnm + CO2 akgdh
m
106.05 15.24 139.21 16.03 175.54 21.50
Scnm → Malm sdh f1 m 17.96 0.84 17.26 0.77 14.08 0.56
Scnm ↔ Malm sdh f2 m 25.11 2.47 22.54 1.92 18.54 1.50
0.66 0.03 0.72 0.03 0.72 0.03
Malm ↔ OAAm mdh f
m
15.00 9.70 11.67 7.84 11.93 6.33
0.55 0.36 0.49 0.33 0.61 0.32
ICitm → Goxm + Scnm icl m 2.43 0.24 2.64 0.30 1.89 0.21
ACAm + Goxm → Malm ms m 0.02 0.06 0.04 0.13 0.02 0.06
PEPc + CO2 → OAA
c ppc c 13.04 1.80 21.76 1.94 24.16 2.35
Malm → Pyrm + CO2 me
m
13.36 4.60 12.31 8.15 6.15 8.43
Malp → Pyrp + CO2 me
p
7.50 0.99 7.02 1.39 6.18 0.71
Gluc → GABAc + CO2 gad
c
92.80 22.42 139.75 30.19 187.34 38.99
GABAc → GABAm gabaT 92.80 22.42 139.75 30.19 187.34 38.99
GABAm ↔ SSAm gat f
m
92.80 22.42 139.75 30.19 187.34 38.99
0.56 0.30 0.57 0.31 0.55 0.31
SSAm → Scnm ssadh m 92.80 22.42 139.75 30.19 187.34 38.99
Sucext → G6Pc + F6Pc subs1 54.48 2.15 78.25 2.69 82.32 4.21
Glnext ↔ Glnc subs2 f 21.09 0.86 24.74 1.36 30.81 1.95
0.99 0.00 0.99 0.00 0.99 0.00
Glnc → Glnp glnT 21.09 0.86 24.74 1.36 30.81 1.95
aKGm → aKGc aKGT1 21.09 0.86 24.74 1.36 30.81 1.95
reversibility %
reversibility %
Substrate entry
Glutamate assimilation
Anaplerotic reactions
Glyoxylate shunt
GABA shunt
reversibility %
TCA cycle
reversibility %
reversibility %
reversibility %
reversibility %
Reaction
Glycolysis and oxPPP
Absolute fluxes ( µmoles/day/cotyledon)
High PI Set 2 TP1 BC3-128 Set 2 TP1 Evans Set 2 TP1
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
aKGc → aKGp aKGT2 21.09 0.86 24.74 1.36 30.81 1.95
aKGp + Glnp → Glup + Glup gogat p 942.16 229.48 861.98 226.61 881.56 236.64
Glup ↔ aKGp gdh f p 921.07 228.63 837.24 225.25 850.75 234.69
0.91 0.14 0.90 0.21 0.91 0.20
Glup ↔ Glnp as f 977.49 227.53 933.18 223.55 981.32 234.67
0.82 0.13 0.85 0.10 0.95 0.04
Malm ↔ Malc malT1 f -3.23 2.45 -12.79 2.59 -16.26 2.43
0.99 0.00 0.99 0.00 0.99 0.00
Malc → Malp malT2 12.18 1.21 10.90 1.68 9.65 0.87
Malc → OAAc mdh c 13.04 1.80 21.76 1.94 24.16 2.35
Malp → OAAP mdh p 4.68 0.22 3.89 0.29 3.47 0.16
3PG → Ser bios1 2.49 0.06 2.09 0.08 1.86 0.06
Ser ↔ Gly + C1 bios2 f 2.41 0.23 2.59 0.29 1.87 0.20
0.56 0.01 0.55 0.01 0.40 0.01
GOx → Gly bios3 2.41 0.23 2.59 0.29 1.87 0.20
CO2 → resp 474.37 33.84 679.31 38.05 771.77 55.77
G6Pc → biomass bios4 9.44 0.71 11.85 0.88 7.58 0.65
G6Pp → biomass bios5 4.09 0.51 5.41 0.30 4.35 0.57
F6Pc → biomass bios6 0.07 0.10 0.09 0.10 0.05 0.08
P5Pc → biomass bios7 4.42 0.59 5.69 0.61 3.73 0.83
P5Pp → biomass bios8 0.38 0.06 0.46 0.01 0.34 0.01
E4Pp → biomass bios9 1.26 0.12 1.06 0.11 0.99 0.08
PEPp → biomass bios10 2.57 0.11 2.10 0.08 2.00 0.07
ACAp → biomass bios11 1.46 0.09 1.33 0.10 1.22 0.07
ACAp → biomass bios12 33.93 0.76 41.33 1.38 25.55 0.60
Pyr → biomass bios13 8.09 0.09 7.49 0.11 6.78 0.07
OAA → biomass bios14 4.68 0.22 3.89 0.29 3.47 0.16
Glu → biomass bios15 5.81 0.07 5.67 0.14 4.86 0.07
Pyr → pyrx 0.08 0.27 1.42 1.07 3.07 1.91
Mal → malx 0.90 1.00 0.00 0.00 0.68 0.35
Scn → scnx 1.91 2.69 17.65 9.53 33.65 7.70
reversibility %
reversibility %
reversibility %
Reaction Absolute fluxes ( µmoles/day/cotyledon)
High PI Set 2 TP1 BC3-128 Set 2 TP1
Malate shuttle
reversibility %
Glutamate assimilation
Evans Set 2 TP1
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
Biosynthesis of Ser and Gly
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
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Table XI-2: Set 3 TP1- Absolute fluxes are expressed in terms of µmoles d-1 cotyledon-1. Each flux is 
represented usually by the name of the gene encoding the enzyme catalyzing the metabolic reaction
Subscripts f indicates forward reaction and superscripts c, p and m indicate cytosol, plastid and mitochondrion.
For reversible reactions, the net flux and reversibility is given. Net fluxes are in the direction of the reaction
with the subscript f. Negative flux indicates that the direction of net flux is exactly reverse of that assumed.
assumed. Reversibilities are reported in percentages; 0 and 0.99 reversibility represent irreversible reaction 
and reaction at equilibrium.
Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6P
c
↔ F6P
c
hxi f
c
-62.23 10.67 -75.63 11.27 -54.97 8.93
0.18 0.21 0.10 0.19 0.26 0.24
G6P
p
↔ F6P
p
hxi f
p
-28.866 22.301 -65.08 25.40 -30.66 26.78
0.826 0.119 0.87 0.09 0.90 0.06
G6P
c
→ P5P
c
+ CO2 pgl
c
46.58 24.57 86.40 23.91 29.97 22.26
G6P
p
→ P5P
p
+ CO2 pgl
p
93.647 29.497 111.22 20.60 97.22 32.63
P5P
c
+ P5P
c
↔ S7P
c
+ T3P
c
tktA f
c
6.99 2.38 5.63 1.85 2.43 1.27
0.97 0.03 0.94 0.13 0.83 0.25
S7P
c
+ T3P
c
↔ F6P
c
+ E4P
c
tal f
c
6.99 2.38 5.63 1.85 2.43 1.27
0.42 0.21 0.35 0.22 0.35 0.23
P5P
c
+ E4P
c
↔ F6P
c
+ T3P
c
tktB f
c
6.99 2.38 5.63 1.85 2.43 1.27
0.09 0.10 0.05 0.10 0.09 0.15
P5P
p
+ P5P
p
↔ S7P
p
+ T3P
p
tktA f
p
38.01 8.05 58.52 9.31 38.03 8.91
0.96 0.01 0.95 0.03 0.97 0.01
S7P
p
+ T3P
p
↔ F6P
p
+ E4P
p
tal f
p
38.01 8.05 58.52 9.31 38.03 8.91
0.82 0.04 0.77 0.05 0.79 0.06
P5P
p
+ E4P
p
↔ F6P
p
+ T3P
p
tktB f
p
36.80 8.03 57.62 9.32 36.58 8.90
0.03 0.10 0.16 0.18 0.08 0.15
F6P
c
→ T3P
c
+ T3P
c
pfk
c
16.25 10.17 7.51 9.38 8.70 9.01
F6P
p
→ T3P
p
+ T3P
p
pfk
p
45.94 10.79 51.06 11.68 43.94 12.03
T3P
c
+ T3P
c
→ F6P
c
pfp
c
1.06 1.72 1.19 2.36 4.00 4.54
T3P
p
+ T3P
p
→ F6P
p
f16bp
p
20.36 1.37 17.10 0.80 24.60 1.49
T3P → 3PG gap 165.60 12.48 178.50 14.37 141.18 13.77
3PG → PEP eno 163.02 12.42 176.62 14.29 138.09 13.62
PEP → Pyr pyk 144.65 11.17 150.87 12.18 121.39 11.80
Pyr
p
→ ACA
p
+ CO2 pdh
p
26.03 1.48 18.55 1.22 36.22 1.84
Pyr
m
→ ACA
m
+ CO2 pdh
m
132.04 12.73 152.33 15.23 86.52 12.70
Pyr
c
→ Pyr
m
pyrT 132.04 12.73 152.33 15.23 86.52 12.70
Reaction Absolute fluxes ( µmoles day-1 cotyledon-1)
High PI Set 3 TP1 BC3-128 Set 3 TP1 Evans Set 3 TP1
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ G6Pp g6pT f 41.55 20.17 29.81 16.42 63.86 23.12
0.55 0.22 0.51 0.23 0.20 0.22
P5Pc ↔ P5Pp p5pT f 42.00 21.65 100.01 17.01 42.72 21.31
0.74 0.27 0.72 0.28 0.00 0.03
T3Pc ↔ T3Pp t3pT f 75.61 15.97 135.15 16.85 129.06 31.36
0.94 0.14 0.81 0.25 0.97 0.02
ACAm + OAAm → ICitm csaco m 90.24 14.13 135.15 12.98 181.35 18.71
ICitm → aKGm + CO2 icdh
m
87.80 13.89 132.52 12.68 179.47 18.50
aKGm → Scnm + CO2 akgdh
m
106.05 15.24 139.21 16.03 175.54 21.50
Scnm → Malm sdh f1 m 17.96 0.84 17.26 0.77 14.08 0.56
Scnm ↔ Malm sdh f2 m 25.11 2.47 22.54 1.92 18.54 1.50
0.66 0.03 0.72 0.03 0.72 0.03
Malm ↔ OAAm mdh f m 15.00 9.70 11.67 7.84 11.93 6.33
0.55 0.36 0.49 0.33 0.61 0.32
ICitm → Goxm + Scnm icl m 2.43 0.24 2.64 0.30 1.89 0.21
ACAm + Goxm → Malm ms m 0.02 0.06 0.04 0.13 0.02 0.06
PEPc + CO2 → OAA
c ppc c 13.04 1.80 21.76 1.94 24.16 2.35
Malm → Pyrm + CO2 me
m
13.36 4.60 12.31 8.15 6.15 8.43
Malp → Pyrp + CO2 me
p
7.50 0.99 7.02 1.39 6.18 0.71
Gluc → GABAc + CO2 gad
c
92.80 22.42 139.75 30.19 187.34 38.99
GABAc → GABAm gabaT 92.80 22.42 139.75 30.19 187.34 38.99
GABAm ↔ SSAm gat f
m
92.80 22.42 139.75 30.19 187.34 38.99
0.56 0.30 0.57 0.31 0.55 0.31
SSAm → Scnm ssadh m 92.80 22.42 139.75 30.19 187.34 38.99
Sucext → G6Pc + F6Pc subs1 54.48 2.15 78.25 2.69 82.32 4.21
Glnext ↔ Glnc subs2 f 21.09 0.86 24.74 1.36 30.81 1.95
0.99 0.00 0.99 0.00 0.99 0.00
Glnc → Glnp glnT 21.09 0.86 24.74 1.36 30.81 1.95
aKGm → aKGc aKGT1 21.09 0.86 24.74 1.36 30.81 1.95
reversibility %
reversibility %
Substrate entry
Glutamate assimilation
Anaplerotic reactions
Glyoxylate shunt
GABA shunt
reversibility %
TCA cycle
reversibility %
reversibility %
reversibility %
reversibility %
Reaction
Glycolysis and oxPPP
Absolute fluxes ( µmoles day-1 cotyledon-1)
High PI Set 2 TP1 BC3-128 Set 2 TP1 Evans Set 2 TP1
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
aKGc → aKGp aKGT2 21.09 0.86 24.74 1.36 30.81 1.95
aKGp + Glnp → Glup + Glup gogat p 942.16 229.48 861.98 226.61 881.56 236.64
Glup ↔ aKGp gdh f
p
921.07 228.63 837.24 225.25 850.75 234.69
0.91 0.14 0.90 0.21 0.91 0.20
Glup ↔ Glnp as f 977.49 227.53 933.18 223.55 981.32 234.67
0.82 0.13 0.85 0.10 0.95 0.04
Malm ↔ Malc malT1 f -3.23 2.45 -12.79 2.59 -16.26 2.43
0.99 0.00 0.99 0.00 0.99 0.00
Malc → Malp malT2 12.18 1.21 10.90 1.68 9.65 0.87
Malc → OAAc mdh c 13.04 1.80 21.76 1.94 24.16 2.35
Malp → OAAP mdh p 4.68 0.22 3.89 0.29 3.47 0.16
3PG → Ser bios1 2.49 0.06 2.09 0.08 1.86 0.06
Ser ↔ Gly + C1 bios2 f 2.41 0.23 2.59 0.29 1.87 0.20
0.56 0.01 0.55 0.01 0.40 0.01
GOx → Gly bios3 2.41 0.23 2.59 0.29 1.87 0.20
CO2 → resp 474.37 33.84 679.31 38.05 771.77 55.77
G6Pc → biomass bios4 9.44 0.71 11.85 0.88 7.58 0.65
G6Pp → biomass bios5 4.09 0.51 5.41 0.30 4.35 0.57
F6Pc → biomass bios6 0.07 0.10 0.09 0.10 0.05 0.08
P5Pc → biomass bios7 4.42 0.59 5.69 0.61 3.73 0.83
P5Pp → biomass bios8 0.38 0.06 0.46 0.01 0.34 0.01
E4Pp → biomass bios9 1.26 0.12 1.06 0.11 0.99 0.08
PEPp → biomass bios10 2.57 0.11 2.10 0.08 2.00 0.07
ACAp → biomass bios11 1.46 0.09 1.33 0.10 1.22 0.07
ACAp → biomass bios12 33.93 0.76 41.33 1.38 25.55 0.60
Pyr → biomass bios13 8.09 0.09 7.49 0.11 6.78 0.07
OAA → biomass bios14 4.68 0.22 3.89 0.29 3.47 0.16
Glu → biomass bios15 5.81 0.07 5.67 0.14 4.86 0.07
Pyr → pyrx 0.08 0.27 1.42 1.07 3.07 1.91
Mal → malx 0.90 1.00 0.00 0.00 0.68 0.35
Scn → scnx 1.91 2.69 17.65 9.53 33.65 7.70
reversibility %
reversibility %
reversibility %
Reaction Absolute fluxes ( µmoles day-1 cotyledon-1)
High PI Set 2 TP1 BC3-128 Set 2 TP1
Malate shuttle
reversibility %
Glutamate assimilation
Evans Set 2 TP1
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
Biosynthesis of Ser and Gly
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
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Table XI-3: Set 2 TP2- Absolute fluxes are expressed in terms of µmoles d-1 cotyledon-1. Each flux is 
represented usually by the name of the gene encoding the enzyme catalyzing the metabolic reaction
Subscripts f indicates forward reaction and superscripts c, p and m indicate cytosol, plastid and mitochondrion.
For reversible reactions, the net flux and reversibility is given. Net fluxes are in the direction of the reaction
with the subscript f. Negative flux indicates that the direction of net flux is exactly reverse of that assumed.
assumed. Reversibilities are reported in percentages; 0 and 0.99 reversibility represent irreversible reaction 
and reaction at equilibrium.
Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ F6Pc hxi f c -55.61 6.89 -90.26 11.19 -76.84 6.77
0.44 0.27 0.57 0.30 0.28 0.26
G6Pp ↔ F6Pp hxi f p -55.82 27.85 -116.52 45.24 -74.61 33.17
0.74 0.21 0.37 0.26 0.85 0.13
G6Pc → P5Pc + CO2 pgl c 66.00 19.60 117.09 29.15 75.59 27.68
G6Pp → P5Pp + CO2 pgl p 80.99 32.66 163.81 54.00 127.55 37.69
P5Pc + P5Pc ↔ S7Pc + T3Pc tktA f c 6.18 2.58 2.72 1.91 4.25 1.88
0.70 0.31 0.89 0.24 0.92 0.20
S7Pc + T3Pc ↔ F6Pc + E4Pc tal f c 6.18 2.58 2.72 1.91 4.25 1.88
0.32 0.19 0.36 0.25 0.29 0.22
P5Pc + E4Pc ↔ F6Pc + T3Pc tktB f c 6.18 2.58 2.72 1.91 4.25 1.88
0.49 0.20 0.17 0.23 0.12 0.16
P5Pp + P5Pp ↔ S7Pp + T3Pp tktA f p 40.41 10.19 88.96 16.34 62.05 11.94
0.88 0.10 0.82 0.14 0.96 0.06
S7Pp + T3Pp ↔ F6Pp + E4Pp tal f p 40.41 10.19 88.96 16.34 62.05 11.94
0.86 0.09 0.82 0.13 0.69 0.09
P5Pp + E4Pp ↔ F6Pp + T3Pp tktB f p 39.18 10.20 87.01 16.35 59.90 11.94
0.79 0.10 0.92 0.05 0.28 0.21
F6Pc → T3Pc + T3Pc pfk c 6.13 4.69 11.87 9.96 4.15 4.87
F6Pp → T3Pp + T3Pp pfk p 23.77 8.59 59.45 15.92 47.34 11.53
T3Pc + T3Pc → F6Pc pfp c 10.50 6.17 7.69 8.58 2.07 5.84
T3Pp + T3Pp → F6Pp f16bp p 23.39 1.92 29.30 3.17 29.85 1.70
T3P → 3PG gap 102.82 10.31 228.81 20.42 163.84 14.35
3PG → PEP eno 100.48 10.19 225.25 20.03 160.57 14.00
PEP → Pyr pyk 92.73 9.40 189.81 17.56 132.26 11.31
Pyrp → ACAp + CO2 pdh
p 43.45 1.63 41.60 2.01 52.96 1.71
Pyrm → ACAm + CO2 pdh
m 56.90 10.27 174.77 19.75 111.41 16.46
Pyrc → Pyrm pyrT 56.90 10.27 174.77 19.75 111.41 16.46
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Reaction Absolute fluxes ( µmoles day-1 cotyledon-1)
High PI Set 2 TP2 BC3-128 Set 2 TP2 Evans Set 2 TP2
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ G6Pp g6pT f 26.50 18.59 53.04 26.38 61.46 27.56
0.55 0.25 0.43 0.24 0.48 0.27
P5Pc ↔ P5Pp p5pT f 39.53 19.18 101.82 29.30 57.09 29.66
0.57 0.33 0.55 0.33 0.81 0.27
T3Pc ↔ T3Pp t3pT f 45.29 10.81 163.61 23.65 93.64 16.79
0.98 0.01 0.96 0.07 0.98 0.04
ACAm + OAAm → ICitm csaco m 55.15 10.19 171.22 19.78 107.40 16.44
ICitm → aKGm + CO2 icdh
m 53.42 9.98 167.72 19.31 103.59 15.90
aKGm → Scnm + CO2 akgdh
m 6.79 16.61 16.61 45.03 7.25 23.30
Scnm → Malm sdh f1 m 25.77 3.16 38.27 3.15 33.24 4.19
Scnm ↔ Malm sdh f2 m 72.22 10.72 188.66 22.28 135.82 19.85
0.80 0.03 0.62 0.03 0.74 0.03
Malm ↔ OAAm mdh f m 59.33 10.23 178.97 19.80 114.33 16.49
0.48 0.35 0.53 0.32 0.50 0.33
ICitm → Goxm + Scnm icl m 1.73 0.20 3.50 0.47 3.80 0.54
ACAm + Goxm → Malm ms m 0.02 0.05 0.05 0.14 0.21 0.32
PEPc + CO2 → OAA
c ppc c 7.26 1.04 35.14 3.58 27.66 3.35
Malm → Pyrm + CO2 me
m 4.53 2.47 24.88 9.25 37.75 6.57
Malp → Pyrp + CO2 me
p 13.08 1.03 16.21 1.27 8.47 1.60
Gluc → GABAc + CO2 gad
c 67.12 17.52 178.49 47.95 133.41 27.00
GABAc → GABAm gabaT 67.12 17.52 178.49 47.95 133.41 27.00
GABAm ↔ SSAm gat f
m 67.12 17.52 178.49 47.95 133.41 27.00
0.55 0.31 0.55 0.32 0.56 0.30
SSAm → Scnm ssadh m 67.12 17.52 178.49 47.95 133.41 27.00
Sucext → G6Pc + F6Pc subs1 49.52 1.79 96.87 4.50 72.67 3.55
Glnext ↔ Glnc subs2 f 24.96 1.07 32.24 1.37 39.04 1.60
0.98 0.01 0.99 0.00 0.97 0.01
Glnc → Glnp glnT 24.96 1.07 32.24 1.37 39.04 1.60
aKGm → aKGc aKGT1 24.96 1.07 32.24 1.37 39.04 1.60
reversibility %
Glutamate assimilation
Anaplerotic reactions
GABA shunt
reversibility %
Substrate entry
TCA cycle
reversibility %
reversibility %
Glyoxylate shunt
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Reaction Absolute fluxes ( µmoles day-1 cotyledon-1)
High PI Set 2 TP2 BC3-128 Set 2 TP2 Evans Set 2 TP2
  
181 
Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
aKGc → aKGp aKGT2 24.96 1.07 32.24 1.37 39.04 1.60
aKGp + Glnp → Glup + Glup gogat p 864.88 236.84 951.20 225.76 1049.37 289.96
Glup ↔ aKGp gdh f
p 839.92 235.77 918.95 224.39 1010.32 288.36
0.83 0.30 0.92 0.20 0.84 0.30
Glup ↔ Glnp as f 863.32 233.98 1041.32 223.69 1071.43 289.55
0.57 0.26 0.94 0.04 0.55 0.25
Malm ↔ Malc malT1 f 8.38 1.33 -15.15 3.51 -16.05 3.54
0.99 0.01 0.99 0.00 0.99 0.00
Malc → Malp malT2 18.08 1.52 24.24 2.24 14.74 2.44
Malc → OAAc mdh c 7.26 1.04 35.14 3.58 27.66 3.35
Malp → OAAP mdh p 5.01 0.49 8.03 0.97 6.27 0.84
3PG → Ser bios1 2.34 0.12 3.57 0.39 3.28 0.35
Ser ↔ Gly + C1 bios2 f 2.34 0.12 3.57 0.39 3.28 0.35
0.54 0.01 0.53 0.01 0.49 0.01
GOx → Gly bios3 4.05 0.23 7.02 0.79 6.87 0.71
CO2 → resp 386.74 24.39 869.54 59.13 634.11 51.73
G6Pc → biomass bios4 12.63 1.29 17.01 0.80 12.47 1.20
G6Pp → biomass bios5 1.33 0.55 5.75 0.34 8.51 0.73
F6Pc → biomass bios6 0.15 0.12 0.19 0.17 0.18 0.16
P5Pc → biomass bios7 7.92 0.70 7.10 0.72 5.75 0.51
P5Pp → biomass bios8 0.52 0.09 0.70 0.08 0.65 0.09
E4Pp → biomass bios9 1.23 0.19 1.94 0.25 2.15 0.38
PEPp → biomass bios10 2.83 0.41 3.86 0.47 3.93 0.62
ACAp → biomass bios11 1.51 0.28 2.31 0.34 2.36 0.58
ACAp → biomass bios12 41.94 1.59 39.29 1.95 50.61 1.60
Pyr → biomass bios13 8.22 0.41 13.06 0.29 12.52 0.66
OAA → biomass bios14 5.01 0.49 8.03 0.97 6.27 0.84
Glu → biomass bios15 6.21 0.62 8.36 0.58 5.79 0.56
Pyr → pyrx 1.76 1.30 1.48 2.17 1.59 1.76
Mal → malx 0.00 0.00 0.00 0.00 0.00 0.00
Scn → scnx 3.42 2.99 9.94 8.85 8.64 6.06
Biosynthesis of Ser and Gly
reversibility %
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
reversibility %
reversibility %
Malate shuttle
reversibility %
High PI Set 2 TP2 BC3-128 Set 2 TP2 Evans Set 2 TP2
Glutamate assimilation
Reaction Absolute fluxes ( µmoles day-1 cotyledon-1)
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APPENDIX XII- RELATIVE FLUXES (GENOTYPE STUDY) 
 
 
 
Table XII-1: Set 2 TP1- Relative fluxes are expressed in terms of 100 mol of sucrose intake. Each flux is represented 
usually by the name of the gene encoding the enzyme catalyzing the metabolic reaction. Subscripts f indicates forward
reaction and superscripts c, p and m indicate cytosol, plastid and mitochondrion. For reversible reactions, the net flux and
reversibility is given. Net fluxes are in the direction of the reaction with the subscript f. Negative flux indicates that the
direction of net flux is exactly reverse of that assumed. Reversibilities are reported in percentages; 0 and 0.99
reversibility represent irreversible reaction and reaction at equilibrium.
Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ F6Pc hxi f c -98.82 13.89 -97.80 10.46 -102.60 25.31
0.62 0.26 0.65 0.29 0.29 0.26
G6Pp ↔ F6Pp hxi f p -88.66 46.34 -95.39 35.98 -37.06 34.36
0.74 0.21 0.62 0.24 0.89 0.10
G6Pc → P5Pc + CO2 pgl c 105.13 37.49 144.56 20.84 115.79 18.80
G6Pp → P5Pp + CO2 pgl p 157.46 49.44 126.53 37.39 109.36 25.15
P5Pc + P5Pc ↔ S7Pc + T3Pc tktA f c 6.64 4.07 3.14 2.99 19.74 6.62
0.78 0.29 0.75 0.32 0.98 0.01
S7Pc + T3Pc ↔ F6Pc + E4Pc tal f c 6.64 4.07 3.14 2.99 19.74 6.62
0.34 0.22 0.33 0.25 0.37 0.24
P5Pc + E4Pc ↔ F6Pc + T3Pc tktB f c 6.64 4.07 3.14 2.99 19.74 6.62
0.28 0.20 0.11 0.22 0.06 0.09
P5Pp + P5Pp ↔ S7Pp + T3Pp tktA f p 78.72 16.12 85.05 12.52 54.06 11.37
0.95 0.09 0.91 0.10 0.94 0.05
S7Pp + T3Pp ↔ F6Pp + E4Pp tal f p 78.72 16.12 85.05 12.52 54.06 11.37
0.75 0.11 0.78 0.09 0.82 0.07
P5Pp + E4Pp ↔ F6Pp + T3Pp tktB f p 76.41 16.12 83.70 12.50 52.85 11.36
0.51 0.22 0.57 0.23 0.40 0.21
F6Pc → T3Pc + T3Pc pfk c 14.33 12.19 8.37 8.61 36.82 19.21
F6Pp → T3Pp + T3Pp pfk p 66.47 17.60 73.36 13.12 69.84 19.51
T3Pc + T3Pc → F6Pc pfp c 6.99 8.42 3.72 5.73 4.47 3.44
T3Pp + T3Pp → F6Pp f16bp p 31.92 5.21 16.24 2.50 19.15 1.65
T3P → 3PG gap 240.05 18.07 247.65 13.50 283.64 11.99
3PG → PEP eno 235.47 17.86 244.97 13.37 281.37 11.86
PEP → Pyr pyk 211.46 15.80 217.17 12.31 251.89 11.04
Pyrp → ACAp + CO2 pdh
p
65.12 4.03 54.59 2.78 32.60 1.86
Pyrm → ACAm + CO2 pdh
m
169.57 22.31 175.99 13.60 222.26 15.10
Pyrc → Pyrm pyrT 169.57 22.31 175.99 13.60 222.26 15.10
Reaction Relative fluxes
reversibility %
reversibility %
reversibility %
reversibility %
High PI Set 2 TP1 BC3-128 Set 2 TP1 Evans Set 2 TP1
reversibility %
reversibility %
Glycolysis and oxPPP
reversibility %
reversibility %
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ G6Pp g6pT f 76.31 36.90 38.07 20.74 77.59 27.58
0.55 0.22 0.51 0.23 0.20 0.22
P5Pc ↔ P5Pp p5pT f 77.08 39.59 127.85 21.43 52.02 25.99
0.74 0.27 0.72 0.28 0.00 0.03
T3Pc ↔ T3Pp t3pT f 138.46 27.42 172.56 19.14 156.76 36.95
0.94 0.14 0.81 0.25 0.97 0.02
ACAm + OAAm → ICitm csaco m 165.06 22.28 172.56 13.61 219.94 15.13
ICitm → aKGm + CO2 icdh
m 160.59 21.85 169.19 13.20 217.64 14.86
aKGm → Scnm + CO2 akgdh
m
23.21 36.53 18.48 35.81 24.47 40.35
Scnm → Malm sdh f1 m 46.15 4.85 28.83 2.62 22.58 2.15
Scnm ↔ Malm sdh f2
m
194.11 23.84 177.88 19.34 212.92 20.61
0.66 0.03 0.72 0.03 0.72 0.03
Malm ↔ OAAm mdh f
m
173.89 22.17 178.42 13.58 224.37 15.03
0.55 0.36 0.49 0.33 0.61 0.32
ICitm → Goxm + Scnm icl m 4.47 0.42 3.37 0.41 2.30 0.27
ACAm + Goxm → Malm ms m 0.04 0.11 0.05 0.17 0.02 0.07
PEPc + CO2 → OAA
c ppc c 23.87 2.78 27.79 2.03 29.31 1.99
Malm → Pyrm + CO2 me
m
24.42 8.19 15.82 10.45 7.43 10.21
Malp → Pyrp + CO2 me
p
13.84 2.26 8.99 1.87 7.53 0.95
Gluc → GABAc + CO2 gad
c
169.94 39.03 178.46 37.29 227.06 43.90
GABAc → GABAm gabaT 169.94 39.03 178.46 37.29 227.06 43.90
GABAm ↔ SSAm gat f
m
169.94 39.03 178.46 37.29 227.06 43.90
0.56 0.30 0.57 0.31 0.55 0.31
SSAm → Scnm ssadh m 169.94 39.03 178.46 37.29 227.06 43.90
Sucext → G6Pc + F6Pc subs1 100.00 0.00 100.00 0.00 100.00 0.00
Glnext ↔ Glnc subs2 f 38.78 2.15 31.64 1.79 37.51 2.86
0.99 0.00 0.99 0.00 0.99 0.00
Glnc → Glnp glnT 38.78 2.15 31.64 1.79 37.51 2.86
aKGm → aKGc aKGT1 38.78 2.15 31.64 1.79 37.51 2.86
reversibility %
Reaction
Glycolysis and oxPPP
Relative fluxes
High PI Set 2 TP1 BC3-128 Set 2 TP1 Evans Set 2 TP1
TCA cycle
reversibility %
reversibility %
reversibility %
Anaplerotic reactions
Glyoxylate shunt
GABA shunt
reversibility %
reversibility %
reversibility %
Substrate entry
Glutamate assimilation
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
aKGc → aKGp aKGT2 38.78 2.15 31.64 1.79 37.51 2.86
aKGp + Glnp → Glup + Glup gogat p 1731.23 427.03 1102.97 293.41 1073.79 298.90
Glup ↔ aKGp gdh f
p
1692.46 424.89 1071.33 291.62 1036.27 296.04
0.91 0.14 0.90 0.21 0.91 0.20
Glup ↔ Glnp as f 1795.53 420.42 1193.77 288.92 1194.23 294.08
0.82 0.13 0.85 0.10 0.95 0.04
Malm ↔ Malc malT1 f -5.79 4.61 -16.30 2.99 -19.70 2.33
0.99 0.00 0.99 0.00 0.99 0.00
Malc → Malp malT2 22.44 2.87 13.97 2.29 11.75 1.25
Malc → OAAc mdh c 23.87 2.78 27.79 2.03 29.31 1.99
Malp → OAAP mdh p 8.60 0.61 4.98 0.43 4.22 0.30
3PG → Ser bios1 4.58 0.21 2.67 0.13 2.27 0.13
Ser ↔ Gly + C1 bios2 f 4.58 0.21 2.67 0.13 2.27 0.13
0.56 0.01 0.55 0.01 0.40 0.01
GOx → Gly bios3 4.43 0.41 3.32 0.39 2.27 0.27
CO2 → resp 869.87 37.21 868.19 39.07 937.11 38.04
G6Pc → biomass bios4 17.38 1.71 15.17 1.32 9.23 0.93
G6Pp → biomass bios5 7.52 1.04 6.92 0.46 5.29 0.74
F6Pc → biomass bios6 0.12 0.19 0.11 0.13 0.06 0.10
P5Pc → biomass bios7 8.14 1.20 7.28 0.83 4.55 1.04
P5Pp → biomass bios8 0.69 0.11 0.58 0.03 0.41 0.02
E4Pp → biomass bios9 2.32 0.23 1.35 0.15 1.21 0.11
PEPp → biomass bios10 4.72 0.28 2.68 0.14 2.44 0.15
ACAp → biomass bios11 2.69 0.26 1.70 0.14 1.49 0.12
ACAp → biomass bios12 62.42 3.81 52.89 2.71 31.12 1.78
Pyr → biomass bios13 14.88 0.77 9.59 0.36 8.26 0.43
OAA → biomass bios14 8.60 0.61 4.98 0.43 4.22 0.30
Glu → biomass bios15 10.68 0.51 7.26 0.34 5.92 0.32
Pyr → pyrx 0.15 0.52 1.82 1.37 3.73 2.32
Mal → malx 1.64 1.82 0.00 0.00 0.83 0.43
Scn → scnx 3.51 4.90 22.44 11.79 40.91 9.28
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
Biosynthesis of Ser and Gly
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
reversibility %
Glutamate assimilation
Evans Set 2 TP1
reversibility %
Reaction Relative fluxes
High PI Set 2 TP1 BC3-128 Set 2 TP1
Malate shuttle
reversibility %
reversibility %
  
185 
 
 
 
 
Table XII-2: Set 3 TP1- Relative fluxes are expressed in terms of 100 mol of sucrose intake. Each flux is represented 
usually by the name of the gene encoding the enzyme catalyzing the metabolic reaction. Subscripts f indicates forward
reaction and superscripts c, p and m indicate cytosol, plastid and mitochondrion. For reversible reactions, the net flux and
reversibility is given. Net fluxes are in the direction of the reaction with the subscript f. Negative flux indicates that the
direction of net flux is exactly reverse of that assumed. Reversibilities are reported in percentages; 0 and 0.99
reversibility represent irreversible reaction and reaction at equilibrium.
Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ F6Pc hxi f c -96.10 16.69 -104.32 14.34 -92.51 14.98
0.18 0.21 0.10 0.19 0.26 0.24
G6Pp ↔ F6Pp hxi f p -44.52 34.30 -89.88 35.05 -51.79 45.52
0.83 0.12 0.87 0.09 0.90 0.06
G6Pc → P5Pc + CO2 pgl c 71.73 37.49 118.87 31.23 50.20 37.10
G6Pp → P5Pp + CO2 pgl p 144.59 45.54 153.80 29.43 163.90 55.91
P5Pc + P5Pc ↔ S7Pc + T3Pc tktA f c 10.80 3.72 7.76 2.51 4.08 2.13
0.97 0.03 0.94 0.13 0.83 0.25
S7Pc + T3Pc ↔ F6Pc + E4Pc tal f c 10.80 3.72 7.76 2.51 4.08 2.13
0.42 0.21 0.35 0.22 0.35 0.23
P5Pc + E4Pc ↔ F6Pc + T3Pc tktB f c 10.80 3.72 7.76 2.51 4.08 2.13
0.09 0.10 0.05 0.10 0.09 0.15
P5Pp + P5Pp ↔ S7Pp + T3Pp tktA f p 58.61 12.17 80.74 12.07 64.01 15.16
0.96 0.01 0.95 0.03 0.97 0.01
S7Pp + T3Pp ↔ F6Pp + E4Pp tal f p 58.61 12.17 80.74 12.07 64.01 15.16
0.82 0.04 0.77 0.05 0.79 0.06
P5Pp + E4Pp ↔ F6Pp + T3Pp tktB f p 56.74 12.13 79.50 12.09 61.57 15.13
0.03 0.10 0.16 0.18 0.08 0.15
F6Pc → T3Pc + T3Pc pfk c 24.98 15.44 10.41 13.04 14.51 14.94
F6Pp → T3Pp + T3Pp pfk p 70.84 16.31 70.35 15.27 73.78 19.67
T3Pc + T3Pc → F6Pc pfp c 1.63 2.64 1.66 3.29 6.78 7.69
T3Pp + T3Pp → F6Pp f16bp p 31.45 2.50 23.66 1.70 41.44 3.25
T3P → 3PG gap 255.20 13.41 246.19 12.71 237.02 16.85
3PG → PEP eno 251.22 13.21 243.58 12.55 231.80 16.50
PEP → Pyr pyk 222.90 12.11 208.08 10.99 203.80 14.57
Pyrp → ACAp + CO2 pdh
p
40.23 3.21 25.66 2.07 61.03 4.47
Pyrm → ACAm + CO2 pdh
m
203.41 15.47 209.95 14.53 145.02 17.46
Pyrc → Pyrm pyrT 203.41 15.47 209.95 14.53 145.02 17.46
Reaction Relative fluxes
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
High PI Set 3 TP1 BC3-128 Set 3 TP1 Evans Set 3 TP1
Glycolysis and oxPPP
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ G6Pp g6pT f 107.64 39.61 70.72 30.73 119.13 39.76
0.53 0.35 0.68 0.26 0.65 0.31
P5Pc ↔ P5Pp p5pT f 30.04 39.17 87.72 32.22 26.55 38.18
0.04 0.15 0.80 0.26 0.51 0.38
T3Pc ↔ T3Pp t3pT f 146.80 29.55 189.83 26.12 137.11 32.31
0.98 0.03 0.68 0.23 40.57 11.24
ACAm + OAAm → ICitm csaco m 198.13 15.47 208.23 14.50 140.19 17.34
ICitm → aKGm + CO2 icdh
m
192.90 14.79 206.61 14.09 135.83 16.57
aKGm → Scnm + CO2 akgdh
m
11.78 33.46 24.36 38.51 55.23 49.98
Scnm → Malm sdh f1 m 36.68 5.04 26.52 3.13 48.86 3.02
Scnm ↔ Malm sdh f2
m
215.43 20.33 216.98 18.92 144.48 19.36
29.16 1.68 0.70 0.04 0.59 0.04
Malm ↔ OAAm mdh f
m
206.78 15.41 212.23 14.50 149.74 17.21
0.57 0.31 0.63 0.30 0.54 0.32
ICitm → Goxm + Scnm icl m 5.23 0.68 1.62 0.41 4.35 0.77
ACAm + Goxm → Malm ms m 0.06 0.16 0.10 0.17 0.48 0.60
PEPc + CO2 → OAA
c ppc c 28.75 2.29 35.64 2.47 28.46 3.07
Malm → Pyrm + CO2 me
m
29.36 10.01 31.35 8.33 9.98 8.38
Malp → Pyrp + CO2 me
p
4.74 1.02 6.76 0.81 8.70 2.24
Gluc → GABAc + CO2 gad
c
210.25 37.14 206.18 36.46 108.30 50.52
GABAc → GABAm gabaT 210.25 37.14 206.18 36.46 108.30 50.52
GABAm ↔ SSAm gat f
m
210.25 37.14 206.18 36.46 108.30 50.52
0.50 0.34 0.50 0.33 0.50 0.34
SSAm → Scnm ssadh m 210.25 37.14 206.18 36.46 108.30 50.52
Sucext → G6Pc + F6Pc subs1 100.00 0.00 100.00 0.00 100.00 0.00
Glnext ↔ Glnc subs2 f 33.28 1.80 29.18 2.26 34.17 7.34
0.99 0.00 0.99 0.00 0.98 0.01
Glnc → Glnp glnT 33.28 1.80 29.18 2.26 34.17 7.34
aKGm → aKGc aKGT1 33.28 1.80 29.18 2.26 34.17 7.34
reversibility %
Glutamate assimilation
Anaplerotic reactions
GABA shunt
reversibility %
Substrate entry
TCA cycle
reversibility %
reversibility %
Glyoxylate shunt
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Reaction Relative fluxes
High PI Set 3 TP1 BC3-128 Set 3 TP1 Evans Set 3 TP1
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
aKGc → aKGp aKGT2 33.28 1.80 29.18 2.26 34.17 7.34
aKGp + Glnp → Glup + Glup gogat p 1427.94 549.75 753.78 216.76 1489.82 397.56
Glup ↔ aKGp gdh f p 1248.94 370.75 724.60 214.49 1455.65 390.21
0.94 0.12 0.95 0.14 0.73 0.27
Glup ↔ Glnp as f 1402.01 366.10 879.29 211.67 1506.44 383.50
0.92 0.06 0.94 0.04 0.69 0.23
Malm ↔ Malc malT1 f -20.65 2.55 -26.50 2.71 -14.75 4.18
0.99 0.00 0.98 0.01 0.97 0.01
Malc → Malp malT2 11.52 1.46 11.53 1.13 18.90 3.26
Malc → OAAc mdh c 28.75 2.29 35.64 2.47 28.46 3.07
Malp → OAAP mdh p 6.78 0.45 4.77 0.32 10.20 1.01
3PG → Ser bios1 3.98 0.20 2.61 0.16 5.21 0.35
Ser ↔ Gly + C1 bios2 f 3.98 0.20 2.61 0.16 5.21 0.35
0.54 0.01 0.45 0.02 0.51 0.02
GOx → Gly bios3 5.18 0.69 1.52 0.40 3.87 0.78
CO2 → resp 885.48 37.66 949.52 33.06 714.09 37.40
G6Pc → biomass bios4 16.73 1.74 14.73 1.39 23.18 2.22
G6Pp → biomass bios5 7.56 0.41 6.80 0.42 7.03 0.46
F6Pc → biomass bios6 0.53 0.48 0.79 0.50 1.15 0.69
P5Pc → biomass bios7 9.28 0.84 7.86 0.80 11.40 1.54
P5Pp → biomass bios8 0.66 0.07 0.55 0.03 0.85 0.05
E4Pp → biomass bios9 1.87 0.22 1.24 0.15 2.45 0.23
PEPp → biomass bios10 3.56 0.24 2.46 0.19 4.76 0.45
ACAp → biomass bios11 2.31 0.18 1.69 0.14 2.86 0.28
ACAp → biomass bios12 37.92 3.10 23.96 2.00 58.17 4.33
Pyr → biomass bios13 12.58 0.63 9.01 0.48 14.93 0.77
OAA → biomass bios14 6.78 0.45 4.77 0.32 10.20 1.01
Glu → biomass bios15 9.38 0.42 6.86 0.37 10.83 0.60
Pyr → pyrx 0.77 0.92 1.57 0.83 1.50 0.93
Mal → malx 0.00 0.00 0.00 0.00 0.00 0.00
Scn → scnx 11.82 8.96 15.18 7.92 23.40 14.80
Biosynthesis of Ser and Gly
reversibility %
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
reversibility %
reversibility %
Malate shuttle
reversibility %
High PI Set 3 TP1 BC3-128 Set 3 TP1 Evans Set 3 TP1
Glutamate assimilation
Reaction Relative fluxes
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Table XII-3: Set 2 TP2- Relative fluxes are expressed in terms of 100 mol of sucrose intake. Each flux is represented 
usually by the name of the gene encoding the enzyme catalyzing the metabolic reaction. Subscripts f indicates forward
reaction and superscripts c, p and m indicate cytosol, plastid and mitochondrion. For reversible reactions, the net flux and
reversibility is given. Net fluxes are in the direction of the reaction with the subscript f. Negative flux indicates that the
direction of net flux is exactly reverse of that assumed. Reversibilities are reported in percentages; 0 and 0.99
reversibility represent irreversible reaction and reaction at equilibrium.
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ F6Pc hxi f c -112.40 14.10 -93.18 10.55 -105.76 7.98
0.44 0.27 0.57 0.30 0.28 0.26
G6Pp ↔ F6Pp hxi f
p
-112.52 55.55 -120.27 45.91 -102.42 44.83
0.74 0.21 0.37 0.26 0.85 0.13
G6Pc → P5Pc + CO2 pgl c 133.27 39.17 120.62 28.99 103.71 37.12
G6Pp → P5Pp + CO2 pgl p 163.43 65.21 169.28 55.19 175.53 51.50
P5Pc + P5Pc ↔ S7Pc + T3Pc tktA f c 12.51 5.23 2.81 1.95 5.86 2.61
0.70 0.31 0.89 0.24 0.92 0.20
S7Pc + T3Pc ↔ F6Pc + E4Pc tal f c 12.51 5.23 2.81 1.95 5.86 2.61
0.32 0.19 0.36 0.25 0.29 0.22
P5Pc + E4Pc ↔ F6Pc + T3Pc tktB f
c 12.51 5.23 2.81 1.95 5.86 2.61
0.49 0.20 0.17 0.23 0.12 0.16
P5Pp + P5Pp ↔ S7Pp + T3Pp tktA f p 81.54 20.02 91.81 16.07 85.26 15.31
0.88 0.10 0.82 0.14 0.96 0.06
S7Pp + T3Pp ↔ F6Pp + E4Pp tal f p 81.54 20.02 91.81 16.07 85.26 15.31
0.86 0.09 0.82 0.13 0.69 0.09
P5Pp + E4Pp ↔ F6Pp + T3Pp tktB f p 79.04 20.06 89.80 16.08 82.30 15.33
0.79 0.10 0.92 0.05 0.28 0.21
F6Pc → T3Pc + T3Pc pfk c 12.31 9.31 12.24 10.11 5.71 6.68
F6Pp → T3Pp + T3Pp pfk p 48.06 17.37 61.34 15.92 65.14 15.51
T3Pc + T3Pc → F6Pc pfp c 21.27 12.58 7.92 8.81 2.87 8.17
T3Pp + T3Pp → F6Pp f16bp p 47.28 4.10 30.32 3.63 41.18 3.21
T3P → 3PG gap 207.55 18.53 236.08 16.16 225.35 15.05
3PG → PEP eno 202.82 18.21 232.39 15.70 220.84 14.53
PEP → Pyr pyk 187.17 16.86 195.83 13.94 181.94 12.02
Pyrp → ACAp + CO2 pdh
p 87.86 4.67 43.06 3.14 73.06 4.43
Pyrm → ACAm + CO2 pdh
m 114.74 19.36 180.26 16.80 152.97 19.11
Pyrc → Pyrm pyrT 114.74 19.36 180.26 16.80 152.97 19.11
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
reversibility %
High PI Set 2 TP2 BC3-128 Set 2 TP2 Evans Set 2 TP2
Glycolysis and oxPPP
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
G6Pc ↔ G6Pp g6pT f 53.59 37.52 54.95 28.01 84.86 38.44
0.55 0.25 0.43 0.24 0.48 0.27
P5Pc ↔ P5Pp p5pT f 79.74 38.38 104.86 29.42 78.19 40.13
0.57 0.33 0.55 0.33 0.81 0.27
T3Pc ↔ T3Pp t3pT f 91.39 21.22 168.70 21.55 128.52 20.36
0.98 0.01 0.96 0.07 0.98 0.04
ACAm + OAAm → ICitm csaco m 111.20 19.23 176.59 16.86 147.44 19.22
ICitm → aKGm + CO2 icdh
m 107.69 18.81 172.96 16.31 142.20 18.46
aKGm → Scnm + CO2 akgdh
m 13.57 33.06 16.85 45.25 9.95 32.15
Scnm → Malm sdh f1
m 52.11 6.72 39.57 3.56 45.83 6.17
Scnm ↔ Malm sdh f2
m 145.73 20.23 194.74 20.63 186.58 23.61
0.80 0.03 0.62 0.03 0.74 0.03
Malm ↔ OAAm mdh f
m 119.65 19.23 184.62 16.89 157.01 19.11
0.48 0.35 0.53 0.32 0.50 0.33
ICitm → Goxm + Scnm icl m 3.50 0.42 3.63 0.54 5.24 0.76
ACAm + Goxm → Malm ms m 0.04 0.11 0.05 0.14 0.28 0.43
PEPc + CO2 → OAA
c ppc c 14.65 1.96 36.27 3.17 38.01 3.75
Malm → Pyrm + CO2 me
m 9.15 4.95 25.75 9.50 51.86 8.24
Malp → Pyrp + CO2 me
p 26.44 2.36 16.77 1.60 11.67 2.24
Gluc → GABAc + CO2 gad
c 135.54 34.71 184.44 48.29 183.36 34.99
GABAc → GABAm gabaT 135.54 34.71 184.44 48.29 183.36 34.99
GABAm ↔ SSAm gat f
m 135.54 34.71 184.44 48.29 183.36 34.99
0.55 0.31 0.55 0.32 0.56 0.30
SSAm → Scnm ssadh m 135.54 34.71 184.44 48.29 183.36 34.99
Sucext → G6Pc + F6Pc subs1 100.00 0.00 100.00 0.00 100.00 0.00
Glnext ↔ Glnc subs2 f 50.48 2.89 33.35 2.09 53.85 3.44
0.98 0.01 0.99 0.00 0.97 0.01
Glnc → Glnp glnT 50.48 2.89 33.35 2.09 53.85 3.44
aKGm → aKGc aKGT1 50.48 2.89 33.35 2.09 53.85 3.44
reversibility %
Glutamate assimilation
Anaplerotic reactions
GABA shunt
reversibility %
Substrate entry
TCA cycle
reversibility %
reversibility %
Glyoxylate shunt
Glycolysis and oxPPP
reversibility %
reversibility %
reversibility %
Reaction Relative fluxes [Standardized w.r.t sucrose (100 moles/day)]
High PI Set 2 TP2 BC3-128 Set 2 TP2 Evans Set 2 TP2
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Reaction
Name
Net Flux S.D. Net Flux S.D. Net Flux S.D.
aKGc → aKGp aKGT2 50.48 2.89 33.35 2.09 53.85 3.44
aKGp + Glnp → Glup + Glup gogat p 1747.00 478.80 984.41 241.09 1446.99 410.61
Glup ↔ aKGp gdh f
p 1696.52 475.91 951.06 239.00 1393.14 407.17
0.83 0.30 0.92 0.20 0.84 0.30
Glup ↔ Glnp as f 1743.66 471.77 1077.44 238.40 1476.78 406.96
0.57 0.26 0.94 0.04 0.55 0.25
Malm ↔ Malc malT1 f 16.97 2.99 -15.58 3.27 -22.01 4.39
0.99 0.01 0.99 0.00 0.99 0.00
Malc → Malp malT2 36.57 3.42 25.09 2.73 20.33 3.53
Malc → OAAc mdh c 14.65 1.96 36.27 3.17 38.01 3.75
Malp → OAAP mdh p 10.12 1.06 8.32 1.13 8.66 1.29
3PG → Ser bios1 4.72 0.32 3.69 0.46 4.52 0.52
Ser ↔ Gly + C1 bios2 f 4.72 0.32 3.69 0.46 4.52 0.52
0.54 0.01 0.53 0.01 0.49 0.01
GOx → Gly bios3 8.19 0.55 7.27 0.95 9.47 1.05
CO2 → resp 780.55 31.62 897.34 38.30 871.55 40.31
G6Pc → biomass bios4 25.53 2.76 17.60 1.15 17.19 1.80
G6Pp → biomass bios5 2.69 1.11 5.94 0.44 11.75 1.20
F6Pc → biomass bios6 0.31 0.24 0.19 0.18 0.25 0.22
P5Pc → biomass bios7 16.02 1.48 7.34 0.81 7.93 0.78
P5Pp → biomass bios8 1.05 0.19 0.73 0.09 0.90 0.13
E4Pp → biomass bios9 2.50 0.39 2.01 0.26 2.96 0.55
PEPp → biomass bios10 5.72 0.86 3.99 0.50 5.41 0.87
ACAp → biomass bios11 3.05 0.58 2.39 0.38 3.25 0.85
ACAp → biomass bios12 84.80 4.51 40.66 3.00 69.80 4.13
Pyr → biomass bios13 16.63 1.03 13.51 0.75 17.26 1.19
OAA → biomass bios14 10.12 1.06 8.32 1.13 8.66 1.29
Glu → biomass bios15 12.56 1.29 8.65 0.78 7.98 0.92
Pyr → pyrx 3.55 2.61 1.52 2.23 2.18 2.40
Mal → malx 0.00 0.00 0.00 0.00 0.00 0.00
Scn → scnx 6.89 5.96 10.18 8.92 11.97 8.48
Biosynthesis of Ser and Gly
reversibility %
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
Fluxes towards biosynthesis (other than those related to Ser and Gly) and effluxes into medium
reversibility %
reversibility %
Malate shuttle
reversibility %
High PI Set 2 TP2 BC3-128 Set 2 TP2 Evans Set 2 TP2
Glutamate assimilation
Reaction Relative fluxes [Standardized w.r.t sucrose (100 moles/day)]
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Table XIII-1: Evans (Set 2 TP1, MM and Set 3 TP1): Comparison of relative multiplet intensities of amino acids from protein and
glucosyl units from starch hydrolysates with their standard deviations (SDs) from 2-D [13C, 1H] HSQC spectrum. s indicates singlet, 
d1 and d2 indicate the first and second doublet and dd indicates the double doublet. Bold faced carbon atom in Isotopomer indicates
labeled carbon atom, normal font indicates unlabeled carbon atom and x indicates unknown labeling state of the carbon atom. Subscripts 
p, c and m for precursor indicates the compartments plastid, cytosol and mitochondrion in which they are present.
Hydroly- Cross peak
sate (multiplet) Intensity SD Intensity SD Intensity SD Precursor Isotopomer
Protein Gly α (s) 0.499 0.005 0.458 0.005 0.469 0.005 T3P/GOx [12x]
Protein Gly α (d) 0.501 0.005 0.542 0.005 0.531 0.005 T3P/GOx [12x]
Protein Ser α (s) 0.321 0.008 0.272 0.008 0.315 0.010 Ser [123]
Protein Ser α (d1) 0.186 0.008 0.211 0.008 0.237 0.010 Ser [123]
Protein Ser α (d2) 0.126 0.008 0.127 0.008 0.115 0.010 Ser [123]
Protein Ser α (dd) 0.367 0.008 0.390 0.008 0.332 0.010 Ser [123]
Protein Ser β (s) 0.485 0.012 0.497 0.015 0.575 0.015 Ser [x23]
Protein Ser β (d) 0.515 0.012 0.503 0.015 0.425 0.015 Ser [x23]
Protein Ala α (s) 0.265 0.010 0.196 0.010 0.220 0.011 Pyr [123]
Protein Ala α (d1) 0.039 0.010 0.023 0.010 0.039 0.011 Pyr [123]
Protein Ala α (d2) 0.174 0.010 0.206 0.010 0.172 0.011 Pyr [123]
Protein Ala α (dd) 0.522 0.010 0.573 0.010 0.562 0.011 Pyr [123]
Protein Ala β (s) 0.284 0.003 0.244 0.002 0.289 0.004 Pyr [x23]
Protein Ala β (d) 0.716 0.003 0.756 0.002 0.711 0.004 Pyr [x23]
Protein Ile γ2 (s) 0.283 0.003 0.242 0.002 0.288 0.004 Pyrp [x23]
Protein Ile γ2 (d) 0.717 0.003 0.759 0.002 0.712 0.004 Pyrp [x23]
Protein Leu δ1 (s) 0.357 0.005 Pyrp [x23]
Protein Leu δ1 (d) 0.643 0.005 Pyrp [x23]
Protein Val α (s) 0.430 0.015 0.354 0.027 0.381 0.015 Pyrp [12x]·[x2x]
Protein Val α (d1) 0.478 0.015 0.558 0.027 0.494 0.015 Pyrp [12x]·[x2x]
Protein Val α (d2) 0.052 0.015 0.053 0.027 0.057 0.015 Pyrp [12x]·[x2x]
Protein Val α (dd) 0.040 0.015 0.034 0.027 0.068 0.015 Pyrp [12x]·[x2x]
Evans Set 3 TP1Evans Set 2 TP1 MM 
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Hydroly- Cross peak
sate (multiplet) Intensity SD Intensity SD Intensity SD Precursor Isotopomer
Protein Val γ1 (s) 0.304 0.006 0.235 0.002 0.305 0.004 Pyrp [x23]
Protein Val γ1 (d) 0.696 0.006 0.765 0.002 0.695 0.004 Pyrp [x23]
Protein Val γ2 (s) 0.899 0.003 0.882 0.002 0.884 0.004 Pyrp [x2x]·[xx3]
Protein Val γ2 (d) 0.101 0.003 0.118 0.002 0.116 0.004 Pyrp [x2x]·[xx3]
Protein Leu δ2 (s) 0.893 0.008 0.877 0.001 0.896 0.005 Pyrp [x2x]·[xx3]
Protein Leu δ2 (d) 0.107 0.008 0.123 0.001 0.104 0.005 Pyrp [x2x]·[xx3]
Protein Phe α (s) 0.252 0.010 0.205 0.012 0.220 0.011 PEPp [123]
Protein Phe α (d1) 0.014 0.010 0.035 0.012 0.020 0.011 PEPp [123]
Protein Phe α (d2) 0.167 0.010 0.151 0.012 0.169 0.011 PEPp [123]
Protein Phe α (dd) 0.567 0.010 0.608 0.012 0.590 0.011 PEPp [123]
Protein Phe β (s) 0.255 0.015 0.161 0.011 PEPp [x23]·[x2x]
Protein Phe β (d1) 0.676 0.015 0.750 0.011 PEPp [x23]·[x2x]
Protein Phe β (d2) 0.003 0.015 0.014 0.011 PEPp [x23]·[x2x]
Protein Phe β (dd) 0.066 0.015 0.074 0.011 PEPp [x23]·[x2x]
Protein Tyr α (s) 0.262 0.011 0.208 0.017 0.200 0.020 PEPp [123]
Protein Tyr α (d1) 0.020 0.011 0.000 0.000 0.021 0.020 PEPp [123]
Protein Tyr α (d2) 0.203 0.011 0.180 0.017 0.189 0.020 PEPp [123]
Protein Tyr α (dd) 0.516 0.011 0.612 0.017 0.590 0.020 PEPp [123]
Protein Tyr β (s) 0.198 0.012 0.155 0.028 0.204 0.015 PEPp [x23]·[x2x]
Protein Tyr β (d) 0.678 0.012 0.737 0.028 0.690 0.015 PEPp [x23]·[x2x] + [x23]·[x2x]
Protein Tyr β (t) 0.124 0.012 0.109 0.028 0.106 0.015 PEPp [x23]·[x2x]
Protein Leu α (s) 0.296 0.010 0.225 0.009 0.249 0.010 ACoA p /Pyrp [1 2 ] ·[x2x]
Protein Leu α (d1) 0.596 0.010 0.709 0.009 0.587 0.010 ACoA p /Pyrp [ 12 ] ·[x2x]
Protein Leu α (d2) 0.040 0.010 0.032 0.009 0.061 0.010 ACoA p /Pyrp [1 2 ] ·[x2x]
Protein Leu α (dd) 0.068 0.010 0.033 0.009 0.102 0.010 ACoA p /Pyrp [ 12 ] ·[x2x]
Protein Leu b (s) 0.810 0.007 0.815 0.007 0.761 0.007 ACoA p /Pyrp [x2] ·[x2x].[x2x]
Protein Leu b (d) 0.149 0.007 0.185 0.007 0.165 0.007 ACoA p /Pyrp [x 2 ] ·[x2x].[x2x]+[x2]·[x2x].[x2x]
Protein Leu b (t) 0.041 0.007 0.000 0.000 0.074 0.007 ACoA p /Pyrp [x 2 ] ·[x2x].[x2x]
Evans Set 2 TP1 MM * Evans Set 3 TP1
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Hydroly- Cross peak
sate (multiplet) Intensity SD Intensity SD Intensity SD Precursor Isotopomer
Protein His β (s) 0.380 0.008 0.321 0.007 0.335 0.010 P5Pp [x234x]
Protein His β (d1) 0.028 0.015 0.019 0.008 0.031 0.010 P5Pp [x234x]
Protein His β (d2) 0.504 0.015 0.551 0.008 0.511 0.010 P5Pp [x234x]
Protein His β (dd) 0.088 0.008 0.108 0.007 0.124 0.010 P5Pp [x234x]
Protein His δ2 (s) 0.622 0.007 0.513 0.008 0.642 0.015 P5Pp [12xxx]
Protein His δ2 (d) 0.378 0.007 0.487 0.008 0.358 0.015 P5Pp [12xxx]
Protein Tyr δ1 (s) 0.262 0.007 0.214 0.008 0.237 0.007 PEP p /E4Pp [x2 3 ] ·[1xxx]
Protein Tyr δ2 (s) PEP p /E4Pp [x2x] ·[43xx]
Protein Tyr δ1 (d) 0.669 0.007 0.692 0.008 0.697 0.007 PEP p /E4Pp [x 23 ] ·[1xxx] + [x2 3 ] ·[1xxx]
Protein Tyr δ2 (d) PEP p /E4Pp [x 2 x] ·[43xx] + [x2x] ·[43xx]
Protein Tyr δ1 (t) 0.069 0.007 0.094 0.008 0.066 0.007 PEP p /E4Pp [x 23 ] ·[1xxx]
Protein Tyr δ2 (t) PEP p /E4Pp [x 2 x] ·[43xx]
Protein Tyr ε1 (s) 0.539 0.007 0.462 0.006 0.526 0.007 PEP p /E4Pp [xx3] ·[12xx]
Protein Tyr ε2 (s) E4Pp [x234]
Protein Tyr ε1 (d) 0.205 0.007 0.190 0.006 0.206 0.007 PEP p /E4Pp [xx 3 ] ·[12xx] + [xx3] ·[12xx]
Protein Tyr ε2 (d) E4Pp [x234] + [x234]
Protein Tyr ε1 (t) 0.256 0.007 0.348 0.006 0.268 0.007 PEP p /E4Pp [xx 3 ] ·[12xx]
Protein Tyr ε2 (t) E4Pp [x234]
Protein Arg β (s) 0.840 0.040 0.830 0.053 0.804 0.040 Glup [x234x]
Protein Arg β (d) 0.160 0.040 0.170 0.053 0.196 0.040 Glup [x234x] + [x234x]
Protein Arg β (t) 0.000 0.040 0.000 0.000 0.000 0.040 Glup [x234x]
Protein Arg δ (s) 0.666 0.010 0.663 0.012 0.641 0.010 Glup [xxx45]
Protein Arg δ (d) 0.334 0.010 0.337 0.012 0.359 0.010 Glup [xxx45]
Protein Glu β (s) 0.836 0.025 0.821 0.017 0.870 0.025 Glu [x234x]
Protein Glu β (d) 0.152 0.025 0.179 0.017 0.130 0.025 Glu [x234x] + [x234x]
Protein Glu β (t) 0.012 0.025 0.000 0.000 0.000 0.025 Glu [x234x]
Protein Glu γ (s) 0.673 0.010 0.694 0.009 Glu [xx345]
Protein Glu γ (d1) 0.026 0.010 0.016 0.009 Glu [xx345]
Evans Set 2 TP1 MM * Evans Set 3 TP1
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Hydroly- Cross peak
sate (multiplet) Intensity SD Intensity SD Intensity SD Precursor Isotopomer
Protein Glu γ (d2) 0.301 0.010 0.290 0.009 Glu [xx345]
Protein Glu γ (dd) 0.000 0.010 0.000 0.000 Glu [xx345]
Protein Pro γ (s) 0.641 0.013 0.639 0.029 0.620 0.013 Glup [xx345]
Protein Pro γ (d) 0.326 0.013 0.361 0.029 0.380 0.013 Glup [xx345] + [xx345]
Protein Pro γ (t) 0.033 0.013 0.000 0.000 0.000 0.013 Glup [xx345]
Protein Pro δ (s) 0.660 0.014 0.641 0.036 0.603 0.014 Glup [xxx45]
Protein Pro δ (d) 0.340 0.014 0.359 0.036 0.397 0.014 Glup [xxx45]
Protein Asp α (s) 0.528 0.009 0.433 0.010 0.458 0.011 OAA [123x]
Protein Asp α (d1) 0.129 0.009 0.087 0.010 0.222 0.011 OAA [123x]
Protein Asp α (d2) 0.196 0.009 0.283 0.010 0.137 0.011 OAA [123x]
Protein Asp α (dd) 0.148 0.009 0.197 0.010 0.184 0.011 OAA [123x]
Protein Asp β (s) 0.520 0.009 0.406 0.010 0.441 0.011 OAA [x234]
Protein Asp β (d1) 0.245 0.009 0.343 0.010 0.122 0.011 OAA [x234]
Protein Asp β (d2) 0.097 0.009 0.082 0.010 0.277 0.011 OAA [x234]
Protein Asp β (dd) 0.138 0.009 0.169 0.010 0.160 0.011 OAA [x234]
Protein Ile α (s) 0.631 0.012 0.596 0.013 0.567 0.014 OAA p /Pyrp [1 2 xx] ·[x2x]
Protein Ile α (d1) 0.239 0.012 0.287 0.013 0.300 0.014 OAA p /Pyrp [ 12 xx] ·[x2x]
Protein Ile α (d2) 0.083 0.012 0.060 0.013 0.049 0.014 OAA p /Pyrp [1 2 xx] ·[x2x]
Protein Ile α (dd) 0.047 0.012 0.058 0.013 0.085 0.014 OAA p /Pyrp [ 12 xx] ·[x2x]
Protein Ile γ1(s) 0.693 0.022 0.660 0.032 0.695 0.022 Pyrp/OAA p [x2x]·[xx 3 4]
Protein Ile γ1(d) 0.307 0.022 0.340 0.032 0.305 0.022 Pyrp/OAA p [x2x]·[xx 3 4]  + [x2x]·[xx 34 ]
Protein Ile γ1(t) 0.000 0.022 0.000 0.000 0.000 0.022 Pyrp/OAA p [x2x]·[xx 34 ]
Protein Ile δ (s) 0.783 0.012 0.732 0.007 0.764 0.012 OAAp [xx34]
Protein Ile δ (d) 0.218 0.012 0.268 0.007 0.237 0.012 OAAp [xx34]
Protein Met γ (s) 0.773 0.020 0.730 0.033 0.759 0.030 OAAp [xx34]
Protein Met γ (d) 0.227 0.020 0.270 0.033 0.241 0.030 OAAp [xx34]
Protein Thr α (s) 0.494 0.010 0.403 0.050 0.393 0.015 OAAp [123x]
Protein Thr α (d1) 0.129 0.010 0.122 0.050 0.111 0.015 OAAp [123x]
Protein Thr α (d2) 0.212 0.010 0.225 0.050 0.199 0.015 OAAp [123x]
Evans Set 2 TP1 Evans Set 3 TP1MM *
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Hydroly- Cross peak
sate (multiplet) Intensity SD Intensity SD Intensity SD Precursor Isotopomer
Protein Thr α (dd) 0.165 0.010 0.250 0.050 0.296 0.015 OAAp [123x]
Protein Thr γ2 (s) 0.736 0.004 0.709 0.006 0.719 0.004 OAAp [xx34]
Protein Thr γ2 (d) 0.264 0.004 0.291 0.006 0.281 0.004 OAAp [xx34]
Protein Lys γ (s) 0.688 0.017 0.655 0.023 0.638 0.017 OAA p /Pyrp [xx3 4 ] ·[xx3]
Protein Lys γ (d) 0.310 0.017 0.345 0.023 0.268 0.017 OAA p /Pyrp [xx 34 ] ·[xx3] + [xx3 4 ]·[xx 3 ]
Protein Lys γ (t) 0.000 0.017 0.000 0.000 0.094 0.017 OAA p /Pyrp [xx 34 ] ·[xx3]
Protein Lys β (s) 0.356 0.011 0.235 0.013 0.314 0.011 OAA p /Pyrp ½{[x2 3 4]  + [x23]·[xxx4] }
Protein Lys β (d) 0.598 0.011 0.660 0.013 0.616 0.011 OAA p /Pyrp ½{[x 23 4]  + [x2 34 ] +
OAA p /Pyrp  [x23]·[xxx4]  + [x23]·[xxx 4 ] }
Protein Lys β (t) 0.047 0.011 0.106 0.013 0.070 0.011 OAA p /Pyrp ½{[x 234 ]  + [x23]·[xxx 4 ] }
Protein Lys δ (s) 0.340 0.012 0.250 0.008 0.295 0.012 OAA p /Pyrp ½{[x2 3 4]  + [x23]·[xxx4] }
Protein Lys δ (d) 0.567 0.012 0.642 0.008 0.612 0.012 OAA p /Pyrp ½{[x 23 4]  + [x2 34 ]  +
 [x23]·[xxx4] + [x23]·[xxx 4 ] }
Protein Lys δ (t) 0.093 0.012 0.108 0.008 0.093 0.012 OAA p /Pyrp ½{[x 234 ]  + [x23]·[xxx 4 ] }
Protein Lys ε (s) 0.406 0.005 0.318 0.005 0.389 0.005 OAA p /Pyrp ½{[x23] + [x 2 3x] }
Protein Lys ε (d) 0.594 0.005 0.682 0.005 0.611 0.005 OAA p /Pyrp ½{[x23] + [x 23 x] }
Protein HMF 1 (s) 0.227 0.030 0.271 0.010 0.166 0.030 G6Pc/F6Pc [12xxxx]
Protein HMF 1 (d) 0.774 0.030 0.729 0.010 0.834 0.030 G6Pc/F6Pc [12xxxx]
Protein LVA 3 (s) 0.291 0.007 0.207 0.005 0.178 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 3 (d1) 0.048 0.007 0.085 0.005 0.037 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 3 (d2) 0.032 0.007 0.029 0.005 0.000 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 3 (dd) 0.630 0.007 0.678 0.005 0.785 0.007 G6Pc/F6Pc [x234xx]
Protein LVA 6 (s) 0.156 0.007 0.132 0.005 0.093 0.007 G6Pc/F6Pc [xxx456]
Protein LVA 6 (d1) 0.028 0.007 0.000 0.005 0.000 0.007 G6Pc/F6Pc [xxx456]
Protein LVA 6 (d2) 0.059 0.007 0.020 0.005 0.041 0.007 G6Pc/F6Pc [xxx456]
Protein LVA 6 (dd) 0.758 0.007 0.848 0.005 0.866 0.007 G6Pc/F6Pc [xxx456]
Starch HMF 1 (s) 0.377 0.015 0.348 0.010 0.409 0.027 G6Pp [12xxxx]
Starch HMF 1 (d) 0.623 0.015 0.653 0.010 0.591 0.027 G6Pp [12xxxx]
Evans Set 2 TP1 Evans Set 3 TP1MM *
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Hydroly- Cross peak
sate (multiplet) Intensity SD Intensity SD Intensity SD Precursor Isotopomer
Starch LVA 3 (s) 0.503 0.007 0.459 0.005 0.399 0.007 G6Pp [x234xx]
Starch LVA 3 (d1) 0.231 0.007 0.245 0.005 0.220 0.007 G6Pp [x234xx]
Starch LVA 3 (d2) 0.072 0.007 0.050 0.005 0.053 0.007 G6Pp [x234xx]
Starch LVA 3 (dd) 0.194 0.007 0.245 0.005 0.327 0.007 G6Pp [x234xx]
Starch LVA 6 (s) 0.243 0.007 0.167 0.005 0.249 0.010 G6Pp [xxx456]
Starch LVA 6 (d1) 0.002 0.007 0.139 0.005 0.000 0.010 G6Pp [xxx456]
Starch LVA 6 (d2) 0.128 0.007 0.029 0.005 0.120 0.010 G6Pp [xxx456]
Starch LVA 6 (dd) 0.627 0.007 0.665 0.005 0.631 0.010 G6Pp [xxx456]
Evans Set 2 TP1 Evans Set 3 TP1MM *
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